[go: up one dir, main page]

WO2025126830A1 - N-substituted oxy-2-aminothiazolecarboxamide compound or salt thereof and agricultural and horticultural bactericide - Google Patents

N-substituted oxy-2-aminothiazolecarboxamide compound or salt thereof and agricultural and horticultural bactericide Download PDF

Info

Publication number
WO2025126830A1
WO2025126830A1 PCT/JP2024/041728 JP2024041728W WO2025126830A1 WO 2025126830 A1 WO2025126830 A1 WO 2025126830A1 JP 2024041728 W JP2024041728 W JP 2024041728W WO 2025126830 A1 WO2025126830 A1 WO 2025126830A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
reaction
salt
caused
aminothiazolecarboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/JP2024/041728
Other languages
French (fr)
Japanese (ja)
Inventor
拓也 岩本
博之 林
久樹 田中
将也 大野
和香奈 ▲瀬▼沼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ishihara Sangyo Kaisha Ltd
Original Assignee
Ishihara Sangyo Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ishihara Sangyo Kaisha Ltd filed Critical Ishihara Sangyo Kaisha Ltd
Publication of WO2025126830A1 publication Critical patent/WO2025126830A1/en
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/781,3-Thiazoles; Hydrogenated 1,3-thiazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00Fungicides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Definitions

  • the present invention relates to novel N-substituted oxy-2-aminothiazolecarboxamide compounds or salts thereof, and agricultural and horticultural fungicides containing them as active ingredients.
  • Patent Document 1 describes N-cycloalkyl-carboxamides, N-cycloalkyl-thiocarboxamides, and N-cycloalkyl-N-substituted carboximidamide derivatives, as well as methods for controlling phytopathogenic fungi using these compounds or compositions.
  • this document does not disclose any N-substituted oxy-2-aminothiazolecarboxamide compounds of formula (I) described below.
  • the objective of the present invention is to provide a new compound that exhibits excellent control effects against harmful plant diseases.
  • R2 is ( C1 - C3 ) alkyl;
  • X 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, cyano or a hydrogen atom;
  • Y 1 , Y 2 , Y 3 and Y 4 each independently represent a halogen atom, a hydrogen atom, a (C 1 -C 6 ) alkyl, a (C 2 -C 6 ) alkenyl, a (C 1 -C 6 ) haloalkyl, cyano, or nitro, or a salt thereof (hereinafter also referred to as compound (I)).
  • Y 1 and Y 4 are each independently a halogen atom, a hydrogen atom, a (C 1 -C 6 ) alkyl, a (C 1 -C 6 ) haloalkyl, a cyano, or a nitro, provided that Y 1 and Y 4 are not both a hydrogen atom;
  • the N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of the above [1] to [3], wherein Y2 and Y3 are each independently a halogen or a hydrogen atom.
  • R 1 is a (C 1 -C 6 ) chain hydrocarbon
  • X 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, or a hydrogen atom
  • Y 1 , Y 2 , Y 3 and Y 4 are each independently halogen, a hydrogen atom, a (C 1 -C 6 ) alkyl, a (C 1 -C 6 ) haloalkyl, or nitro.
  • Y 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, or nitro;
  • a method for controlling harmful plant diseases comprising applying an effective amount of the N-substituted oxy-2-aminothiazolecarboxamide compound or its salt described in any one of [1] to [8] above to a plant body, a plant pathogen, or soil.
  • Compound (I) of the present invention exhibits excellent control effects against harmful plant diseases and is useful as an agricultural and horticultural fungicide.
  • the halogen or the halogen as a substituent may be a fluorine, chlorine, bromine, or iodine atom.
  • the number of halogen as a substituent may be one or more than one, and when there are two or more, the halogen atoms may be the same or different.
  • the substitution position of the halogen as a substituent may be any position.
  • C P -C T means that the number of carbon atoms is P to T.
  • C 1 -C 6 means that the number of carbon atoms is 1 to 6.
  • the expression “optionally substituted” means that the compound has a substituent or is unsubstituted.
  • Acyclic hydrocarbon means (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkynyl, or (C 2 -C 6 ) alkenyl.
  • (C 1 -C 6 ) alkyl represents a straight or branched alkyl group having 1 to 6 carbon atoms, for example, methyl, ethyl, normal propyl, isopropyl, normal butyl, isobutyl, secondary butyl, tertiary butyl, normal pentyl, isopentyl, neopentyl, secondary pentyl, tertiary pentyl, 2-methylbutyl, 3-pentyl, normal hexyl, isohexyl, secondary hexyl, 2-methylpentyl, 3-methylpentyl, 3-hexyl, 2-ethylbutyl, 3-methylpentan-2-yl, 4-methylpentan-2-yl, 2,3-dimethylbutyl, tertiary hexyl, 2,2-dimethylbutyl, neohexyl, 3-methylpentan-3-yl, 2-methylpentan-3
  • (C 1 -C 3 ) alkyl represents a linear or branched alkyl group having 1 to 3 carbon atoms, and specific examples thereof include the alkyl groups having 1 to 3 carbon atoms among the specific examples of (C 1 -C 6 ) alkyl mentioned above.
  • (C 2 -C 6 )alkynyl represents a straight or branched alkynyl group having 2 to 6 carbon atoms and at least one triple bond at any position, such as ethynyl, 1-propynyl, propargyl (also simply referred to as 2-propynyl), 1-butynyl, 2-butynyl, 3-butynyl, 3-butyn-2-yl, 1,3-butadiynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 3-methyl-1-butynyl, 3-pentyn-2-yl, 1-pentyn-3-yl, 4-pentyn-2-yl, 2-methyl-3-butynyl, 1,3-pentadiynyl, 1,4-pentadiynyl, 2,4-pentadiynyl, 1-hexynyl, 2
  • (C 2 -C 3 )alkynyl represents a linear alkynyl group having one triple bond at any position and having 2 to 3 carbon atoms, and specific examples thereof include alkynyl groups having 2 to 3 carbon atoms among the specific examples of (C 2 -C 6 )alkynyl mentioned above.
  • (C 2 -C 6 )alkenyl represents a straight or branched alkenyl group having from 2 to 6 carbon atoms with at least one double bond at any position.
  • vinyl also simply referred to as ethenyl
  • allyl also simply referred to as 2-propenyl
  • 1-propenyl isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 2-buten-2-yl, 3-buten-2-yl, 2-methyl-1-propenyl, 2-methyl-2-propenyl, 3-buten-3-yl, 1,3-butadienyl, 1,3-butadien-2-yl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 3-methyl-1-butenyl, 2-methyl-1-butenyl, 2-penten-1-yl, 3-methyl-2-buten-2-yl, 3-methyl-2-butenyl, 2-methyl-2-butenyl, 3-penten
  • the (C 1 -C 6 ) chain hydrocarbon may be substituted with at least one T 1.
  • the (C 1 -C 6 ) chain hydrocarbon may be substituted with 1 to 13 T 1 .
  • the substitution position of T 1 may be any substitution position on the (C 1 -C 6 ) chain hydrocarbon.
  • each T 1 may be the same or different.
  • R 1 in compound (I) is a (C 1 -C 6 ) alkyl substituted with at least one T 1
  • specific examples include the following substituents: cyanomethyl, 2-cyanoethyl, 3-cyanopropyl, 4-cyanobutyl, 5-cyanopentyl, 6-cyanohexyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, propoxycarbonylmethyl, 2-(methoxycarbonyl)ethyl, isopropoxycarbonylmethyl, and the like.
  • (C 1 -C 6 )haloalkyl represents a linear or branched alkyl group having 1 to 6 carbon atoms, which is partially or fully substituted by 1 to 13 identical or different halogen atoms, such as fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, bromomethyl, dibromomethyl, tribromomethyl, chlorodifluoromethyl, dichlorofluoromethyl, chlorofluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 1,1-difluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, perfluoroethyl, 1-chloroethyl, 2-chloroethyl, 1,1-dichloroethyl, 2,2-dichloroethyl, 2,2,2-trichloroethyl, 1-chloro-1
  • (C 1 -C 3 )haloalkyl represents a straight or branched alkyl group having 1 to 3 carbon atoms, which is partially or completely substituted with 1 to 7 identical or different halogen atoms.
  • Specific examples of (C 1 -C 3 )haloalkyl include haloalkyl groups having 1 to 3 carbon atoms among the specific examples of (C 1 -C 6 )haloalkyl mentioned above.
  • Salts of compound (I) include any salts that are agriculturally acceptable, such as alkali metal salts (e.g., sodium salt, potassium salt, etc.), alkaline earth metal salts (e.g., magnesium salt, calcium salt, etc.), amine salts (dimethylamine salt, triethylamine salt, etc.), inorganic acid salts (e.g., hydrochloride, perchlorate, sulfate, nitrate, etc.), or organic acid salts (e.g., acetate, methanesulfonate, paratoluenesulfonate, oxalate, etc.).
  • alkali metal salts e.g., sodium salt, potassium salt, etc.
  • alkaline earth metal salts e.g., magnesium salt, calcium salt, etc.
  • amine salts dimethylamine salt, triethylamine salt, etc.
  • inorganic acid salts e.g., hydrochloride, perchlorate
  • Compound (I) exists in various isomers, such as optical isomers and geometric isomers, and the present invention may include both each isomer and a mixture of isomers.
  • Compound (I) also includes various isomers other than those mentioned above, within the scope of common technical knowledge in the relevant technical field. Furthermore, various isomers can be produced separately using common technical knowledge in the relevant technical field and general experimental techniques.
  • compound (I) can be produced according to the following reactions A to E and a conventional method for producing a salt, but the method for obtaining the compound is not limited to these methods.
  • compound (I) of the present invention can also be produced by applying various substituent conversion reactions well known in the art (e.g., alkylation reaction, haloalkylation reaction, cross-coupling reaction such as Suzuki coupling reaction, Sandmeyer type reaction, halogenation reaction, oxidation reaction, reduction reaction, etc.) to the substituent on the pyridine ring.
  • substituent conversion reactions well known in the art
  • protection and deprotection reactions commonly used in the art may be applied in the production of the compound of the present invention, if necessary.
  • it may be carried out under an inert gas atmosphere such as nitrogen or argon, if necessary, and a salt reagent may be used.
  • Reaction A is a deprotection reaction, in which the Boc group is removed from the compound of formula (XX-a) to obtain the compound of formula (I), where the Boc group is a tert-butoxycarbonyl group.
  • Reaction A can be carried out under known conditions used to remove the Boc group, for example, the method described in Greene's PROTECTIVE GROUPS in ORGANIC SYNTHESIS (John Wiley and Sons, 2007, Peter G.M. Wuts, Theodora W. Greene). More specifically, for example, it can be carried out by reacting with an acid such as trifluoroacetic acid or hydrogen chloride in the presence of a solvent, or by reacting with trimethylsilyl triflate in the presence of a solvent and a base such as 2,6-lutidine.
  • an acid such as trifluoroacetic acid or hydrogen chloride
  • trimethylsilyl triflate in the presence of a solvent and a base such as 2,6-lutidine.
  • Reaction B is a method of reacting a compound of formula (II) with a compound of formula (III) to obtain a compound of formula (XX-b).
  • Reaction C is a method of reacting a compound of formula (II-a) with a compound of formula (III) to obtain a compound of formula (XX-b).
  • R 1a is H or a (C 1 -C 6 ) chain hydrocarbon optionally substituted with at least one T 1
  • L is a leaving group such as halogen, alkoxy, aryloxy, alkylcarbonyloxy, arylcarbonyloxy, etc.
  • the other symbols are as defined above.
  • Reaction B can usually be carried out in the presence of a dehydrating condensation agent and a solvent, with the addition of a base as necessary.
  • the compound of formula (III) in reaction B can be used in an amount of 0.5 to 3 equivalents, preferably 0.8 to 1.5 equivalents, per equivalent of the compound of formula (II) (the equivalent is a molar equivalent, and the same applies below).
  • the dehydration condensation agent in reaction B is a carbodiimide-based condensation agent such as N,N'-dicyclohexylcarbodiimide (DCC), 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (EDC) or its hydrochloride; an imidazole-based condensation agent such as 1,1'-carbonyldiimidazole (CDI); a triazine-based condensation agent such as 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMT-MM); a 1H-benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (P
  • suitable dehydrating condensing agents include, but are not limited to, phosphonium condensing agents such as 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyr
  • dehydrating condensing agents such as 1-hydroxybenzotriazole (HOBt) may be added.
  • the dehydration condensation agent can be used in an amount of 0.5 to 5 equivalents, preferably 1 to 2 equivalents, per equivalent of the compound of formula (II), and the additive can be used in an amount of 0.2 to 5 equivalents, preferably 1 to 2 equivalents, per equivalent of the compound of formula (II).
  • the base in reaction B may be one or more of the following, selected appropriately from carbonates such as sodium carbonate, potassium carbonate, and cesium carbonate; hydrogen carbonates such as sodium hydrogen carbonate and potassium hydrogen carbonate; metal hydroxides such as sodium hydroxide and potassium hydroxide; metal hydrides such as sodium hydride and potassium hydride; amines such as triethylamine and N,N-diisopropylethylamine; pyridines such as pyridine, 4-dimethylaminopyridine, and 2,6-lutidine; and alkali metal carboxylates such as sodium acetate and potassium acetate.
  • the base may be used in an amount of 0.5 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (II).
  • the solvent in reaction B may be any solvent that is inert to the reaction, and may be selected from one or more of the following: aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; aliphatic hydrocarbons such as carbon tetrachloride, methyl chloride, chloroform, dichloromethane, dichloroethane, trichloroethane, hexane, and cyclohexane; ethers such as dioxane, tetrahydrofuran, diethyl ether, and dimethoxyethane; esters such as methyl acetate and ethyl acetate; aprotic polar solvents such as dimethyl sulfoxide, sulfolane, N,N-dimethylacetamide, N,N-dimethylformamide, N-methylpyrrolidone, pyridine, acetonitrile, and propionitrile; ketones such as
  • the reaction temperature for reaction B is usually about -20°C to 150°C, preferably about 0°C to 100°C, and the reaction time is usually about 0.5 to 48 hours, preferably about 1 to 24 hours.
  • Reaction C can be carried out in the presence of a solvent, optionally with the addition of a base.
  • the compound of formula (III) can be used in an amount of 0.5 to 3 equivalents, preferably 0.8 to 1.5 equivalents, per equivalent of the compound of formula (II-a).
  • the base in reaction C may be one or more of the following, selected appropriately from carbonates such as sodium carbonate, potassium carbonate, and cesium carbonate; hydrogen carbonates such as sodium hydrogen carbonate and potassium hydrogen carbonate; metal hydroxides such as sodium hydroxide and potassium hydroxide; metal hydrides such as sodium hydride and potassium hydride; amines such as triethylamine and N,N-diisopropylethylamine; pyridines such as pyridine, 4-dimethylaminopyridine, and 2,6-lutidine; and alkali metal carboxylates such as sodium acetate and potassium acetate.
  • the base may be used in an amount of 0.1 to 10 equivalents, preferably 0.5 to 5 equivalents, per equivalent of the compound of formula (II-a).
  • the solvent in reaction C may be any solvent that is inert to the reaction, and may be selected from one or more of the following: aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; aliphatic hydrocarbons such as carbon tetrachloride, methyl chloride, chloroform, dichloromethane, dichloroethane, trichloroethane, hexane, and cyclohexane; ethers such as dioxane, tetrahydrofuran, diethyl ether, and dimethoxyethane; esters such as methyl acetate and ethyl acetate; aprotic polar solvents such as dimethyl sulfoxide, sulfolane, N,N-dimethylacetamide, N,N-dimethylformamide, N-methylpyrrolidone, pyridine, acetonitrile, and propionitrile; ketones such as
  • the reaction temperature for reaction C is usually about -20°C to 150°C, preferably about 0°C to 100°C, and the reaction time is usually about 0.5 to 48 hours, preferably about 1 to 24 hours.
  • the compound of formula (III) used in reaction B and reaction C can be prepared according to the following reaction 2-2 or reaction 2-4.
  • the compound of formula (II) used in reaction B can be produced in accordance with the following reaction 1-1 or 1-2 or a known method, or a commercially available product may be used.
  • the compound of formula (II-a) used in reaction C can be produced from the compound of formula (II) according to the following reaction 1-4 or a known method, or a commercially available product may be used.
  • Reaction D is a method of obtaining a compound of formula (XX-a) by reacting a compound of formula (XX-c) with a compound of formula (IV).
  • L 1 is a leaving group such as halogen, trifluoromethanesulfonyloxy, methanesulfonyloxy, paratoluenesulfonyloxy, etc., and the other symbols are as defined above.
  • Reaction D can be carried out usually in the presence of a base and a solvent, with the addition of a phase transfer catalyst as necessary.
  • the compound of formula (IV) in reaction D can be used in an amount of 1 to 5 equivalents, preferably 1 to 3 equivalents, per equivalent of the compound of formula (XX-c).
  • the base in reaction D may be one or more of the following, selected appropriately and mixed: alkali metal alkoxides such as sodium methoxide, sodium ethoxide, and potassium tert-butoxide; carbonates such as sodium carbonate, potassium carbonate, and cesium carbonate; hydrogen carbonates such as sodium hydrogen carbonate and potassium hydrogen carbonate; metal hydroxides such as sodium hydroxide and potassium hydroxide; metal hydrides such as sodium hydride and potassium hydride; amines such as triethylamine and N,N-diisopropylethylamine; pyridines such as pyridine, 4-dimethylaminopyridine, and 2,6-lutidine; organolithium compounds such as n-butyllithium and lithium diisopropylamide; alkali metal carboxylates such as sodium acetate and potassium acetate; etc.
  • the base may be used in an amount of 1 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (
  • the solvent in reaction D may be any solvent inert to the reaction, and may be one or more of the following: aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; aliphatic hydrocarbons such as carbon tetrachloride, methyl chloride, chloroform, dichloromethane, dichloroethane, trichloroethane, hexane, and cyclohexane; ethers such as dioxane, tetrahydrofuran, diethyl ether, and dimethoxyethane; esters such as methyl acetate and ethyl acetate; alcohols such as methanol, ethanol, propanol, and tert-butanol; aprotic polar solvents such as dimethyl sulfoxide, sulfolane, N,N-dimethylacetamide, N,N-dimethylformamide, N-methylpyrrolidone
  • the phase transfer catalyst in reaction D may be, for example, a quaternary ammonium salt such as tetrabutylammonium bromide, benzyltriethylammonium chloride, or tetrabutylammonium hydrogen sulfate; or a crown ether such as 18-crown-6-ether; etc.
  • the phase transfer catalyst may be used in an amount of 0.1 to 3 equivalents per equivalent of the compound of formula (XX-c).
  • the reaction temperature for reaction D is usually about -20°C to 150°C, preferably about 0°C to 100°C, and the reaction time is usually about 10 minutes to 48 hours, preferably about 1 to 24 hours.
  • the compound of formula (IV) used in reaction D can be produced according to known methods, or a commercially available product may be used.
  • Reaction E is a method of obtaining a compound of formula (XX-a) by reacting a compound of formula (II-b) with a compound of formula (V).
  • Reaction E can be carried out in the same manner as reaction D above.
  • 1 to 5 equivalents, preferably 1 to 2 equivalents, of the compound of formula (V) can be used per equivalent of the compound of formula (II-b).
  • 1 to 10 equivalents, preferably 1 to 5 equivalents, of the base can be used per equivalent of the compound of formula (II-b).
  • 0.1 to 3 equivalents of the phase transfer catalyst can be used per equivalent of the compound of formula (II-b).
  • the compound of formula (II-b) used in reaction E can be produced in accordance with reaction 1-3 below or a known method, or a commercially available product may be used.
  • the compound of formula (V) used in reaction E can be produced in accordance with reaction 2-7, reaction 2-8, reaction 2-9 below or a known method, or a commercially available product may be used.
  • reactions A to E can be produced according to the methods for producing the intermediates shown below (reactions 1-1 to 1-5 and reactions 2-1 to 2-9) and the usual methods for producing salts, but are not limited to these methods. These compounds may be produced according to known methods or commercially available products may be used.
  • Reaction 1-1 is a method for obtaining a compound of formula (II) by oxidizing a compound of formula (1)
  • reaction 1-2 is a method for obtaining a compound of formula (II) by hydrolyzing a compound of formula (2).
  • Reaction 1-3 is a method of reacting a compound of formula (II) or a compound of formula (II-a) with a compound of formula (3) to obtain a compound of formula (II-b).
  • Reaction 1-4 is a method for obtaining a compound of formula (II-a) by halogenating, esterifying or carbonylating a compound of formula (II).
  • Reaction 1-5 is a method for protecting the amino group of a compound of formula (VI) with a Boc group to obtain a compound of formula (VII).
  • Reaction 1-1 can be carried out under general Pinnic oxidation conditions, for example, according to the method described in Bioorganic & Medicinal Chemistry, 2004, 12, 6171-6182.
  • the compound of formula (1) used in reaction 1-1 can be produced according to a known method, for example, the method described in Bioorganic & Medicinal Chemistry, 2004, 12, 6171-6182, Journal of Organic Chemistry, 2005, 70, 567-574, International Publication No. 2020/028141, or Organic Process Research and Development, 2021, 25, 1167-1175, or reaction 1-5, or a commercially available product may be used.
  • Reaction 1-2 can be carried out under general ester hydrolysis conditions, for example, in accordance with the method described in WO 2009/100171.
  • the compound of formula (2) used in reaction 1-2 can be produced according to known methods, such as those described in International Publication No. 2012/006760, Japanese Patent Registration No. 5851663, or the method described in reaction 1-5, or a commercially available product may be used.
  • Reaction 1-3 can be carried out in accordance with the above reaction B or reaction C.
  • the compound of formula (3) can be used in an amount of 0.5 to 10 equivalents, preferably 0.7 to 5 equivalents, per equivalent of the compound of formula (II) or the compound of formula (II-a).
  • the compound of formula (3) used in reaction 1-3 can be produced in accordance with known methods, for example, the methods described in WO 2006/138350 and U.S. Patent Application Publication No. 2014/0378399, or a commercially available product may be used.
  • the compound of formula (II-a) used in reaction 1-3 can be produced by a known method or according to the method described in reaction 1-4, or a commercially available product may be used.
  • reaction 1-4 can usually be carried out by reacting the compound of formula (II) with a halogenating agent in the presence of a solvent, and N,N-dimethylformamide may be added as necessary.
  • a halogenating agent in reaction 1-4 include oxalyl chloride, thionyl chloride, phosphorus oxychloride, phosphorus oxybromide, phosphorus trichloride, phosphorus tribromide, phosphorus pentachloride, sulfuryl chloride, etc.
  • the halogenating agent can be used in an amount of 1 to 10 equivalents, preferably 1 to 3 equivalents, relative to 1 equivalent of the compound of formula (II), and an excess amount may be used if no problem occurs in the reaction.
  • the amount of N,N-dimethylformamide used in reaction 1-4 is a catalytic amount, for example, 0.01 to 0.3 equivalents per equivalent of the compound of formula (II).
  • the compound of formula (II) when L of the compound of formula (II-a) is alkoxy or aryloxy, the compound of formula (II) can be reacted with an alcohol or an arylhydroxyl group usually in the presence of a solvent and a dehydration condensing agent, with the addition of a base as necessary, to carry out esterification.
  • the alcohols in reaction 1-4 include methanol, ethanol, etc.
  • the aryl hydroxyl compounds in reaction 1-4 include phenol, etc.
  • the alcohols or aryl hydroxyl compounds can be used in an amount of 0.5 to 5 equivalents, preferably 0.8 to 1.5 equivalents, per equivalent of the compound of formula (II), and an excess amount may be used if no problem occurs in the reaction.
  • the dehydration condensation agent in reaction 1-4 As the dehydration condensation agent in reaction 1-4, those listed in reaction B above can be used.
  • a general additive e.g., 1-hydroxybenzotriazole (HOBt) or the like
  • the dehydration condensation agent can be used in an amount of 0.5 to 5 equivalents, preferably 1 to 2 equivalents, relative to 1 equivalent of the compound of formula (II), and the additive can be used in an amount of 0.2 to 5 equivalents, preferably 1 to 2 equivalents, relative to 1 equivalent of the compound of formula (II).
  • a base When a base is used together with the dehydration condensation agent in reaction 1-4, those listed in reaction B above can be used.
  • the base can be used in an amount of 0.5 to 10 equivalents, preferably 1 to 5 equivalents, relative to 1 equivalent of the compound of formula (II).
  • the compound of formula (II) when L in the compound of formula (II-a) is alkoxy, the compound of formula (II) can be reacted with an alkyl halide in the presence of a solvent and a base to carry out esterification.
  • the alkyl halide in the reaction 1-4 include methyl iodide, ethyl iodide, etc.
  • the alkyl halide can be used in an amount of 0.5 to 5 equivalents, preferably 0.8 to 1.5 equivalents, per equivalent of the compound of the formula (II).
  • the base that can be used in the reaction with the alkyl halide in Reaction 1-4 is the same as that mentioned in Reaction D.
  • the base can be used in an amount of 0.5 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (II).
  • reaction 1-4 when L of the compound of formula (II-a) is alkylcarbonyloxy or arylcarbonyloxy, the compound of formula (II) can be reacted with a carbonylating agent usually in the presence of a solvent and a base to carry out carbonylation.
  • a carbonylating agent in reaction 1-4 include acetyl chloride, pivaloyl chloride, benzoyl chloride, acetic anhydride, and benzoic anhydride.
  • the carbonylating agent can be used in an amount of 0.5 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (II), and an excess amount may be used if no problem occurs in the reaction.
  • the bases listed in reaction B above can be used.
  • the base can be used in an amount of 0.5 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (II).
  • the solvent in reaction 1-4 may be any solvent inert to the reaction, and may be one or more of the following: aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; aliphatic hydrocarbons such as carbon tetrachloride, methyl chloride, chloroform, dichloromethane, dichloroethane, trichloroethane, hexane, and cyclohexane; ethers such as dioxane, tetrahydrofuran, diethyl ether, and dimethoxyethane; esters such as methyl acetate and ethyl acetate; aprotic polar solvents such as dimethyl sulfoxide, sulfolane, N,N-dimethylacetamide, N,N-dimethylformamide, N-methylpyrrolidone, pyridine, acetonitrile, and propionitrile; ketones such as acetone
  • the reaction temperature in Reaction 1-4 is usually about -50°C to 200°C, preferably about -20°C to 100°C, and the reaction time is usually about 0.1 to 12 hours.
  • the compound of formula (II) used in reactions 1-3 and 1-4 can be produced in accordance with reactions 1-1 and 1-2, or known methods, or a commercially available product may be used.
  • Reactions 1-5 can be carried out according to typical reaction conditions for protecting an amino group with a Boc group, for example, the method described in Greene's PROTECTIVE GROUPS in ORGANIC SYNTHESIS (John Weekey and Sons, 2007, Peter G. M. Wuts, Theodora W. Greene).
  • the compound of formula (VI) used in reaction 1-5 can be produced in accordance with known methods, such as those described in International Publication No. 2018/041563 and U.S. Patent Application Publication No. 2008/312255, or a commercially available product may be used.
  • Reaction 2-1 is a method of reacting a compound of formula (10) with a compound of formula (3-a) to obtain a compound of formula (11).
  • Reaction 2-2 is a method of reducing the compound of formula (11) to obtain a compound of formula (III).
  • Reactions 2-1 and 2-2 can be carried out consecutively without isolating the compound of formula (11).
  • Reaction 2-3 is a method for obtaining a compound of formula (11-b) by reacting a compound of formula (11-a) with a compound of formula (IV).
  • Reaction 2-4 is a method for obtaining a compound of formula (III) by reacting a compound of formula (V) with a compound of formula (3-a).
  • Reaction 2-5 is a method for obtaining a compound of formula (10) from a compound of formula (12) using a hydride reducing agent.
  • Reaction 2-6 is a method for obtaining a compound of formula (13) by reducing a compound of formula (10).
  • Reaction 2-7 is a method for obtaining a compound of formula (V) from a compound of formula (13) using a halogenating agent or a sulfonylating agent.
  • Reaction 2-8 is a method for obtaining a compound of formula (V-b) from a compound of formula (V-a) using a halogenating agent, and
  • Reaction 2-9 is a method for obtaining a compound of formula (V-b) from a compound of formula (14) using a halogenating agent.
  • L 2 in the formula is a leaving group such as trifluoromethanesulfonyloxy, methanesulfonyloxy, paratoluenesulfonyloxy, etc.
  • L 3 is a halogen, and the other symbols are as defined above.
  • Reaction 2-1 can be carried out by adding an acid, a base or a dehydrating agent as necessary. Reaction 2-1 can also be carried out in the presence of a solvent.
  • the compound of formula (3-a) in reaction 2-1 can be used in an amount of 1 to 5 equivalents per equivalent of the compound of formula (10), and an excess amount can be used if there are no problems with the reaction.
  • the compound of formula (3-a) in reaction 2-1 can be a salt of the compound of formula (3-a) (e.g., hydrochloride, sulfate, or trifluoroacetate).
  • the acid in reaction 2-1 may be either an inorganic acid or an organic acid, and examples of the inorganic acid include hydrochloric acid, sulfuric acid, etc., and examples of the organic acid include acetic acid, methanesulfonic acid, paratoluenesulfonic acid, etc.
  • the acid may be used in an amount of 0.1 to 10 equivalents relative to 1 equivalent of the compound of formula (10), and an excess amount may be used if no problem occurs in the reaction.
  • Examples of the base in reaction 2-1 include alkali metal alkoxides such as sodium methoxide, sodium ethoxide, and potassium tert-butoxide; carbonates such as sodium carbonate and potassium carbonate; hydrogen carbonates such as sodium hydrogen carbonate and potassium hydrogen carbonate; metal hydroxides such as sodium hydroxide and potassium hydroxide; metal hydrides such as sodium hydride and potassium hydride; amines such as triethylamine and N,N-diisopropylethylamine; pyridines such as pyridine, 4-dimethylaminopyridine, and 2,6-lutidine; alkali metal carboxylates such as sodium acetate and potassium acetate; etc.
  • the base can be used in an amount of 0.5 to 5 equivalents relative to 1 equivalent of the compound of formula (3-a).
  • the dehydrating agent in reaction 2-1 may, for example, be anhydrous magnesium sulfate, anhydrous sodium sulfate, or molecular sieves.
  • the solvent in Reaction 2-1 may be any solvent inert to the reaction, and may be appropriately selected from, for example, one or more of aromatic hydrocarbons such as toluene and xylene; aliphatic hydrocarbons such as carbon tetrachloride, methyl chloride, chloroform, dichloromethane, dichloroethane, trichloroethane, hexane and cyclohexane; ethers such as dioxane, tetrahydrofuran, diethyl ether and dimethoxyethane; esters such as methyl acetate and ethyl acetate; aprotic polar solvents such as acetonitrile; protic polar solvents such as methanol and ethanol; and water.
  • aromatic hydrocarbons such as
  • the reaction temperature for reaction 2-1 is usually about -20°C to 200°C, preferably about 0°C to 150°C, and the reaction time is usually about 0.5 to 48 hours, preferably about 1 to 24 hours.
  • the compound of formula (10) used in reaction 2-1 can be produced according to reaction 2-5 or a known method, or a commercially available product may be used.
  • Reaction 2-2 can usually be carried out in the presence of a reducing agent and a solvent, and can also be carried out by adding an acid if necessary.
  • the reducing agent in reaction 2-2 may be, for example, sodium borohydride, sodium cyanoborohydride, sodium triacetoxyborohydride, or 2-picoline borane complex.
  • the reducing agent may be used in an amount of 0.5 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (11).
  • the acid to be added may be either an inorganic acid or an organic acid, and examples of the inorganic acid include hydrochloric acid, and examples of the organic acid include acetic acid and trifluoroacetic acid.
  • the acid may be used in an amount of 1 to 10 equivalents per equivalent of the compound of formula (11).
  • the solvent in reaction 2-2 may be any solvent that is inert to the reaction, and may be one or more of the following: aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; aliphatic hydrocarbons such as carbon tetrachloride, methyl chloride, chloroform, dichloromethane, dichloroethane, trichloroethane, hexane, and cyclohexane; ethers such as dioxane, tetrahydrofuran, diethyl ether, and dimethoxyethane; esters such as methyl acetate and ethyl acetate; protic polar solvents such as methanol and ethanol; and water.
  • aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene
  • aliphatic hydrocarbons such as carbon tetrachloride, methyl chloride, chloroform,
  • the reaction temperature for reaction 2-2 is usually about -20°C to 150°C, preferably about 0°C to 100°C, and the reaction time is usually about 0.5 to 48 hours, preferably about 1 to 24 hours.
  • Reaction 2-3 can be carried out in accordance with reaction D.
  • the compound of formula (IV) can be used in an amount of 1 to 5 equivalents, preferably 1 to 2 equivalents, per equivalent of the compound of formula (11-a).
  • the base in reaction 2-3 can be used in an amount of 1 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (11-a).
  • the phase transfer catalyst in reaction 2-3 can be used in an amount of 0.1 to 3 equivalents per equivalent of the compound of formula (11-a).
  • the reaction temperature for reaction 2-3 is usually about -20°C to 150°C, preferably about 0°C to 100°C, and the reaction time is usually about 10 minutes to 48 hours, preferably about 1 to 24 hours.
  • Reaction 2-4 can be carried out in accordance with reaction E.
  • the compound of formula (3-a) in reaction 2-4 can be used in an amount of 1 to 5 equivalents, preferably 1 to 3 equivalents, per equivalent of the compound of formula (V).
  • the compound of formula (3-a) in reaction 2-4 can be used in the form of a salt of the compound of formula (3-a) (e.g., hydrochloride, sulfate, or trifluoroacetate).
  • the base in reaction 2-4 can be used in an amount of 1 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (V).
  • the phase transfer catalyst in reaction 2-4 can be used in an amount of 0.1 to 3 equivalents per equivalent of the compound of formula (V).
  • the reaction temperature for reaction 2-4 is usually about -20°C to 150°C, preferably about 0°C to 100°C, and the reaction time is usually about 10 minutes to 48 hours, preferably about 1 to 24 hours.
  • the compound of formula (V) used in reaction 2-4 can be produced in accordance with a known method, the method described in reaction 2-7, reaction 2-8, or reaction 2-9, or a commercially available product can be used.
  • Reaction 2-5 can be carried out under general conditions for converting a cyano group to a formyl group, for example, according to the method described in Journal of Medicinal Chemistry, 2008, 51, 4021-4029.
  • the compound of formula (12) used in reaction 2-5 can be produced according to known methods, or a commercially available product can be used.
  • Reaction 2-6 can be carried out under general conditions for reducing formyl groups, for example, according to the method described in Bioorganic & Medicinal Chemistry Letters, 2012, 22, 901-906.
  • Reaction 2-7 can be carried out, for example, under conditions for halogenating a general hydroxyl group or conditions for sulfonylating a general hydroxyl group.
  • conditions for reaction 2-7 include the methods described in Journal of Medicinal Chemistry, 2003, 46, 453-456 and WO 2020/106307.
  • Reaction 2-8 can be carried out under conditions for halogenating a leaving group such as a general mesyl group, for example, according to the method described in Journal of Medicinal Chemistry, 2010, 53, 8421-8439.
  • the compound of formula (V-a) used in reaction 2-8 can be produced in accordance with reaction 2-7 or a known method, or a commercially available product may be used.
  • Reaction 2-9 can be carried out under general conditions for halogenating pyridylmethyl, for example, according to the method described in Journal of Medicinal Chemistry, 2011, 54, 6106-6116.
  • the target compound in each of the above reactions, can be obtained by carrying out normal post-treatments (solvent removal, neutralization, distillation, washing, extraction, filtration, drying, etc.) after the reaction is completed.
  • the target compound can be isolated by appropriately selecting one or more of these normal post-treatments. If necessary, the target compound can then be purified by normal methods such as column chromatography and recrystallization.
  • Each intermediate produced by the above reactions can also be used as a crude product in the next reaction step without isolation or purification.
  • Compound (I) is useful as an active ingredient of agricultural and horticultural fungicides capable of controlling harmful plant diseases at low doses.
  • Compound (I) can control plant diseases caused by plant pathogens belonging to, for example, Oomycota, Endomyxa, Olpidiomycota, Ascomycota, Basidiomycota, and Blastocladiomycota.
  • compound (I) is particularly effective in controlling plant diseases caused by plant pathogens belonging to Oomycota, Endomyxa, and Olpidiomycota.
  • plant pathogens that belong to the above-mentioned category include the following.
  • Oomycota Plant pathogenic fungi belonging to various classifications such as Albuginales, Anisolopidiales, Lagenidiales, Leptomitales, Myzocytiopsidales, Olpidiopsidales, Peronosporales, Pythiales, Rhipidiales, Saprolegniales, and Sclerosporales.
  • Endomyxa Plant pathogenic fungi belonging to the classifications Haplosporida, Paradiniida, Paramyxida, Gromiida, Phagomyxida, Plasmodiophorida, and Vampyrellida.
  • Olpidiomycota Plant pathogens belonging to classifications such as Olpidiales.
  • Ascomycota Plant pathogenic fungi belonging to various classifications such as Cladosporiales, Diaporthales, Erysiphales, Glomerellales, Helotiales, Hypocreales, Magnaporthales, Mycosphaerellales, Myriangiales, Pleosporales, and Venturiales.
  • Basidiomycota Plant pathogenic fungi belonging to various classes such as Agaricales, Cantharellales, Pucciniales, and Ustilaginales.
  • Blastocladiomycota Examples include those belonging to the classification Physodermatales, etc.
  • plant pathogenic fungi include the following. Potato or tomato phytophthora blight (Phytophthora infestans), fig phytophthora (Phytophthora palmivora), pear or strawberry phytophthora blight (Phytophthora cactorum), wax gourd, pumpkin, bell pepper or chili pepper phytophthora (Phytophthora capsici), tomato gray rot (Phytophthora capsici), eggplant or watermelon brown rot (Phytophthora capsici), citrus brown rot (Phytophthora citricola), adzuki bean stem rot (Phytophthora vignae f. sp.
  • Phytophthora Phytophthora spp. such as Pseudoperonospora cubensis (cucumber, pumpkin, melon, zucchini downy mildew), Pseudoperonospora humuli (hop downy mildew), Plasmopara spp. such as Plasmopara viticola (grape downy mildew), Plasmopara nivea (honeybee downy mildew), Hyaloperonospora spp.
  • Hyaloperonospora brassicae cabbage or Chinese cabbage downy mildew
  • Bremia spp. such as Bremia lactucae (lettuce downy mildew), Pythium graminicola (rice seedling blight), Pythium snow rot (wheat snow rot) Pythium genus fungi such as Pythium aphanidermatum, Pythium zingiberis, and Pythium ultimum var.
  • Aphanomyces genus fungi such as Aphanomyces raphani and Aphanomyces cochlioides
  • Albugo genus fungi such as Albugo macrospora, Albugo wasabiae, and Albugo ipomoeae-aquaticae
  • Peronospora japonica and Peronospora japonica Peronospora genus fungi such as Peronospora manshurica, Peronospora parasitica, Peronospora destructor, Peronospora farinosa f. sp. Spinaciae, and Peronospora belbahrii.
  • Plasmodiophora species such as Plasmodiophora brassicae, which causes clubroot disease of Chinese cabbage, cabbage, cauliflower, turnip, broccoli or turnip; Polymyxa species such as Polymyxa betae, which transmits Beet necrotic yellow vein virus; Spongospora species such as Spongospora subterranea, which causes potato powdery scab; Olpidium species such as Olpidium virulentus, which transmits Mirafiori lettuce bigvein virus.
  • Erysiphe species such as wheat powdery mildew (Erysiphe graminis); Setosphaeria species such as corn leaf spot (Setosphaeria turcica); Sphaerotheca species such as cucumber powdery mildew (Sphaerotheca fuliginea) and strawberry powdery mildew (Sphaerotheca humuli); grape powdery mildew (Un Uncinula species such as Podosphaera leucotricha; Mycosphaerella pinodes, Mycosphaerella pomi, Mycosphaerella musicola, Mycosphaerella necator, Mycosphaerella pinodes, Mycosphaerella pomi, Mycosphaerella musicola, Mycosphaerella pinodes ...
  • Venturia species such as Venturia inaequalis (apple spot) and Venturia nashicola (pear spot); Pyrenophora teres (barley net blotch) and Pyrenophora graminea (barley leaf spot); Pyrenophora fungi such as Sclerotinia sclerotiorum, which causes sclerotinia rot of beans, cucumbers, cabbage, Chinese cabbage, chili peppers, bell peppers and onions; Sclerotinia borealis, which causes snow mould of wheat, Sclerotinia minor, which causes sclerotinia rot of tomato and Sclerotinia trifoliorum, which causes sclerotinia rot of alfalfa.
  • Botryotinia spp. such as Botryotinia arachidis; Cochliobolus spp., such as Cochliobolus miyabeanus; Didymella spp., such as Didymella bryoniae; Gibberella spp., such as Gibberella fujikuroi; Elsinoe spp., such as Elsinoe ampelina and Elsinoe fawcettii; Diaporthe spp., such as Diaporthe citri and Diaporthe sp.; Monilinia mali and Monilinia fructicola; Glomerella such as Glomerella cingulata.
  • Rhizoctonia fungi such as Rhizoctonia solani
  • Ustilago fungi such as Ustilago nuda
  • Puccinia fungi such as Puccinia coronata, Puccinia recondita, and Puccinia striiformis
  • Phakopsora fungi such as Phakopsora pachyrhizi
  • Typhula fungi such as Typhula incarnata or Typhula ishikariensis.
  • Septoria fungi such as Septoria nodorum, Septoria tritici; Botrytis cinerea, Botrytis allii, Botrytis squamosa, Botrytis byssoidea, Botrytis tulipae, Botrytis squam ...
  • rytis fungi Fusarium fungi such as Fusarium graminearum and Fusarium oxysporum; Pyricularia fungi such as Pyricularia oryzae; Cercospora fungi such as Cercospora beticola and Cercospora kakivora; Colletotrichum fungi such as Colletotrichum orbiculare and Colletotrichum coffeeum; fungi of the genus Alternaria, such as Alternaria alternata apple pathotype, Alternaria alternata Japanese pear pathotype, Alternaria solani, Alternaria brassicae, Alternaria brassicicola, Alternaria porri; fungi of the genus Phoma, such as Phoma lingam; fungi of the genus Wheat eye Pseudocercosporella species, such as Pseudocercosporella herpotrichoides; Pseudocercospora species, such as Pseudocercospor
  • Gloeosporium species such as Gloeosporium kaki, which causes anthracnose; Fulvia species such as Fulvia fulva, which causes tomato leaf mold; Corynespora species such as Corynespora cassiicola, which causes brown spot of cucumber; and Physoderma species such as Physoderma maydis, which causes brown spot of corn.
  • compound (I) can control the various plant pathogenic fungi mentioned above, it can preventively or therapeutically control various diseases.
  • compound (I) is effective against various diseases that are problematic in the agricultural and horticultural fields, for example, rice diseases such as seedling damping-off caused by Pythium, rice blast caused by Pyricularia, bakanae disease caused by Fusarium, whole leaf blight caused by Cochliobolus, and sheath blight caused by Rhizoctonia; wheat diseases such as powdery mildew caused by Erysiphe, red mold disease or crown rot caused by Fusarium, rust caused by Puccinia, brown snow mold caused by Pythium, bare smut caused by Ustilago, eyespot disease caused by Pseudocircospora, leaf blight or streaking blight caused by Septoria; and wheat diseases such as red mold disease caused by Fusarium, spot disease caused by Physoderma, rust caused by Puccinia, soot
  • Corn diseases such as southern leaf blight, root rot caused by Pythium, and smut caused by Ustilago; sugarcane diseases such as smut caused by Ustilago, leaf burn caused by Stagonospora, rust caused by Puccinia, top rot caused by Gibberella, sooty mildew caused by Caldariomyces, and leaf blight caused by Pseudocircospora; legume diseases such as powdery mildew caused by Oidium, rust caused by Phakopsora, downy mildew caused by Peronospora, late blight or stem blight caused by Phytophthora, anthracnose caused by Colletotrichum, sclerotinia rot caused by Sclerotinia, gray mold caused by Botrytis, root rot or damping off caused by Fusarium; Diseases of Brassicaceae crops such as downy mildew caused by Spora or Hyaloperonospora, black spot caused by Altern
  • diseases of wheat such as red mold or crown rot caused by Fusarium, anthracnose caused by Colletotrichum, cattail smut caused by Tillettsia, bare smut caused by Ustilago, stripe disease caused by Cephalosporium, and spot blight caused by Septoria; diseases of corn such as southern leaf spot caused by Bipolaris, anthracnose caused by Colletotrichum, and damping-off caused by Fusarium; diseases of rice crops such as red rot caused by Glomerella, black rot caused by Ceratocystis, and downy mildew caused by Sclerospora; purple spot caused by Circospora, downy mildew caused by Peronospora, and downy mildew caused by Fusarium.
  • soybean diseases such as damping-off, ascochyta caused by Septoria fungus, black spot caused by Diaporthe fungus, anthracnose caused by Colletotrichum fungus, and sleeping disease caused by Septogloeum fungus
  • cabbage diseases such as black spot or black sooty mold caused by Alternaria fungus, downy mildew caused by Peronospora fungus, black spot bacterial disease caused by Pseudomonas fungus, black rot caused by Xanthomonas fungus, and root rot caused by Phoma fungus
  • radish diseases such as black spot caused by Alternaria fungus, yellows caused by Fusarium fungus, and black rot caused by Xanthomonas fungus
  • Chinese cabbage diseases such as black spot caused by Alternaria fungus, black rot caused by Xanthomonas fungus, and yellowing disease caused by Verticillium fungus.
  • Brassicaceae crop diseases such as blight; tomato diseases such as ring spot caused by Alternaria, canker caused by Clavibacter, and bacterial spot caused by Xanthomonas; eggplant diseases such as brown spot caused by Alternaria and brown spot caused by Phomopsis; potato diseases such as scab caused by Streptomyces, silver scab caused by Helminthosporium, and powdery scab caused by Spongospora; cucurbit diseases such as black spot caused by Alternaria, bacterial spot caused by Pseudomonas, and bacterial brown spot caused by Xanthomonas; cucurbit diseases such as black spot caused by Alternaria and ash spot caused by Botrytis.
  • Compound (I) can preventively or therapeutically control the various diseases mentioned above. Using the test method described in the Examples below, certain compounds (I) of the present invention can exert excellent preventive or therapeutic control effects at low concentrations (e.g., 100 ppm, 25 ppm, 12.5 ppm, 6.3 ppm, 3.1 ppm, 1.6 ppm, 0.8 ppm, 0.4 ppm, 0.2 ppm, or 0.1 ppm).
  • concentrations e.g., 100 ppm, 25 ppm, 12.5 ppm, 6.3 ppm, 3.1 ppm, 1.6 ppm, 0.8 ppm, 0.4 ppm, 0.2 ppm, or 0.1 ppm.
  • compound (I) has excellent rain resistance, residual activity, and penetrability, so that applying compound (I) to a plant body can control harmful fungi on the above-ground parts of the plant for a certain period of time.
  • an effective amount of compound (I) can be applied to plants, plant pathogens or soil.
  • the above-mentioned effective amount means the application amount of compound (I) at which compound (I) exerts a control effect against various harmful plant diseases.
  • the plant body means above-ground parts of a plant such as trunks, stems, leaves, flowers, spikes, and fruits, underground parts of a plant such as tubers, rhizomes, and roots, as well as seeds, seedlings, and transplants of a plant.
  • the soil means agricultural land such as fields, paddy fields, orchards, and non-agricultural land such as lawns and forests where plants are cultivated.
  • the plants to which compound (I) is applied are not particularly limited as long as they are agriculturally and horticulturally useful, and examples thereof include Gramineae crops (rice, wheat, barley, oats, rye, corn, sugarcane, etc.), Leguminous crops (soybean, kidney bean, adzuki bean, pea, peanut, edamame, alfalfa, etc.), Brassicaceae crops (cabbage, Chinese cabbage, radish, turnip, broccoli, cauliflower, rapeseed, rapeseed, etc.), and the like.
  • Gramineae crops rice, wheat, barley, oats, rye, corn, sugarcane, etc.
  • Leguminous crops soybean, kidney bean, adzuki bean, pea, peanut, edamame, alfalfa, etc.
  • Brassicaceae crops cabbage, Chinese cabbage, radish, turnip, broccoli, cauliflower, rapeseed
  • Asteraceae crops (lettuce, burdock, chrysanthemum, sunflower, etc.), Solanaceae crops (potato, eggplant, tomato, bell pepper, tobacco, chili pepper, etc.), Cucurbitaceae crops (cucumber, pumpkin, melon, watermelon, wax gourd, zucchini, etc.), Amaryllidaceae Allium crops (green onion, Chinese chive, shallot, garlic, onion, scallion, etc.), Umbelliferae crops (celery, carrot, parsley, mitsuba, etc.), Liliaceae crops (lily, tulip, etc.), crops of the Polygonaceae family (buckwheat, etc.), crops of the Convolvulaceae family (sweet potato, water beet, etc.), crops of the Chenopodiaceae family (spinach, sugar beet, etc.), crops of the Vitaceae family (grapes, etc.), crops of the Rosaceae family (roses
  • plants include plants that have been developed using genetic engineering or gene editing techniques, such as plants that have been endowed with environmental stress resistance, herbicide resistance, pest resistance, or disease resistance, or plants that have been modified in terms of growth, fertility, product quality, yield, etc.
  • Compound (I) is usually formulated and used in various forms, such as dusts, granules, granular water-dispersible agents, wettable powders, aqueous suspensions, oily suspensions, water-soluble agents, emulsions, liquids, pastes, aerosols, micro-dispersible agents, and microcapsules, by mixing compound (I) with an auxiliary agent.
  • an auxiliary agent such as dusts, granules, granular water-dispersible agents, wettable powders, aqueous suspensions, oily suspensions, water-soluble agents, emulsions, liquids, pastes, aerosols, micro-dispersible agents, and microcapsules.
  • any formulation form normally used in the relevant field can be used.
  • the auxiliary agents used in the formulation include solid carriers and liquid carriers, and surfactants and other formulation auxiliary agents can also be added as necessary.
  • solid carrier examples include diatomaceous earth, slaked lime, calcium carbonate, talc, white carbon, kaolin, bentonite, kaolinite, sericite, clay, sodium carbonate, baking soda, mirabilite, zeolite, starch, and finely powdered silica.
  • liquid carrier examples include water, toluene, xylene, solvent naphtha, dioxane, acetone, isophorone, methyl isobutyl ketone, chlorobenzene, cyclohexane, dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, and alcohol.
  • the surfactant include fatty acid salts, benzoates, alkyl sulfosuccinates, dialkyl sulfosuccinates, polycarboxylates, alkyl sulfates, alkyl sulfates, alkylaryl sulfates, alkyl diglycol ether sulfates, alcohol sulfates, alkyl sulfonates, alkylaryl sulfonates, aryl sulfonates, lignin sulfonates, alkyl diphenyl ether disulfonates, polystyrene sulfonates, alkyl phosphates, alkylaryl phosphates, styrylaryl phosphates, polyoxyethylene alkyl ether sulfates, polyoxyethylene alkylaryl ether phosphates, polyoxyethylene alkylaryl ether phosphates, polyoxyethylene alkylaryl ether sulfate ...
  • surfactants and spreaders examples include anionic surfactants and spreaders such as oxyethylene alkylaryl phosphate ester salts and salts of naphthalenesulfonic acid formalin condensates; and nonionic surfactants and spreaders such as sorbitan fatty acid esters, glycerin fatty acid esters, fatty acid polyglycerides, fatty acid alcohol polyglycol ethers, acetylene glycol, acetylene alcohol, oxyalkylene block polymers, polyoxyethylene alkyl ethers, polyoxyethylene alkylaryl ethers, polyoxyethylene styrylaryl ethers, polyoxyethylene glycol alkyl ethers, polyethylene glycol, polyoxyethylene fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene glycerin fatty acid esters, polyoxyethylene hydrogenated castor oil, and polyoxypropylene fatty acid esters.
  • anionic surfactants and spreaders such as
  • formulation adjuvants include vegetable oils and mineral oils such as olive oil, kapok oil, castor oil, palm oil, camellia oil, coconut oil, sesame oil, corn oil, rice bran oil, peanut oil, cottonseed oil, soybean oil, rapeseed oil, linseed oil, tung oil, and liquid paraffin; silicones; and xanthan gum.
  • vegetable oils and mineral oils such as olive oil, kapok oil, castor oil, palm oil, camellia oil, coconut oil, sesame oil, corn oil, rice bran oil, peanut oil, cottonseed oil, soybean oil, rapeseed oil, linseed oil, tung oil, and liquid paraffin; silicones; and xanthan gum.
  • auxiliary agents may be appropriately selected and used, either alone or in combination, as long as it does not deviate from the object of the present invention.
  • auxiliary agents those known in the art may also be appropriately selected and used, for example, various commonly used auxiliary agents such as bulking agents, thickening agents, antisettling agents, antifreezing agents, dispersion stabilizers, phytotoxicity reducing agents, and antifungal agents.
  • the mixing ratio of compound (I) to various auxiliary agents is generally 0.001:99.999 to 95:5, preferably 0.005:99.995 to 90:10, by weight.
  • these preparations When these preparations are actually used, they may be used as is, or diluted to a predetermined concentration with a diluent such as water, and various spreading agents (surfactants, vegetable oils, mineral oils, etc.) may be added as necessary.
  • an effective amount of compound (I) can be applied by a commonly used application method, i.e., spray treatment, soil treatment, seed treatment, etc.
  • a commonly used application method compound (I) can be applied at an active ingredient concentration of 0.1 to 10,000 ppm, preferably 1 to 2,000 ppm, more preferably 1 to 1,000 ppm.
  • a composition containing compound (I) as an active ingredient hereinafter also referred to as the present composition
  • a diluted version thereof can be applied.
  • the appropriate application amount can be about 10 to 100,000 g of the present composition per hectare.
  • the appropriate application amount can be about 0.01 to 1,000 g of the present composition per hectare.
  • the appropriate application amount can be about 0.001 to 100 g, preferably about 0.01 to 1 g, of the present composition per kg of seeds.
  • the spray treatment is a treatment method for controlling plant pathogens by spraying an effective amount of the composition onto the surface of the trunk, buds, stems, leaves, flowers, spikes, or fruits of a plant, or onto plant pathogens.
  • Examples of the spray treatment include spraying onto stems and leaves, and spraying onto tree trunks.
  • the soil treatment is a method of treating soil with the present composition in order to transfer an effective amount of compound (I) from the roots of a plant to the inside of the plant in order to protect crops from damage caused by plant pathogens.
  • Examples of the treatment include irrigation treatment (irrigating the present composition into the soil for plant cultivation), soil incorporation treatment (mixing the present composition with the soil for plant cultivation), planting hole treatment, treatment at the base of a plant or between plants (spraying or irrigation), and incorporation treatment into soil used for culture soil, seedling boxes, seedling trays, paper pots, seedling beds, etc.
  • the seed treatment is a treatment method for controlling plant pathogens by treating the seeds, bulbs, etc. of crops with the present composition directly or in the vicinity thereof in order to protect crops from damage caused by plant pathogens.
  • Examples of the treatment include coating treatment, dressing treatment, and immersion treatment.
  • Treatment include seedling treatment (irrigation or immersion), immersion treatment of bulbs, tubers, bulbs, roots, etc., and hydroponic treatment such as mixing with a hydroponic nutrient solution. Treatment may be performed on the whole plant or a part of it (stems, leaves, buds, flowers, ears, fruits, trunks, seeds, bulbs, tubers, bulbs, roots, etc.).
  • the present composition can be mixed or used in combination with other ingredients selected from other agricultural and horticultural chemicals, fertilizers, safeners, etc., and in this case, even more excellent effects and activity may be exhibited.
  • the above-mentioned mixture or combination use means that the present composition and other components are used simultaneously, separately or with an interval of time.
  • Other agricultural and horticultural drugs include herbicides, insecticides, acaricides, nematicides, soil pesticides, fungicides, antiviral agents, attractants, antibiotics, plant hormones, plant growth regulators, etc.
  • the mixed fungicide composition in which the present composition and one or more active ingredient compounds of other fungicides are mixed or used in combination may improve the scope of application, timing of drug treatment, control activity, etc. in a favorable direction.
  • the present composition and the active ingredient compounds of other fungicides may be formulated separately and mixed at the time of spraying, or both may be formulated together and used. Such mixed fungicides are also included in the present invention
  • the mixing ratio of compound (I) and the active ingredient compounds of other fungicides cannot be specified in general due to differences in weather conditions, formulation form, target crop, application time, application location, type and occurrence of harmful plant diseases, etc., but can generally be 1:300 to 300:1, preferably 1:100 to 100:1, by weight.
  • the appropriate application amount is 0.1 to 70,000 g, preferably 1 to 30,000 g, of the total active ingredient compounds per hectare.
  • the present invention also includes a method for controlling harmful plant diseases by applying such a mixed fungicidal composition.
  • the active ingredient compounds (common names) of the fungicides in the above other agricultural and horticultural agents can be appropriately selected, for example, from the following compound groups. Even if not specifically stated, if these compounds have various structural isomers such as salts, alkyl esters, and optical isomers, these are of course included.
  • Anilinopyrimidine compounds such as mepanipyrim, pyrimethanil, and cyprodinil; Triazolopyrimidine compounds such as ametoctradin; Triazolobenzothiazole compounds such as tricyclazole; Pyridinamine compounds such as fluazinam; Triadimefon, bitertanol, triflumizole, etaconazole, propiconazole, penconazole, flusilazole, myclobutanil, cyproconazole, tebuconazole, hexaconazole, fluconazole-cis, prochloraz, metconazole, epoxiconazole, tetraconazole, oxpoconazole fumarate azole compounds such as fumarate, prothioconazole, triadimenol, flutriafol, difenoconazole, fluquinconazole, fenbuconazole, bromu
  • Quinoxaline compounds such as chinomethionat; Dithiocarbamate compounds such as maneb, zineb, mancozeb, polycarbamate, metiram, propineb, thiram; Organochlorine compounds such as phthalide, chlorothalonil, and quintozene; Imidazole compounds such as benomyl, thiophanate-methyl, carbendazim, thiabendazole, and fuberiazole; Cyanoacetamide compounds such as cymoxanil; acylamino acid compounds such as metalaxyl, metalaxyl-M (also known as mefenoxam), oxadixyl, ofurace, benalaxyl, benalaxyl-M (also known as chiralaxyl or chiralaxyl), furalaxyl, and valifenalate; Anilides such as cyprofuram, carboxin, oxycarboxin, thi
  • Sulfamide compounds such as dichlofluanid; Copper compounds such as cupric hydroxide, oxine copper, anhydrous copper sulfate, copper nonylphenolsulfonate, copper 8-hydroxyquinoline, and copper dodecylbenzenesulfonate bis(ethylenediamine)copper(II) complex (also known as DBEDC); Organophosphates such as fosetyl-Al, tolclofos-Methyl, edifenphos, iprobenfos; Phthalimide compounds such as captan, captafol, and folpet; Dicarboximide compounds such as procymidone, iprodione, and vinclozolin; Benzanilide compounds such as flutolanil, mepronil, benodanil, and flufenoxadiazam; Amide compounds such as carpropamid, diclocymet, silthiofam, and fenoxanil; pyrazo
  • benzamide compounds such as fluopicolide, fluopyram, zoxamide, and fluopimomide
  • Furanilide compounds such as fenfuram
  • Thiophene amide compounds such as isofetamide
  • Piperazine compounds such as triforine
  • Pyridine compounds such as pyrifenox, pyrisoxazole, and aminopyrifen
  • Pyrimidine compounds such as fenarimol, ferimzone, nuarimol, and flumetylsulforim
  • Piperidine compounds such as fenpropidin
  • Morpholine compounds such as fenpropimorph and tridemorph
  • Organotin compounds such as fentin hydroxide and fentin acetate
  • Urea compounds such as pencycuron
  • Carboxylic acid amide compounds such as dimethomorph, flumorph, pyrimorph, iprovalicarb, benthiavalicarb-isopropyl, and mandipropamid
  • strobilurin compounds such as azoxystrobin, kresoxim-methyl, metominostrobin, trifloxystrobin, picoxystrobin, oryzastrobin, dimoxystrobin, pyraclostrobin, fluoxastrobin, pyraoxystrobin, pyrametostrobin, coumoxystrobin, enoxastrobin, phenaminestrobin, flufenoxystrobin, triclopyricarb, and mandestrobin; Oxazole compounds such as famoxadone and oxathiapiprolin; Thiazolecarboxamide compounds such as ethaboxam; Imidazolinone compounds such as fenamidone; benzenesulfonamide compounds such as flusulfamide; Oxime ether compounds such as cyflufenamid; Anthraquinone compounds such as dithianon; Crotonic acid compounds such as meptyldinocap; Antibiotics such as validamycin,
  • Guanidine compounds such as iminoctadine, dodine, and guazatine; Aliphatic nitrogen-based compounds such as butylamine and seboctylamine; Quinoline compounds such as tebufloquin, quinoxyfen, quinofumelin, ipflufenoquin, and feneptamidoquin; Thiazolidine compounds such as flutianil; Carbamate compounds such as propamocarb hydrochloride, pyribencarb, and tolprocarb; Tetrazole compounds such as picarbutrazox and metyltetraprole; Sulfonamide compounds such as amisulbrom and cyazofamid; Allyl phenyl ketone compounds such as metrafenone and pyriophenone; Benzothiazole compounds such as probenazole and dichlobentiazox; Phenylpyrazole compounds such as fenpyrazamine; Dithiolane compounds such as isoprothi
  • Sulfur, sulfur-based compounds such as lime sulfur
  • Other compounds include pyroquilon, diclomezine, chloropicrin, dazomet, metam-sodium, proquinazid, spiroxamine, dipymetitrone, etc.
  • Microbial germicides such as Bacillus amyloliqefaciens strain QST713, Bacillus amyloliqefaciens strain FZB24, Bacillus amyloliqefaciens strain MBI600, Bacillus amyloliqefaciens strain D747, Pseudomonas fluorescens, Bacillus subtilis, Trichoderma atroviride SKT-1; and plant extracts such as tea tree oil.
  • the active ingredient compounds (common names) of the insecticides, nematicides, acaricides, or soil pesticides among the other agricultural and horticultural agents mentioned above can be appropriately selected, for example, from the following compound groups. Even if not specifically stated, if these compounds have various structural isomers such as salts, alkyl esters, and optical isomers, these are of course included.
  • Carbamate compounds such as carbaryl, propoxur, aldicarb, carbofuran, thiodicarb, methomyl, oxamyl, ethiofencarb, pirimicarb, fenobucarb, carbosulfan, benfuracarb, bendiocarb, furathiocarb, isoprocarb, metolcarb, xylylcarb, XMC (3,5-xylyl methylcarbamate), and fenothiocarb;
  • Nereistoxin derivatives such as cartap, thiocyclam, thiocyclam oxalate, thiocyclam hydrochloride, bensultap, thiosultap, monosultap (also known as thiosultap-monosodium), bisultap (also known as thiosultap-disodium), and polythialan;
  • Organochlorines such as dicofol,
  • Fenvalerate permethrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, theta-cypermethrin, beta-cypermethrin, deltamethrin, cyhalothrin, gamma-cyhalothrin , lambda-cyhalothrin, tefluthrin, kappa-tefluthrin, etofenprox, flufenprox, cyfluthrin, beta-cyfluthrin, fenpropathrin, flucythrinate, fluvalinate, cycloprotrin hrin), pyrethrins, esfenvalerate, tetramethrin, resmethrin, protrifenbute, bifenthrin, kappa-bifenthrin, acrinathrin
  • Benzoyl urea compounds such as diflubenzuron, chlorfluazuron, teflubenzuron, flufenoxuron, lufenuron, novaluron, triflumuron, hexaflumuron, bistrifluron, noviflumuron, fluazuron, and flufenoxuron; Juvenile hormone-like compounds such as methoprene, pyriproxyfen, fenoxycarb, diofenolan; Pyridazinone compounds such as pyridaben; Pyrazole compounds such as fenpyroximate, fipronil, ethiprole, acetoprole, pyrafluprole, pyriprole, cyenopyrafen, and flufiprole; Pyrazolecarboxamide compounds such as pyflubumide, tebufenpyrad, tolfenpyrad, dimpropyridaz; Pyridylpyrazole
  • Neonicotinoid compounds such as imidacloprid, nitenpyram, acetamiprid, thiacloprid, thiamethoxam, clothianidin, nidinotefuran, dinotefuran, and nithiazine; Hydrazine compounds such as tebufenozide, methoxyfenozide, chromafenozide, and halofenozide; Pyridine compounds such as pyridalyl, flonicamid, and flumetnicam; Tetronic acid compounds such as spirodiclofen, spiromesifen, and spirobudifen; Tetramic acid compounds such as spirotetramat and spiropidione; Strobilurin compounds such as fluacrypyrim, bifemetstrobin, pyriminostrobin, and flupyroxystrobin; Pyrimidinamine compounds such as flufenerim and pyrimidifen; Organ
  • Thiourea compounds such as diafenthiuron and chloromethiuron; Formamidine compounds such as amitraz, chlordimeform, and chloromebuform; Pyridine azomethine compounds such as pymetrozine and pyrifluquinazone; Isoxazolines such as afoxolaner, fluralaner, fluxametamide, sarolaner, and isoflualanam; Other compounds include buprofezin, hexythiazox, triazamate, chlorfenapyr, indoxacarb, acequinocyl, etoxazole, 1,3-dichloropropene, benclothiaz, bifenazate, propargite, clofentezine, metaflumizone, cyflumetofen, fenazaquin, amidoflumet, sulfluramid, hydramethylnon, metaldehyde, sulfoxaflor, and fluence.
  • the present composition may also be applied in combination with the following compounds: Microbial pesticides such as crystal protein toxins produced by Bacillus thuringiensis, such as Bacillus thuringiensis aizawai, Bacillus thuringiensis kurstaki, Bacillus thuringiensis israelensis, Bacillus thuringiensis japonensis, and Bacillus thuringiensis tenebrionis, insect pathogenic virus agents, insect pathogenic fungal agents, and nematode pathogenic fungal agents; Antibiotics and semi-synthetic antibiotics such as abamectin, emamectin benzoate, ivermectin, milbemectin, milbemycin oxime, lepimectin, spinosad, spinetoram; Natural products such as azadirachtin, rotenone, and ryanodine; repellents such as deet; Physical control agents such as paraffin oil, mineral oil; RNA
  • N-substituted oxy-2-aminothiazolecarboxamide compound represented by formula (I) or a salt thereof [2] The N-substituted oxy-2- aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkynyl, or (C 2 -C 6 ) alkenyl optionally substituted with at least one T 1.
  • N-substituted oxy -2- aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is a fluorine atom, a chlorine atom, methyl, trifluoromethyl, cyano or nitro, and Y 2 , Y 3 and Y 4 are each independently a fluorine atom, a chlorine atom or a hydrogen atom.
  • N-substituted oxy -2 -aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is a fluorine atom, a chlorine atom, methyl, trifluoromethyl, or nitro, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom, and Y 4 is a hydrogen atom.
  • R 1 is a (C 1 -C 6 ) chain hydrocarbon
  • X 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, or a hydrogen atom
  • Y 1 , Y 2 , Y 3 , and Y 4 are each independently halogen, hydrogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, or nitro.
  • An agricultural and horticultural fungicide comprising the N-substituted oxy-2-aminothiazolecarboxamide compound or its salt according to any one of [1] to [77] above as an active ingredient.
  • a method for controlling plant diseases comprising applying an effective amount of the N-substituted oxy-2-aminothiazolecarboxamide compound or its salt according to any one of [1] to [77] to a plant body, a plant pathogen, or soil.
  • the melting point which is a physical property value of the compound of the present invention, was measured using a melting point measuring device (Buchi, model number M-565).
  • 1 H-NMR spectrum data was measured in a measurement solvent using an FT-NMR device (JEOL, product name JNM-ECX (500 MHz) or Bruker, product name AVANCE III HD (300 MHz)) ( 1 H-nuclear magnetic resonance spectroscopy).
  • the measurement solvent may contain tetramethylsilane (TMS) as an internal standard.
  • room temperature means a temperature of about 10 to 30°C.
  • the organic layer obtained by extraction was washed successively with a saturated aqueous solution of potassium sodium tartrate, water, and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure to obtain an oily crude product of 2-chloro-5,6-difluoronicotinaldehyde (2.03 g).
  • the crude product (2.03 g) was dissolved in methanol (100 mL), and sodium borohydride (0.52 g) was added to the resulting solution at 0° C., and the resulting mixture was stirred overnight at room temperature to obtain a reaction solution.
  • Aqueous hydrochloric acid was added to the reaction solution to quench it.
  • the quenched reaction solution was neutralized with saturated aqueous sodium bicarbonate solution. Methanol was distilled off, and ethyl acetate was added to the resulting residue. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate. The organic layer obtained by extraction was washed successively with water and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure. The resulting residue was purified by column chromatography (eluent: ethyl acetate/heptane) to obtain oily (2-chloro-5,6-difluoropyridin-3-yl)methanol (1.49 g).
  • O-methylhydroxylamine hydrochloride (96.31 mg) was added to the obtained mixture at room temperature, and the mixture was stirred at 50° C. for 7.5 hours to obtain a reaction solution.
  • the obtained reaction solution was allowed to cool to room temperature, and then water was added to the reaction solution to quench it.
  • Ethyl acetate and heptane were added successively to the quenched reaction solution, and the aqueous layer was extracted with a mixed solvent of ethyl acetate and heptane.
  • the organic layer obtained by extraction was washed successively with water and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure.
  • an aqueous solution (22 mL) of sodium dihydrogen phosphate (14.49 g) was added at 0° C., and the mixture was stirred to obtain a mixture.
  • an aqueous solution (44 mL) of sodium chlorite (13.6 g, 80%) was added to the mixture, and the mixture was stirred overnight at room temperature.
  • An aqueous solution of hydrochloric acid was added to the reaction solution to adjust it to acidic, and ethyl acetate was further added for extraction.
  • the extracted organic layer was washed successively with water and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure.
  • the obtained solid was dissolved in a saturated aqueous solution of sodium hydrogen carbonate, and the aqueous layer was washed with ethyl acetate.
  • Aqueous hydrochloric acid was added to the aqueous layer washed with ethyl acetate to adjust it to acidity.
  • Ethyl acetate was added to the aqueous layer adjusted to acidity, and the aqueous layer was extracted with ethyl acetate.
  • the organic layer obtained by extraction was washed successively with water and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure to obtain a solid.
  • Tetrahydrofuran (3 mL) was added to the obtained acid chloride to dissolve it, and then a solution of N-[(2-chloro-5,6-difluoropyridin-3-yl)methyl]-O-methylhydroxylamine (100 mg) in tetrahydrofuran (2 mL) and diisopropylethylamine (0.13 mL) were added successively at room temperature, and the mixture was stirred at 50° C. for 2.5 hours under a nitrogen atmosphere to obtain a reaction solution. The obtained reaction solution was allowed to cool to room temperature, and then the reaction solution was quenched using a saturated aqueous solution of sodium bicarbonate.
  • the obtained reaction solution was allowed to cool to room temperature, and then a saturated aqueous solution of sodium bicarbonate was slowly added to the reaction solution to adjust the reaction solution to basicity.
  • the aqueous layer of the reaction solution adjusted to basicity was extracted with ethyl acetate.
  • the organic layer obtained by extraction was washed successively with water and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure.
  • the obtained residue was purified by column chromatography (eluent: ethyl acetate/heptane) to obtain the title target compound (compound No. 17, 117 mg) as a solid.
  • a salt of compound (I) the type of salt is indicated in the remarks column in Table 1.
  • compounds described as HCl salt are hydrochlorides
  • compounds described as TsOH salt are paratoluenesulfonates
  • compounds described as Na salt are sodium salts.
  • compound No. 68 is the hydrochloride salt of compound No. 17.
  • Compound No. 69 is the paratoluenesulfonate salt of compound No. 17.
  • Compound No. 70 is the sodium salt of compound No. 17.
  • Tables 2 and 3 show the physical properties of compound (I) synthesized according to the above-mentioned production method and examples.
  • Table 2 shows the melting point of compound (I).
  • Table 3 shows the 1 H-NMR spectrum data of compound (I) [measured by 1 H-nuclear magnetic resonance spectroscopy; ⁇ is the chemical shift value (ppm)].
  • the numbers in Tables 2 and 3 have the same meanings as in Table 1.
  • *1 indicates the temperature at which the compound decomposed when its melting point was measured.
  • s is singlet, brs is broadened singlet, d is doublet, t is triplet, q is quartet, and m is multiplet.
  • Example 68 hereinafter also referred to as comparative compound A described in Patent Document 1 shown below as a comparison subject.
  • Test Example Preparation of drug solutions containing test compounds: The test compound was mixed with acetone or dimethyl sulfoxide to dissolve the test compound. Water was added to the test compound solution to dilute the test compound, which is the active ingredient, to a predetermined concentration (400 ppm) to obtain a drug solution. This drug solution was used in the following Test Examples 1 to 3.
  • Test Example 1 Fungicidal effect test against tomato late blight ( Phytophthora infestans ) (preventive effect test) Tomatoes were grown in vinyl pots with a diameter of 6 cm, and when they reached the 4.5-5.5 leaf stage, 10 ml of the drug solution was sprayed with a spray gun. After the drug solution dried (on the day of treatment), a spore suspension of Phytophthora infestans was sprayed and inoculated, and the plants were placed in an inoculation box at a temperature of 20°C and a humidity of 95% or more for 16 hours.
  • Control rate (%) 100 - (X/Y) x 100 X: Lesion area rate of test compound (%), Y: Lesion area rate of untreated area (%) Test compound: Compound No.
  • Test Example 2 Fungicidal effect test against cucumber downy mildew ( Pseudoperonospora cubensis ) (preventive effect test) Cucumbers were grown in vinyl pots with a diameter of 6 cm, and when they reached the 1.2-1.5 leaf stage, 10 ml of the drug solution was sprayed with a spray gun. After the drug solution dried (on the day of treatment or the day after treatment), a spore suspension of cucumber downy mildew ( Pseudoperonospora cubensis ) was sprayed and inoculated, and the plants were placed in an inoculation box at a temperature of 20°C and a humidity of 95% or more for 24 hours.
  • Test Example 3 Fungicidal effect test against tomato late blight ( Phytophthora infestans ) (therapeutic effect test) Tomatoes were grown in vinyl pots with a diameter of 6 cm, and when they reached the 4.5-5.5 leaf stage, they were inoculated by spraying a spore suspension of Phytophthora infestans , and placed in an inoculation box at a temperature of 20°C and a humidity of 95% or more for 4 hours. Then, 10 ml of the liquid was sprayed with a spray gun, and after the liquid dried (on the day of treatment), the pot was placed in a thermostatic chamber at 20°C.
  • each liquid (active ingredient concentration 400 ppm) using the following compounds of the present invention as test compounds showed a control rate of 80% or more against tomato late blight.
  • Test compound Compound No. 3, 7, 8, 10, 11, 13, 17, 19, 32, 34, 41, 51, 54, 55, 57, 58, 61, 84, 87
  • the control rate of the solution containing the comparative compound A was less than 30%.
  • the compound of the present invention exhibits excellent control effects against harmful plant diseases. Therefore, the compound of the present invention is useful as an agricultural and horticultural fungicide.
  • Formulation Example 1 (1) 20 parts by weight of compound (I) (2) 72 parts by weight of clay (3) 8 parts by weight of sodium lignin sulfonate The above ingredients are uniformly mixed to give a wettable powder.
  • Formulation Example 2 (1) Compound (I) 5 parts by weight (2) Talc 95 parts by weight or more are uniformly mixed to give a dusting agent.
  • Formulation Example 3 (1) Compound (I) 20 parts by weight (2) N,N-dimethylacetamide 20 parts by weight (3) Polyoxyethylene alkylphenyl ether 10 parts by weight (4) Xylene 50 parts by weight The above ingredients are uniformly mixed and dissolved to prepare an emulsion.
  • Formulation Example 4 (1) 68 parts by weight of clay (2) 2 parts by weight of sodium lignin sulfonate (3) 5 parts by weight of polyoxyethylene alkylaryl sulfate (4) 25 parts by weight of finely powdered silica A mixture of the above components and compound (I) are mixed in a weight ratio of 4:1 to obtain a wettable powder.
  • Formulation Example 5 (1) 50 parts by weight of compound (I), (2) 2 parts by weight of polyoxyethylene alkylphenyl ether phosphate triethanolamine salt, (3) 0.2 parts by weight of silicone, and (4) 47.8 parts by weight of water.
  • Formulation Example 7 (1) Compound (I) 2.5 parts by weight (2) N-methyl-2-pyrrolidone 2.5 parts by weight (3) Soybean oil 95.0 parts by weight The above ingredients are uniformly mixed and dissolved to prepare an ultra low volume formulation.
  • Formulation Example 8 (1) 20 parts by weight of compound (I) (2) 2 parts by weight of polyoxyethylene alkylphenyl ether phosphate triethanolamine salt (3) 0.2 parts by weight of silicone (4) 0.1 parts by weight of xanthan gum (5) 5 parts by weight of ethylene glycol (6) 72.7 parts by weight of water The above ingredients are uniformly mixed and pulverized to obtain an aqueous suspension.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • General Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • Health & Medical Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Provided is a novel compound exhibiting an excellent control effect on harmful plant diseases. This N-substituted oxy-2-aminothiazolecarboxamide compound represented by formula (I) (in the formula, each symbol is as described in the description) or a salt thereof exhibits an excellent control effect on harmful plant diseases.

Description

N-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩及び農園芸用殺菌剤N-substituted oxy-2-aminothiazolecarboxamide compound or its salt and agricultural and horticultural fungicide

 本発明は新規N-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩、及びそれらを有効成分として含有する農園芸用殺菌剤に関する。 The present invention relates to novel N-substituted oxy-2-aminothiazolecarboxamide compounds or salts thereof, and agricultural and horticultural fungicides containing them as active ingredients.

 特許文献1には、N-シクロアルキル-カルボキサミド、N-シクロアルキル-チオカルボキサミド及びN-シクロアルキル-N-置換カルボキシイミドアミド誘導体、並びにこれら化合物又は組成物を使用し植物病原性菌類を防除する方法が記載されている。しかしながら、この文献には、後記式(I)のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物が一切開示されていない。 Patent Document 1 describes N-cycloalkyl-carboxamides, N-cycloalkyl-thiocarboxamides, and N-cycloalkyl-N-substituted carboximidamide derivatives, as well as methods for controlling phytopathogenic fungi using these compounds or compositions. However, this document does not disclose any N-substituted oxy-2-aminothiazolecarboxamide compounds of formula (I) described below.

国際公報第2008/037789号International Publication No. 2008/037789

 既存の農園芸用殺菌剤において、施用場面によっては有害な植物病害に対する実用上不十分な防除効果、薬剤耐性菌の出現及び環境負荷(周辺の植物や生態系への影響)などの問題より、新規な農園芸用殺菌剤が切望されている。本発明の課題は、有害な植物病害に対して優れた防除効果を発揮する新規な化合物を提供することである。 There is a strong demand for new agricultural and horticultural fungicides due to problems with existing fungicides, such as insufficient effectiveness in controlling harmful plant diseases depending on the application situation, the emergence of drug-resistant bacteria, and environmental burden (impact on surrounding plants and ecosystems). The objective of the present invention is to provide a new compound that exhibits excellent control effects against harmful plant diseases.

 本発明者らは上記の課題を解決すべく鋭意検討した結果、構造中に特定のピリジン-3-イルメチル基を有する、下記式(I)のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩が農園芸用分野で問題となる有害な植物病害に対して優れた防除効果を発揮することを見出した。
 すなわち、本発明は以下の通りである。
[1]式(I):
The present inventors have conducted intensive studies to solve the above problems, and as a result have found that an N-substituted oxy-2-aminothiazolecarboxamide compound having a specific pyridin-3-ylmethyl group in its structure and represented by the following formula (I), or a salt thereof, exhibits excellent control effects against harmful plant diseases that are problematic in the agricultural and horticultural fields.
That is, the present invention is as follows.
[1] Formula (I):

[式中、Rは、少なくとも1個のTで置換されていてもよい(C-C)鎖式炭化水素であり、
は、シアノ、又は-C(=O)O-Rであり、
は、(C-C)アルキルであり、
は、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、シアノ又は水素原子であり、
、Y、Y及びYは、それぞれ独立に、ハロゲン、水素原子、(C-C)アルキル、(C-C)アルケニル、(C-C)ハロアルキル、シアノ、又はニトロである]で表されるN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩(以下、化合物(I)ともいう)。
[In the formula, R 1 is a (C 1 -C 6 ) chain hydrocarbon optionally substituted with at least one T 1 ,
T 1 is cyano or -C(=O)O-R 2 ;
R2 is ( C1 - C3 ) alkyl;
X 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, cyano or a hydrogen atom;
and Y 1 , Y 2 , Y 3 and Y 4 each independently represent a halogen atom, a hydrogen atom, a (C 1 -C 6 ) alkyl, a (C 2 -C 6 ) alkenyl, a (C 1 -C 6 ) haloalkyl, cyano, or nitro, or a salt thereof (hereinafter also referred to as compound (I)).

[2]Rが、(C-C)アルキル又は(C-C)アルキニルである、前記[1]に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。 [2] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is (C 1 -C 6 ) alkyl or (C 2 -C 6 ) alkynyl.

[3]Rが、メチル、エチル、又はプロパルギルである、前記[1]に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。 [3] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is methyl, ethyl, or propargyl.

[4]Y及びYが、それぞれ独立に、ハロゲン、水素原子、(C-C)アルキル、(C-C)ハロアルキル、シアノ又はニトロであり、但し、Y及びYが同時に水素原子になることはなく、
及びYが、それぞれ独立に、ハロゲン又は水素原子である、前記[1]から前記[3]のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
[4] Y 1 and Y 4 are each independently a halogen atom, a hydrogen atom, a (C 1 -C 6 ) alkyl, a (C 1 -C 6 ) haloalkyl, a cyano, or a nitro, provided that Y 1 and Y 4 are not both a hydrogen atom;
The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of the above [1] to [3], wherein Y2 and Y3 are each independently a halogen or a hydrogen atom.

[5]Rが、(C-C)鎖式炭化水素であり、
が、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又は水素原子であり、
、Y、Y及びYが、それぞれ独立に、ハロゲン、水素原子、(C-C)アルキル、(C-C)ハロアルキル、又はニトロである前記[1]に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
[5] R 1 is a (C 1 -C 6 ) chain hydrocarbon;
X 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, or a hydrogen atom;
The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein Y 1 , Y 2 , Y 3 and Y 4 are each independently halogen, a hydrogen atom, a (C 1 -C 6 ) alkyl, a (C 1 -C 6 ) haloalkyl, or nitro.

[6]Rが、(C-C)アルキル又は(C-C)アルキニルである、前記[5]に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。 [6] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [5], wherein R 1 is (C 1 -C 6 ) alkyl or (C 2 -C 6 ) alkynyl.

[7]Rが、メチル、又はプロパルギルである、前記[1]、前記[4]、前記[5]のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。 [7] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of the above [1], [4], and [5], wherein R 1 is methyl or propargyl.

[8]Yが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又はニトロであり、
、Y及びYが、それぞれ独立に、ハロゲン又は水素原子である、前記[1]~前記[3]及び前記[5]~前記[7]のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
[8] Y 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, or nitro;
The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of the above [1] to [3] and the above [5] to [7], wherein Y 2 , Y 3 and Y 4 are each independently a halogen or a hydrogen atom.

[9]前記[1]~前記[8]のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩を有効成分として含有する農園芸用殺菌剤。 [9] An agricultural and horticultural fungicide containing, as an active ingredient, the N-substituted oxy-2-aminothiazolecarboxamide compound or its salt described in any one of [1] to [8] above.

[10]前記[1]~前記[8]のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩の有効量を、植物体、植物病原菌又は土壌に施用する、有害な植物病害を防除する方法。 [10] A method for controlling harmful plant diseases, comprising applying an effective amount of the N-substituted oxy-2-aminothiazolecarboxamide compound or its salt described in any one of [1] to [8] above to a plant body, a plant pathogen, or soil.

 本発明の化合物(I)は、有害な植物病害に対して優れた防除効果を発揮し、農園芸用殺菌剤として有用である。 Compound (I) of the present invention exhibits excellent control effects against harmful plant diseases and is useful as an agricultural and horticultural fungicide.

 化合物(I)の置換基及び化学構造について説明する。なお、本明細書において、化合物(I)に包含される化合物を本発明化合物とも記す。 The substituents and chemical structure of compound (I) are described below. In this specification, compounds included in compound (I) are also referred to as the compounds of the present invention.

 化合物(I)において、ハロゲン又は置換基としてのハロゲンは、フッ素、塩素、臭素、又はヨウ素の各原子が挙げられる。置換基としてのハロゲンの数は1個又は2個以上であってもよく、2個以上の場合、各ハロゲン原子は各々同一でも相異なってもよい。また、置換基としてのハロゲンの置換位置は何れの位置でもよい。 In compound (I), the halogen or the halogen as a substituent may be a fluorine, chlorine, bromine, or iodine atom. The number of halogen as a substituent may be one or more than one, and when there are two or more, the halogen atoms may be the same or different. In addition, the substitution position of the halogen as a substituent may be any position.

 化合物(I)において、「C-C」は、炭素原子数がP乃至Tであることを意味する。例えば「C-C」は、炭素原子数が1乃至6であることを意味する。また、「置換されてもよい」との表記は、置換基を有すること又は無置換であることを意味する。 In compound (I), "C P -C T " means that the number of carbon atoms is P to T. For example, "C 1 -C 6 " means that the number of carbon atoms is 1 to 6. In addition, the expression "optionally substituted" means that the compound has a substituent or is unsubstituted.

 (C-C)鎖式炭化水素は、(C-C)アルキル、(C-C)アルキニル、又は(C-C)アルケニルを意味する。 (C 1 -C 6 ) Acyclic hydrocarbon means (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkynyl, or (C 2 -C 6 ) alkenyl.

 (C-C)アルキルは、炭素原子数1~6個の直鎖又は分岐鎖状のアルキル基を表す。例えば、メチル、エチル、ノルマルプロピル、イソプロピル、ノルマルブチル、イソブチル、セカンダリーブチル、ターシャリーブチル、ノルマルペンチル、イソペンチル、ネオペンチル、セカンダリーペンチル、ターシャリーペンチル、2-メチルブチル、3-ペンチル、ノルマルヘキシル、イソヘキシル、セカンダリーヘキシル、2-メチルペンチル、3-メチルペンチル、3-ヘキシル、2-エチルブチル、3-メチルペンタン-2-イル、4-メチルペンタン-2-イル、2,3-ジメチルブチル、ターシャリーヘキシル、2,2-ジメチルブチル、ネオヘキシル、3-メチルペンタン-3-イル、2-メチルペンタン-3-イル又は2,3-ジメチルブタン-2-イル等の基を挙げることができる。
 本明細書において(C-C)アルキルは、炭素原子数1~3個の直鎖又は分岐鎖状のアルキル基を表し、その具体例には上記の(C-C)アルキルの具体例の中で炭素原子数1~3個のアルキル基が該当する。
(C 1 -C 6 ) alkyl represents a straight or branched alkyl group having 1 to 6 carbon atoms, for example, methyl, ethyl, normal propyl, isopropyl, normal butyl, isobutyl, secondary butyl, tertiary butyl, normal pentyl, isopentyl, neopentyl, secondary pentyl, tertiary pentyl, 2-methylbutyl, 3-pentyl, normal hexyl, isohexyl, secondary hexyl, 2-methylpentyl, 3-methylpentyl, 3-hexyl, 2-ethylbutyl, 3-methylpentan-2-yl, 4-methylpentan-2-yl, 2,3-dimethylbutyl, tertiary hexyl, 2,2-dimethylbutyl, neohexyl, 3-methylpentan-3-yl, 2-methylpentan-3-yl, or 2,3-dimethylbutan-2-yl.
In the present specification, (C 1 -C 3 ) alkyl represents a linear or branched alkyl group having 1 to 3 carbon atoms, and specific examples thereof include the alkyl groups having 1 to 3 carbon atoms among the specific examples of (C 1 -C 6 ) alkyl mentioned above.

 (C-C)アルキニルは、任意の位置に少なくとも1つの三重結合を有する、炭素原子数2~6個の直鎖又は分岐鎖状のアルキニル基を表す。例えば、エチニル、1-プロピニル、プロパルギル(単に2-プロピニルともいう)、1-ブチニル、2-ブチニル、3-ブチニル、3-ブチン-2-イル、1,3-ブタジイニル、1-ペンチニル、2-ペンチニル、3-ペンチニル、4-ペンチニル、3-メチル-1-ブチニル、3-ペンチン-2-イル、1-ペンチン-3-イル、4-ペンチン-2-イル、2-メチル-3-ブチニル、1,3-ペンタジイニル、1,4-ペンタジイニル、2,4-ペンタジイニル、1-ヘキシニル、2-ヘキシニル、3-ヘキシニル、4-ヘキシニル、5-ヘキシニル、4-メチル-1-ペンチニル、3-メチル-1-ペンチニル、3,3-ジメチル-1-ブチニル、4-メチル-2-ペンチニル、3-ヘキシン-2-イル、4-ヘキシン-2-イル、2-メチル-3-ペンチニル、3-メチル-4-ペンチン-2-イル、5-ヘキシン-2-イル、2,4-ヘキサジイニル、3,5-ヘキサジイニル、3,5-ヘキサジイン-2-イル又は1,3,5-ヘキサトリイニル等の基を挙げることができる。
 本明細書において(C-C)アルキニルは、任意の位置に1つの三重結合を有する、炭素原子数2~3個の直鎖状のアルキニル基を表し、その具体例には上記の(C-C)アルキニルの具体例の中で炭素原子数2~3個のアルキニル基が該当する。
(C 2 -C 6 )alkynyl represents a straight or branched alkynyl group having 2 to 6 carbon atoms and at least one triple bond at any position, such as ethynyl, 1-propynyl, propargyl (also simply referred to as 2-propynyl), 1-butynyl, 2-butynyl, 3-butynyl, 3-butyn-2-yl, 1,3-butadiynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 3-methyl-1-butynyl, 3-pentyn-2-yl, 1-pentyn-3-yl, 4-pentyn-2-yl, 2-methyl-3-butynyl, 1,3-pentadiynyl, 1,4-pentadiynyl, 2,4-pentadiynyl, 1-hexynyl, 2 ... xynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 4-methyl-1-pentynyl, 3-methyl-1-pentynyl, 3,3-dimethyl-1-butynyl, 4-methyl-2-pentynyl, 3-hexyn-2-yl, 4-hexyn-2-yl, 2-methyl-3-pentynyl, 3-methyl-4-pentyn-2-yl, 5-hexyn-2-yl, 2,4-hexadiynyl, 3,5-hexadiyn-2-yl, 3,5-hexadiyn-2-yl, or 1,3,5-hexatriynyl groups.
In the present specification, (C 2 -C 3 )alkynyl represents a linear alkynyl group having one triple bond at any position and having 2 to 3 carbon atoms, and specific examples thereof include alkynyl groups having 2 to 3 carbon atoms among the specific examples of (C 2 -C 6 )alkynyl mentioned above.

 (C-C)アルケニルは、任意の位置に少なくとも1つの二重結合を有する、炭素原子数2~6個の直鎖又は分岐鎖状のアルケニル基を表す。例えば、ビニル(単にエテニルともいう)、アリル(単に2-プロペニルともいう)、1-プロペニル、イソプロペニル、1-ブテニル、2-ブテニル、3-ブテニル、2-ブテン-2-イル、3-ブテン-2-イル、2-メチル-1-プロペニル、2-メチル-2-プロペニル、3-ブテン-3-イル、1,3-ブタジエニル、1,3-ブタジエン-2-イル、1-ペンテニル、2-ペンテニル、3-ペンテニル、4-ペンテニル、3-メチル-1-ブテニル、2-メチル-1-ブテニル、2-ペンテン-1-イル、3-メチル-2-ブテン-2-イル、3-メチル-2-ブテニル、2-メチル-2-ブテニル、3-ペンテン-2-イル、3-メチル-3-ブテニル、2-メチル-3-ブテニル、1,3-ペンタジエニル、2,4-ペンタジエニル、2,4-ペンタジエン-2-イル、1-ヘキセニル、2-ヘキセニル、3-ヘキセニル、4-ヘキセニル、5-ヘキセニル、2-ヘキセン-2-イル、2-エチル-1-ブテニル、4-メチル-3-ペンテニル、3-メチル-3-ペンテニル、2-メチル-3-ペンテニル、2,3-ジメチル-2-ブテニル、4-メチル-3-ペンテン-2-イル、4-メチル-3-ペンテニル、3-メチル-3-ペンテニル、1,3-ヘキサジエニル、1,4-ヘキサジエニル、1,5-ヘキサジエニル、2,4-ヘキサジエニル、2,5-ヘキサジエニル又は1,3,5-ヘキサトリエニル等の基を挙げることができる。また、幾何異性体がある場合、E体又はZ体のどちらか一方のみ、或いはE体とZ体との任意の割合の混合物であり、指定される炭素数の範囲であれば、特に限定されることはない。 (C 2 -C 6 )alkenyl represents a straight or branched alkenyl group having from 2 to 6 carbon atoms with at least one double bond at any position. For example, vinyl (also simply referred to as ethenyl), allyl (also simply referred to as 2-propenyl), 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 2-buten-2-yl, 3-buten-2-yl, 2-methyl-1-propenyl, 2-methyl-2-propenyl, 3-buten-3-yl, 1,3-butadienyl, 1,3-butadien-2-yl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 3-methyl-1-butenyl, 2-methyl-1-butenyl, 2-penten-1-yl, 3-methyl-2-buten-2-yl, 3-methyl-2-butenyl, 2-methyl-2-butenyl, 3-penten-2-yl, 3-methyl-3-butenyl, 2-methyl 3-butenyl, 1,3-pentadienyl, 2,4-pentadienyl, 2,4-pentadien-2-yl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 2-hexen-2-yl, 2-ethyl-1-butenyl, 4-methyl-3-pentenyl, 3-methyl-3-pentenyl, 2-methyl-3-pentenyl, 2,3-dimethyl-2-butenyl, 4-methyl-3-penten-2-yl, 4-methyl-3-pentenyl, 3-methyl-3-pentenyl, 1,3-hexadienyl, 1,4-hexadienyl, 1,5-hexadienyl, 2,4-hexadienyl, 2,5-hexadienyl, or 1,3,5-hexatrienyl groups. Furthermore, when there are geometric isomers, they are either the E or Z isomer, or a mixture of the E and Z isomers in any ratio, and are not particularly limited as long as they are within the specified range of carbon numbers.

 前記(C-C)鎖式炭化水素は、少なくとも1個のTで置換されていてもよい。前記(C-C)鎖式炭化水素がTで置換される場合、前記(C-C)鎖式炭化水素は1~13個のTで置換可能である。
 前記(C-C)鎖式炭化水素が少なくとも1個のTで置換された場合、Tの置換位置は、前記(C-C)鎖式炭化水素上の何れの置換位置でもよい。
 前記(C-C)鎖式炭化水素が2個以上のTで置換された場合、各Tは各々同一でも相異なってもよい。
The (C 1 -C 6 ) chain hydrocarbon may be substituted with at least one T 1. When the (C 1 -C 6 ) chain hydrocarbon is substituted with T 1 , the (C 1 -C 6 ) chain hydrocarbon may be substituted with 1 to 13 T 1 .
When the (C 1 -C 6 ) chain hydrocarbon is substituted with at least one T 1 , the substitution position of T 1 may be any substitution position on the (C 1 -C 6 ) chain hydrocarbon.
When the (C 1 -C 6 ) chain hydrocarbon is substituted with two or more T 1 s , each T 1 may be the same or different.

 例えば、化合物(I)のRが少なくとも1個のTで置換された(C-C)アルキルである場合、具体的には、下記の置換基が含まれる。例えば、シアノメチル、2-シアノエチル、3-シアノプロピル、4-シアノブチル、5-シアノペンチル、6-シアノヘキシル、メトキシカルボニルメチル、エトキシカルボニルメチル、プロポキシカルボニルメチル、2-(メトキシカルボニル)エチル、又はイソプロポキシカルボニルメチル等が挙げられる。 For example, when R 1 in compound (I) is a (C 1 -C 6 ) alkyl substituted with at least one T 1 , specific examples include the following substituents: cyanomethyl, 2-cyanoethyl, 3-cyanopropyl, 4-cyanobutyl, 5-cyanopentyl, 6-cyanohexyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, propoxycarbonylmethyl, 2-(methoxycarbonyl)ethyl, isopropoxycarbonylmethyl, and the like.

 (C-C)ハロアルキルは、1~13個の同一のまたは異なるハロゲン原子により部分的または完全に置換された炭素原子数1~6個の直鎖状又は分岐鎖状のアルキル基を表す。例えば、フルオロメチル、ジフルオロメチル、トリフルオロメチル、クロロメチル、ジクロロメチル、トリクロロメチル、ブロモメチル、ジブロモメチル、トリブロモメチル、クロロジフルオロメチル、ジクロロフルオロメチル、クロロフルオロメチル、1-フルオロエチル、2-フルオロエチル、1,1-ジフルオロエチル、2,2-ジフルオロエチル、2,2,2-トリフルオロエチル、パーフルオロエチル、1-クロロエチル、2-クロロエチル、1,1-ジクロロエチル、2,2-ジクロロエチル、2,2,2-トリクロロエチル、1-クロロ-1-フルオロエチル、2-クロロ-2-フルオロエチル、1-フルオロプロピル、2-フルオロプロピル、1-フルオロ-2-プロピル、3-フルオロプロピル、2-フルオロ-2-プロピル、1,1-ジフルオロプロピル、2,2-ジフルオロプロピル、3,3-ジフルオロプロピル、3,3,3-トリフルオロプロピル、パーフルオロプロピル、パーフルオロイソプロピル、2,2,3,3,3-ペンタフルオロプロピル、1,1,1,3,3,3-ヘキサフルオロイソプロピル、1-フルオロブチル、2-フルオロブチル、3-フルオロブチル、4-フルオロブチル、1,1-ジフルオロブチル、2,2-ジフルオロブチル、3,3-ジフルオロブチル、4,4-ジフルオロブチル、4,4,4-トリフルオロブチル、3,3,4,4,4-ペンタフルオロブチル、2,2,3,3,4,4,4-ヘプタフルオロブチル、パーフルオロブチル、2,3,3,3,4,4,4-ヘプタフルオロイソブチル、1-フルオロペンチル、2-フルオロペンチル、3-フルオロペンチル、4-フルオロペンチル、5-フルオロペンチル、1,1-ジフルオロペンチル、2,2-ジフルオロペンチル、3,3-ジフルオロペンチル、4,4-ジフルオロペンチル、5,5-ジフルオロペンチル、5,5,5-トリフルオロペンチル、4,4,5,5,5-ペンタフルオロペンチル、3,3,4,4,5,5,5-ヘプタフルオロペンチル、2,2,3,3,4,4,5,5,5-ノナフルオロペンチル、パーフルオロペンチル、1-フルオロヘキシル、2-フルオロヘキシル、3-フルオロヘキシル、4-フルオロヘキシル、5-フルオロヘキシル、6-フルオロヘキシル、1,1-ジフルオロヘキシル、2,2-ジフルオロヘキシル、3,3-ジフルオロヘキシル、4,4-ジフルオロヘキシル、5,5-ジフルオロヘキシル、6,6-ジフルオロヘキシル、6,6,6‐トリフルオロヘキシル、5,5,6,6,6-ペンタフルオロヘキシル、4,4,5,5,6,6,6-ヘプタフルオロヘキシル、3,3,4,4,5,5,6,6,6-ノナフルオロヘキシル、2,2,3,3,4,4,5,5,6,6,6-ウンデカフルオロヘキシル、又はパーフルオロヘキシル等の基を挙げることができる。
 本明細書において(C-C)ハロアルキルは、1~7個の同一のまたは異なるハロゲン原子により部分的または完全に置換された炭素原子数1~3個の直鎖又は分岐鎖状のアルキル基を表す。(C-C)ハロアルキルの具体例には上記の(C-C)ハロアルキルの具体例の中で炭素原子数1~3個のハロアルキル基が該当する。
(C 1 -C 6 )haloalkyl represents a linear or branched alkyl group having 1 to 6 carbon atoms, which is partially or fully substituted by 1 to 13 identical or different halogen atoms, such as fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, bromomethyl, dibromomethyl, tribromomethyl, chlorodifluoromethyl, dichlorofluoromethyl, chlorofluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 1,1-difluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, perfluoroethyl, 1-chloroethyl, 2-chloroethyl, 1,1-dichloroethyl, 2,2-dichloroethyl, 2,2,2-trichloroethyl, 1-chloro-1-fluoroethyl, 2-chloro-2-fluoroethyl, 1-fluoropropyl, 2-fluoropropyl, 1 ... -fluoro-2-propyl, 3-fluoropropyl, 2-fluoro-2-propyl, 1,1-difluoropropyl, 2,2-difluoropropyl, 3,3-difluoropropyl, 3,3,3-trifluoropropyl, perfluoropropyl, perfluoroisopropyl, 2,2,3,3,3-pentafluoropropyl, 1,1,1,3,3,3-hexafluoroisopropyl, 1-fluorobutyl, 2-fluorobutyl, 3-fluorobutyl, 4-fluorobutyl, 1,1-difluorobutyl, 2,2-difluorobutyl, 3,3-difluorobutyl, 4,4-difluorobutyl, 4,4,4-trifluorobutyl, 3,3,4,4,4-pentafluorobutyl, 2,2,3,3,4,4,4-heptafluorobutyl, perfluorobutyl, 2,3,3,3,4,4,4-heptafluoroisobutyl, 1-fluoropentyl, 2-fluoropentyl, 3-fluoropentyl, 4-fluoropentyl, 5-fluoropentyl, 1,1-difluoropentyl, 2,2-difluoropentyl, 3,3-difluoropentyl, 4,4-difluoropentyl, 5,5-difluoropentyl, 5,5,5-trifluoropentyl, 4,4,5,5,5-pentafluoropentyl, 3,3,4,4,5,5,5-heptafluoropentyl, 2,2,3,3,4,4,5,5,5-nonafluoropentyl, perfluoropentyl, 1-fluoro Examples of such groups include hexyl, 2-fluorohexyl, 3-fluorohexyl, 4-fluorohexyl, 5-fluorohexyl, 6-fluorohexyl, 1,1-difluorohexyl, 2,2-difluorohexyl, 3,3-difluorohexyl, 4,4-difluorohexyl, 5,5-difluorohexyl, 6,6-difluorohexyl, 6,6,6-trifluorohexyl, 5,5,6,6,6-pentafluorohexyl, 4,4,5,5,6,6,6-heptafluorohexyl, 3,3,4,4,5,5,6,6,6-nonafluorohexyl, 2,2,3,3,4,4,5,5,6,6,6-undecafluorohexyl, and perfluorohexyl.
In the present specification, (C 1 -C 3 )haloalkyl represents a straight or branched alkyl group having 1 to 3 carbon atoms, which is partially or completely substituted with 1 to 7 identical or different halogen atoms. Specific examples of (C 1 -C 3 )haloalkyl include haloalkyl groups having 1 to 3 carbon atoms among the specific examples of (C 1 -C 6 )haloalkyl mentioned above.

 化合物(I)の塩としては、農業上許容されるものであればあらゆるものが含まれるが、例えば、アルカリ金属塩(例えば、ナトリウム塩、カリウム塩など)、アルカリ土類金属塩(例えば、マグネシウム塩、カルシウム塩など)、アミン塩(ジメチルアミン塩、トリエチルアミン塩など)、無機酸塩(例えば、塩酸塩、過塩素酸塩、硫酸塩、硝酸塩など)又は有機酸塩(例えば酢酸塩、メタンスルホン酸塩、パラトルエンスルホン酸塩、シュウ酸塩など)などが挙げられる。 Salts of compound (I) include any salts that are agriculturally acceptable, such as alkali metal salts (e.g., sodium salt, potassium salt, etc.), alkaline earth metal salts (e.g., magnesium salt, calcium salt, etc.), amine salts (dimethylamine salt, triethylamine salt, etc.), inorganic acid salts (e.g., hydrochloride, perchlorate, sulfate, nitrate, etc.), or organic acid salts (e.g., acetate, methanesulfonate, paratoluenesulfonate, oxalate, etc.).

 化合物(I)は、各種異性体、例えば光学異性体、幾何異性体などが存在するが、本発明には各異性体及び異性体混合物の双方が含まれることがある。なお、化合物(I)には、当該技術分野における技術常識の範囲内において、前記したもの以外の各種異性体も含まれる。さらに、当該技術分野における技術常識及び一般的な実験手法を用いて、各種異性体を作り分けることができる。 Compound (I) exists in various isomers, such as optical isomers and geometric isomers, and the present invention may include both each isomer and a mixture of isomers. Compound (I) also includes various isomers other than those mentioned above, within the scope of common technical knowledge in the relevant technical field. Furthermore, various isomers can be produced separately using common technical knowledge in the relevant technical field and general experimental techniques.

 また、異性体の種類によっては、記載した構造式と異なる化学構造となる場合があるが、当業者であればそれらが異性体の関係にあることが十分認識できる為、本発明の範囲内であることは明らかである。 In addition, depending on the type of isomer, the chemical structure may differ from the structural formula shown, but since a person skilled in the art would be able to fully recognize that these are isomers, it is clear that they are within the scope of the present invention.

 次に化合物(I)の製造方法について説明する。
 化合物(I)は、以下に示す反応A~反応E、及び通常の塩の製造方法に従って製造することができるが、当該化合物を得る方法は、これらの方法に限定されるものではない。例えば、本発明の化合物(I)は、ピリジン環上の置換基に、本分野において周知の種々の置換基変換反応(例えば、アルキル化反応、ハロアルキル化反応、鈴木カップリング反応などのクロスカップリング反応、ザンドマイヤー型反応、ハロゲン化反応、酸化反応、還元反応等)を、適用することによって製造することも可能である。また、必要に応じて、本発明化合物の製造において、本分野において通常使用される保護及び脱保護反応を適用してもよい。反応を実施するにあたり、必要な場合は窒素やアルゴンなどの不活性ガス雰囲気下で実施してもよく、塩の試薬を用いてもよい。
Next, a method for producing compound (I) will be described.
Compound (I) can be produced according to the following reactions A to E and a conventional method for producing a salt, but the method for obtaining the compound is not limited to these methods. For example, compound (I) of the present invention can also be produced by applying various substituent conversion reactions well known in the art (e.g., alkylation reaction, haloalkylation reaction, cross-coupling reaction such as Suzuki coupling reaction, Sandmeyer type reaction, halogenation reaction, oxidation reaction, reduction reaction, etc.) to the substituent on the pyridine ring. In addition, protection and deprotection reactions commonly used in the art may be applied in the production of the compound of the present invention, if necessary. When carrying out the reaction, it may be carried out under an inert gas atmosphere such as nitrogen or argon, if necessary, and a salt reagent may be used.

[反応A]
 反応Aは、脱保護反応であり、式(XX-a)の化合物よりBoc基を除くことにより、式(I)の化合物を得る方法である。ここで、Boc基は、tert-ブトキシカルボニル基である。
[Reaction A]
Reaction A is a deprotection reaction, in which the Boc group is removed from the compound of formula (XX-a) to obtain the compound of formula (I), where the Boc group is a tert-butoxycarbonyl group.

 式中の記号は前述の通りである。 The symbols in the formula are as described above.

 反応Aは、Boc基を除くために用いられる公知の条件、例えば、Greene’s PROTECTIVE GROUPS in ORGANIC SYNTHESIS(John Wiley and Sons、2007年、Peter G.M.Wuts、Theodora W.Greene)に記載の方法によって行うことができる。より具体的には、例えば、溶媒存在下、トリフルオロ酢酸や塩化水素などの酸と反応させる、あるいは溶媒及び2,6-ルチジンのような塩基存在下、トリメチルシリルトリフラートと反応させることによって行うことができる。 Reaction A can be carried out under known conditions used to remove the Boc group, for example, the method described in Greene's PROTECTIVE GROUPS in ORGANIC SYNTHESIS (John Wiley and Sons, 2007, Peter G.M. Wuts, Theodora W. Greene). More specifically, for example, it can be carried out by reacting with an acid such as trifluoroacetic acid or hydrogen chloride in the presence of a solvent, or by reacting with trimethylsilyl triflate in the presence of a solvent and a base such as 2,6-lutidine.

[反応B]及び[反応C]
 反応Bは、式(II)の化合物と式(III)の化合物を反応させ式(XX-b)の化合物を得る方法である。反応Cは、式(II-a)の化合物と式(III)の化合物を反応させ式(XX-b)の化合物を得る方法である。
[Reaction B] and [Reaction C]
Reaction B is a method of reacting a compound of formula (II) with a compound of formula (III) to obtain a compound of formula (XX-b). Reaction C is a method of reacting a compound of formula (II-a) with a compound of formula (III) to obtain a compound of formula (XX-b).

 式中、R1aはH、又は少なくとも1個のTで置換されていてもよい(C-C)鎖式炭化水素であり、Lは脱離基であり、例えば、ハロゲン、アルコキシ、アリールオキシ、アルキルカルボニルオキシ、アリールカルボニルオキシなどが挙げられる。その他の記号は前述の通りである。 In the formula, R 1a is H or a (C 1 -C 6 ) chain hydrocarbon optionally substituted with at least one T 1 , and L is a leaving group such as halogen, alkoxy, aryloxy, alkylcarbonyloxy, arylcarbonyloxy, etc. The other symbols are as defined above.

 反応Bは、通常、脱水縮合剤及び溶媒の存在下、必要に応じて塩基を加えて行うことができる。反応Bにおける式(III)の化合物は、式(II)の化合物1当量に対して、0.5~3当量、望ましくは0.8~1.5当量使用できる(当量はモル当量であり、以下も同様である)。 Reaction B can usually be carried out in the presence of a dehydrating condensation agent and a solvent, with the addition of a base as necessary. The compound of formula (III) in reaction B can be used in an amount of 0.5 to 3 equivalents, preferably 0.8 to 1.5 equivalents, per equivalent of the compound of formula (II) (the equivalent is a molar equivalent, and the same applies below).

 反応Bにおける脱水縮合剤は、N,N’-ジシクロヘキシルカルボジイミド(DCC)、1-[3-(ジメチルアミノ)プロピル]-3-エチルカルボジイミド(EDC)又はその塩酸塩のようなカルボジイミド系縮合剤;1,1’-カルボニルジイミダゾール(CDI)のようなイミダゾール系縮合剤;4-(4,6-ジメトキシ-1,3,5-トリアジン-2-イル)-4-メチルモルホリニウムクロリド(DMT-MM)のようなトリアジン系縮合剤;1H-ベンゾトリアゾール-1-イルオキシトリピロリジノホスホニウムヘキサフルオロホスファート(PyBOP)のようなホスホニウム系縮合剤;1-[ビス(ジメチルアミノ)メチレン]-1H-1,2,3-トリアゾロ[4,5-b]ピリジニウム 3-オキシドヘキサフルオロホスファート(HATU)のようなウロニウム系縮合剤;2-メチル-6-ニトロ安息香酸無水物(MNBA)のような酸無水物;2-クロロ-1-メチルピリジニウム p-トルエンスルホナートのような2-ハロピリジニウム塩;プロピルホスホン酸無水物(環状トリマー)(T3P);ジフェニルリン酸アジド(DPPA);などが挙げられるが、これらに限定されるものではない。必要に応じて1-ヒドロキシベンゾトリアゾール(HOBt)などの脱水縮合剤とともに使用される一般的な添加剤を添加してもよい。前記脱水縮合剤は、式(II)の化合物1当量に対して、0.5~5当量、望ましくは1~2当量使用でき、添加剤は式(II)の化合物1当量に対して、0.2~5当量、望ましくは1~2当量使用できる。 The dehydration condensation agent in reaction B is a carbodiimide-based condensation agent such as N,N'-dicyclohexylcarbodiimide (DCC), 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (EDC) or its hydrochloride; an imidazole-based condensation agent such as 1,1'-carbonyldiimidazole (CDI); a triazine-based condensation agent such as 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMT-MM); a 1H-benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (P Examples of suitable dehydrating condensing agents include, but are not limited to, phosphonium condensing agents such as 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU); acid anhydrides such as 2-methyl-6-nitrobenzoic anhydride (MNBA); 2-halopyridinium salts such as 2-chloro-1-methylpyridinium p-toluenesulfonate; propylphosphonic anhydride (cyclic trimer) (T3P); diphenylphosphoric azide (DPPA); and the like. If necessary, common additives used together with dehydrating condensing agents such as 1-hydroxybenzotriazole (HOBt) may be added. The dehydration condensation agent can be used in an amount of 0.5 to 5 equivalents, preferably 1 to 2 equivalents, per equivalent of the compound of formula (II), and the additive can be used in an amount of 0.2 to 5 equivalents, preferably 1 to 2 equivalents, per equivalent of the compound of formula (II).

 反応Bにおける塩基は、例えば、炭酸ナトリウム、炭酸カリウム、炭酸セシウムのような炭酸塩;炭酸水素ナトリウム、炭酸水素カリウムのような炭酸水素塩;水酸化ナトリウム、水酸化カリウムのような金属水酸化物;水素化ナトリウム、水素化カリウムのような金属水素化物;トリエチルアミン、N,N-ジイソプロピルエチルアミンのようなアミン類;ピリジン、4-ジメチルアミノピリジン、2,6-ルチジンのようなピリジン類;酢酸ナトリウム、酢酸カリウムなどのアルカリ金属カルボン酸塩;などから1種又は2種以上を適宜選択、混合して使用することができる。前記塩基は、式(II)の化合物1当量に対して、0.5~10当量、望ましくは1~5当量使用できる。 The base in reaction B may be one or more of the following, selected appropriately from carbonates such as sodium carbonate, potassium carbonate, and cesium carbonate; hydrogen carbonates such as sodium hydrogen carbonate and potassium hydrogen carbonate; metal hydroxides such as sodium hydroxide and potassium hydroxide; metal hydrides such as sodium hydride and potassium hydride; amines such as triethylamine and N,N-diisopropylethylamine; pyridines such as pyridine, 4-dimethylaminopyridine, and 2,6-lutidine; and alkali metal carboxylates such as sodium acetate and potassium acetate. The base may be used in an amount of 0.5 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (II).

 反応Bにおける溶媒は、反応に不活性な溶媒であればいずれのものでもよく、例えば、ベンゼン、トルエン、キシレン、クロロベンゼンのような芳香族炭化水素類;四塩化炭素、塩化メチル、クロロホルム、ジクロロメタン、ジクロロエタン、トリクロロエタン、ヘキサン、シクロヘキサンのような脂肪族炭化水素類;ジオキサン、テトラヒドロフラン、ジエチルエーテル、ジメトキシエタンのようなエーテル類;酢酸メチル、酢酸エチルのようなエステル類;ジメチルスルホキシド、スルホラン、N,N-ジメチルアセトアミド、N,N-ジメチルホルムアミド、N-メチルピロリドン、ピリジン、アセトニトリル、プロピオニトリルのような非プロトン性極性溶媒;アセトン、メチルエチルケトンのようなケトン類;メタノール、エタノールのようなプロトン性極性溶媒;水;などから1種又は2種以上を適宜選択できる。 The solvent in reaction B may be any solvent that is inert to the reaction, and may be selected from one or more of the following: aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; aliphatic hydrocarbons such as carbon tetrachloride, methyl chloride, chloroform, dichloromethane, dichloroethane, trichloroethane, hexane, and cyclohexane; ethers such as dioxane, tetrahydrofuran, diethyl ether, and dimethoxyethane; esters such as methyl acetate and ethyl acetate; aprotic polar solvents such as dimethyl sulfoxide, sulfolane, N,N-dimethylacetamide, N,N-dimethylformamide, N-methylpyrrolidone, pyridine, acetonitrile, and propionitrile; ketones such as acetone and methyl ethyl ketone; protic polar solvents such as methanol and ethanol; and water.

 反応Bの反応温度は、通常-20℃~150℃程度、望ましくは0℃~100℃程度であり、反応時間は、通常0.5~48時間程度、望ましくは1~24時間程度である。 The reaction temperature for reaction B is usually about -20°C to 150°C, preferably about 0°C to 100°C, and the reaction time is usually about 0.5 to 48 hours, preferably about 1 to 24 hours.

 反応Cは、溶媒の存在下、必要に応じて塩基を加えて行うことができる。反応Cにおける式(III)の化合物は、式(II-a)の化合物1当量に対して、0.5~3当量、望ましくは0.8~1.5当量使用できる。 Reaction C can be carried out in the presence of a solvent, optionally with the addition of a base. In reaction C, the compound of formula (III) can be used in an amount of 0.5 to 3 equivalents, preferably 0.8 to 1.5 equivalents, per equivalent of the compound of formula (II-a).

 反応Cにおける塩基は、例えば、炭酸ナトリウム、炭酸カリウム、炭酸セシウムのような炭酸塩;炭酸水素ナトリウム、炭酸水素カリウムのような炭酸水素塩;水酸化ナトリウム、水酸化カリウムのような金属水酸化物;水素化ナトリウム、水素化カリウムのような金属水素化物;トリエチルアミン、N,N-ジイソプロピルエチルアミンのようなアミン類;ピリジン、4-ジメチルアミノピリジン、2,6-ルチジンのようなピリジン類;酢酸ナトリウム、酢酸カリウムなどのアルカリ金属カルボン酸塩;などから1種又は2種以上を適宜選択、混合して使用することができる。前記塩基は、式(II-a)の化合物1当量に対して、0.1~10当量、望ましくは0.5~5当量使用できる。 The base in reaction C may be one or more of the following, selected appropriately from carbonates such as sodium carbonate, potassium carbonate, and cesium carbonate; hydrogen carbonates such as sodium hydrogen carbonate and potassium hydrogen carbonate; metal hydroxides such as sodium hydroxide and potassium hydroxide; metal hydrides such as sodium hydride and potassium hydride; amines such as triethylamine and N,N-diisopropylethylamine; pyridines such as pyridine, 4-dimethylaminopyridine, and 2,6-lutidine; and alkali metal carboxylates such as sodium acetate and potassium acetate. The base may be used in an amount of 0.1 to 10 equivalents, preferably 0.5 to 5 equivalents, per equivalent of the compound of formula (II-a).

 反応Cにおける溶媒は、反応に不活性な溶媒であればいずれのものでもよく、例えば、ベンゼン、トルエン、キシレン、クロロベンゼンのような芳香族炭化水素類;四塩化炭素、塩化メチル、クロロホルム、ジクロロメタン、ジクロロエタン、トリクロロエタン、ヘキサン、シクロヘキサンのような脂肪族炭化水素類;ジオキサン、テトラヒドロフラン、ジエチルエーテル、ジメトキシエタンのようなエーテル類;酢酸メチル、酢酸エチルのようなエステル類;ジメチルスルホキシド、スルホラン、N,N-ジメチルアセトアミド、N,N-ジメチルホルムアミド、N-メチルピロリドン、ピリジン、アセトニトリル、プロピオニトリルのような非プロトン性極性溶媒;アセトン、メチルエチルケトンのようなケトン類;メタノール、エタノールのようなプロトン性極性溶媒;水;などから1種又は2種以上を適宜選択できる。 The solvent in reaction C may be any solvent that is inert to the reaction, and may be selected from one or more of the following: aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; aliphatic hydrocarbons such as carbon tetrachloride, methyl chloride, chloroform, dichloromethane, dichloroethane, trichloroethane, hexane, and cyclohexane; ethers such as dioxane, tetrahydrofuran, diethyl ether, and dimethoxyethane; esters such as methyl acetate and ethyl acetate; aprotic polar solvents such as dimethyl sulfoxide, sulfolane, N,N-dimethylacetamide, N,N-dimethylformamide, N-methylpyrrolidone, pyridine, acetonitrile, and propionitrile; ketones such as acetone and methyl ethyl ketone; protic polar solvents such as methanol and ethanol; and water.

 反応Cの反応温度は、通常-20℃~150℃程度、望ましくは0℃~100℃程度であり、反応時間は、通常0.5~48時間程度、望ましくは1~24時間程度である。 The reaction temperature for reaction C is usually about -20°C to 150°C, preferably about 0°C to 100°C, and the reaction time is usually about 0.5 to 48 hours, preferably about 1 to 24 hours.

 反応B及び反応Cで使用される式(III)の化合物は、下記反応2-2又は反応2-4に従って製造することができる。
 反応Bで使用される式(II)の化合物は、下記反応1-1、反応1-2又は公知の方法に準じて製造することができ、又は市販品を使用しても良い。
 反応Cで使用される式(II-a)の化合物は、式(II)の化合物より下記反応1-4又は公知の方法に準じて製造することができ、又は市販品を使用しても良い。
The compound of formula (III) used in reaction B and reaction C can be prepared according to the following reaction 2-2 or reaction 2-4.
The compound of formula (II) used in reaction B can be produced in accordance with the following reaction 1-1 or 1-2 or a known method, or a commercially available product may be used.
The compound of formula (II-a) used in reaction C can be produced from the compound of formula (II) according to the following reaction 1-4 or a known method, or a commercially available product may be used.

[反応D]
 反応Dは、式(XX-c)の化合物を式(IV)の化合物と反応させることにより、式(XX-a)の化合物を得る方法である。
[Reaction D]
Reaction D is a method of obtaining a compound of formula (XX-a) by reacting a compound of formula (XX-c) with a compound of formula (IV).

 式中、Lは脱離基であり、例えば、ハロゲン、トリフルオロメタンスルホニルオキシ、メタンスルホニルオキシ、パラトルエンスルホニルオキシなどが挙げられ、その他の記号は前述の通りである。 In the formula, L 1 is a leaving group such as halogen, trifluoromethanesulfonyloxy, methanesulfonyloxy, paratoluenesulfonyloxy, etc., and the other symbols are as defined above.

 反応Dは、通常、塩基及び溶媒の存在下で、必要に応じて相間移動触媒を添加して行うことができる。反応Dにおける式(IV)の化合物は、式(XX-c)化合物1当量に対して、1~5当量、望ましくは1~3当量使用できる。 Reaction D can be carried out usually in the presence of a base and a solvent, with the addition of a phase transfer catalyst as necessary. The compound of formula (IV) in reaction D can be used in an amount of 1 to 5 equivalents, preferably 1 to 3 equivalents, per equivalent of the compound of formula (XX-c).

 反応Dにおける塩基は、例えば、ナトリウムメトキシド、ナトリウムエトキシド、カリウムtert-ブトキシドのようなアルカリ金属アルコキシド;炭酸ナトリウム、炭酸カリウム、炭酸セシウムのような炭酸塩;炭酸水素ナトリウム、炭酸水素カリウムのような炭酸水素塩;水酸化ナトリウム、水酸化カリウムのような金属水酸化物;水素化ナトリウム、水素化カリウムのような金属水素化物;トリエチルアミン、N,N-ジイソプロピルエチルアミンのようなアミン類;ピリジン、4-ジメチルアミノピリジン、2,6-ルチジンのようなピリジン類;n-ブチルリチウム、リチウムジイソプロピルアミドのような有機リチウム化合物;酢酸ナトリウム、酢酸カリウムなどのアルカリ金属カルボン酸塩;などから1種又は2種以上を適宜選択、混合して使用することができる。前記塩基は、式(XX-c)の化合物1当量に対して1~10当量、望ましくは1~5当量使用できる。 The base in reaction D may be one or more of the following, selected appropriately and mixed: alkali metal alkoxides such as sodium methoxide, sodium ethoxide, and potassium tert-butoxide; carbonates such as sodium carbonate, potassium carbonate, and cesium carbonate; hydrogen carbonates such as sodium hydrogen carbonate and potassium hydrogen carbonate; metal hydroxides such as sodium hydroxide and potassium hydroxide; metal hydrides such as sodium hydride and potassium hydride; amines such as triethylamine and N,N-diisopropylethylamine; pyridines such as pyridine, 4-dimethylaminopyridine, and 2,6-lutidine; organolithium compounds such as n-butyllithium and lithium diisopropylamide; alkali metal carboxylates such as sodium acetate and potassium acetate; etc. The base may be used in an amount of 1 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (XX-c).

 反応Dにおける溶媒は、反応に不活性な溶媒であればいずれのものでもよく、例えば、ベンゼン、トルエン、キシレン、クロロベンゼンのような芳香族炭化水素類;四塩化炭素、塩化メチル、クロロホルム、ジクロロメタン、ジクロロエタン、トリクロロエタン、ヘキサン、シクロヘキサンのような脂肪族炭化水素類;ジオキサン、テトラヒドロフラン、ジエチルエーテル、ジメトキシエタンのようなエーテル類;酢酸メチル、酢酸エチルのようなエステル類;メタノール、エタノール、プロパノール、tert-ブタノールのようなアルコール類;ジメチルスルホキシド、スルホラン、N,N-ジメチルアセトアミド、N,N-ジメチルホルムアミド、N-メチルピロリドン、ピリジン、アセトニトリル、プロピオニトリルのような非プロトン性極性溶媒;アセトン、メチルエチルケトンのようなケトン類;水;などから1種又は2種以上を適宜選択できる。 The solvent in reaction D may be any solvent inert to the reaction, and may be one or more of the following: aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; aliphatic hydrocarbons such as carbon tetrachloride, methyl chloride, chloroform, dichloromethane, dichloroethane, trichloroethane, hexane, and cyclohexane; ethers such as dioxane, tetrahydrofuran, diethyl ether, and dimethoxyethane; esters such as methyl acetate and ethyl acetate; alcohols such as methanol, ethanol, propanol, and tert-butanol; aprotic polar solvents such as dimethyl sulfoxide, sulfolane, N,N-dimethylacetamide, N,N-dimethylformamide, N-methylpyrrolidone, pyridine, acetonitrile, and propionitrile; ketones such as acetone and methyl ethyl ketone; and water.

 反応Dにおける相間移動触媒は、例えば、テトラブチルアンモニウムブロミド、ベンジルトリエチルアンモニウムクロリド、硫酸水素テトラブチルアンモニウムのような第四級アンモニウム塩;18-クラウン-6-エーテルのようなクラウンエーテル類;などが挙げられる。前記相間移動触媒は、式(XX-c)の化合物1当量に対して0.1~3当量使用できる。 The phase transfer catalyst in reaction D may be, for example, a quaternary ammonium salt such as tetrabutylammonium bromide, benzyltriethylammonium chloride, or tetrabutylammonium hydrogen sulfate; or a crown ether such as 18-crown-6-ether; etc. The phase transfer catalyst may be used in an amount of 0.1 to 3 equivalents per equivalent of the compound of formula (XX-c).

 反応Dの反応温度は、通常-20℃~150℃程度、望ましくは0℃~100℃程度であり、反応時間は、通常10分~48時間程度、望ましくは1~24時間程度である。 The reaction temperature for reaction D is usually about -20°C to 150°C, preferably about 0°C to 100°C, and the reaction time is usually about 10 minutes to 48 hours, preferably about 1 to 24 hours.

 反応Dで使用される式(IV)の化合物は、公知の方法に準じて製造することができ、又は市販品を使用しても良い。 The compound of formula (IV) used in reaction D can be produced according to known methods, or a commercially available product may be used.

[反応E]
 反応Eは、式(II-b)の化合物を式(V)の化合物と反応させることにより、式(XX-a)の化合物を得る方法である。
[Reaction E]
Reaction E is a method of obtaining a compound of formula (XX-a) by reacting a compound of formula (II-b) with a compound of formula (V).

 式中の記号は前述の通りである。 The symbols in the formula are as described above.

 反応Eは、上記反応Dに準じて行うことができる。反応Eにおける式(V)の化合物は、式(II-b)の化合物1当量に対して、1~5当量、望ましくは1~2当量使用できる。反応Eにおける塩基は、式(II-b)の化合物1当量に対して1~10当量、望ましくは1~5当量使用できる。反応Eにおける相間移動触媒は、式(II-b)の化合物1当量に対して0.1~3当量使用できる。 Reaction E can be carried out in the same manner as reaction D above. In reaction E, 1 to 5 equivalents, preferably 1 to 2 equivalents, of the compound of formula (V) can be used per equivalent of the compound of formula (II-b). In reaction E, 1 to 10 equivalents, preferably 1 to 5 equivalents, of the base can be used per equivalent of the compound of formula (II-b). In reaction E, 0.1 to 3 equivalents of the phase transfer catalyst can be used per equivalent of the compound of formula (II-b).

 反応Eで使用される式(II-b)の化合物は、下記反応1-3又は公知の方法に準じて製造することができ、又は市販品を使用しても良い。反応Eで使用される式(V)の化合物は、下記反応2-7、反応2-8、反応2-9又は公知の方法に準じて製造することができ、又は市販品を使用しても良い。 The compound of formula (II-b) used in reaction E can be produced in accordance with reaction 1-3 below or a known method, or a commercially available product may be used. The compound of formula (V) used in reaction E can be produced in accordance with reaction 2-7, reaction 2-8, reaction 2-9 below or a known method, or a commercially available product may be used.

 反応A~反応Eで使用した化合物は、下記の各中間体の製造方法(反応1-1~反応1-5及び反応2-1~反応2-9)及び通常の塩の製造方法に従って製造することができるが、これらの方法に限定されるものではなく、これらの化合物は、公知の方法に準じて製造しても良く、又は市販品を使用しても良い。 The compounds used in reactions A to E can be produced according to the methods for producing the intermediates shown below (reactions 1-1 to 1-5 and reactions 2-1 to 2-9) and the usual methods for producing salts, but are not limited to these methods. These compounds may be produced according to known methods or commercially available products may be used.

各中間体の製造方法
[反応1-1]~[反応1-5]
 反応1-1は、式(1)の化合物を酸化し式(II)の化合物を得る方法である。反応1-2は、式(2)の化合物を加水分解し式(II)の化合物を得る方法である。
 反応1-3は式(II)の化合物又は式(II-a)の化合物を式(3)の化合物と反応させ式(II-b)の化合物を得る方法である。
 反応1-4は式(II)の化合物をハロゲン化、エステル化又はカルボニル化により式(II-a)の化合物を得る方法である。
 反応1-5は式(VI)の化合物のアミノ基をBoc基で保護し、式(VII)の化合物を得る方法である。
Methods for producing each intermediate: [Reaction 1-1] to [Reaction 1-5]
Reaction 1-1 is a method for obtaining a compound of formula (II) by oxidizing a compound of formula (1), and reaction 1-2 is a method for obtaining a compound of formula (II) by hydrolyzing a compound of formula (2).
Reaction 1-3 is a method of reacting a compound of formula (II) or a compound of formula (II-a) with a compound of formula (3) to obtain a compound of formula (II-b).
Reaction 1-4 is a method for obtaining a compound of formula (II-a) by halogenating, esterifying or carbonylating a compound of formula (II).
Reaction 1-5 is a method for protecting the amino group of a compound of formula (VI) with a Boc group to obtain a compound of formula (VII).

 各反応における、式中、Zはアルキルであり、ZはH、又はアルキルオキシであり、その他の記号は前述の通りである。
 反応1-1は、一般的なピニック酸化の条件、例えば、Bioorganic & Medicinal Chemistry、2004、12、6171-6182に記載の方法に準じて行うことができる。
In each reaction, in the formula, Z 1 is alkyl, Z 2 is H or alkyloxy, and the other symbols are as defined above.
Reaction 1-1 can be carried out under general Pinnic oxidation conditions, for example, according to the method described in Bioorganic & Medicinal Chemistry, 2004, 12, 6171-6182.

 反応1-1で使用される式(1)の化合物は、公知の方法、例えば、Bioorganic & Medicinal Chemistry,2004,12、6171-6182、Journal of Organic Chemistry,2005,70,567-574、国際公開第2020/028141号、又はOrganic Process Research and Development,2021,25,1167-1175に記載の方法、又は反応1-5に準じて製造することができ、又は市販品を使用しても良い。 The compound of formula (1) used in reaction 1-1 can be produced according to a known method, for example, the method described in Bioorganic & Medicinal Chemistry, 2004, 12, 6171-6182, Journal of Organic Chemistry, 2005, 70, 567-574, International Publication No. 2020/028141, or Organic Process Research and Development, 2021, 25, 1167-1175, or reaction 1-5, or a commercially available product may be used.

 反応1-2は、一般的なエステルの加水分解の条件、例えば、国際公開第2009/100171号に記載の方法に準じて行うことができる。 Reaction 1-2 can be carried out under general ester hydrolysis conditions, for example, in accordance with the method described in WO 2009/100171.

 反応1-2で使用される式(2)の化合物は、公知の方法、例えば、国際公開第2012/006760号、日本登録特許第5851663号、又は反応1-5に記載の方法に準じて製造することができ、又は市販品を使用しても良い。 The compound of formula (2) used in reaction 1-2 can be produced according to known methods, such as those described in International Publication No. 2012/006760, Japanese Patent Registration No. 5851663, or the method described in reaction 1-5, or a commercially available product may be used.

 反応1-3は、上記反応B又は反応Cに準じて行うことができる。反応1-3における式(3)の化合物は、式(II)の化合物又は式(II-a)の化合物の各1当量に対して、0.5~10当量、望ましくは0.7~5当量使用できる。 Reaction 1-3 can be carried out in accordance with the above reaction B or reaction C. In reaction 1-3, the compound of formula (3) can be used in an amount of 0.5 to 10 equivalents, preferably 0.7 to 5 equivalents, per equivalent of the compound of formula (II) or the compound of formula (II-a).

 反応1-3で使用される式(3)の化合物は、公知の方法に準じて、例えば、国際公開第2006/138350号、米国特許出願公開第2014/0378399号に記載の方法に準じて製造することができ、又は市販品を使用しても良い。 The compound of formula (3) used in reaction 1-3 can be produced in accordance with known methods, for example, the methods described in WO 2006/138350 and U.S. Patent Application Publication No. 2014/0378399, or a commercially available product may be used.

 反応1-3で使用される式(II-a)の化合物は、公知の方法又は反応1-4に記載の方法に準じて製造することができ、又は市販品を使用しても良い。 The compound of formula (II-a) used in reaction 1-3 can be produced by a known method or according to the method described in reaction 1-4, or a commercially available product may be used.

 反応1-4は、式(II-a)の化合物のLがハロゲンである場合、通常、溶媒の存在下で式(II)の化合物とハロゲン化剤を反応させて行うことができ、必要に応じてN,N-ジメチルホルムアミドを添加してもよい。
 反応1-4におけるハロゲン化剤としては、例えば塩化オキサリル、塩化チオニル、オキシ塩化リン、オキシ臭化リン、三塩化リン、三臭化リン、五塩化リン、塩化スルフリル等が挙げられる。前記ハロゲン化剤は、式(II)の化合物1当量に対して1~10当量、望ましくは1~3当量使用でき、反応に問題がなければ過剰量を使用してもよい。
 反応1-4で、N,N-ジメチルホルムアミドを使用する場合は、N,N-ジメチルホルムアミドの使用量は触媒量であり、例えば式(II)の化合物1当量に対して0.01~0.3当量使用できる。
When L in the compound of formula (II-a) is halogen, reaction 1-4 can usually be carried out by reacting the compound of formula (II) with a halogenating agent in the presence of a solvent, and N,N-dimethylformamide may be added as necessary.
Examples of the halogenating agent in reaction 1-4 include oxalyl chloride, thionyl chloride, phosphorus oxychloride, phosphorus oxybromide, phosphorus trichloride, phosphorus tribromide, phosphorus pentachloride, sulfuryl chloride, etc. The halogenating agent can be used in an amount of 1 to 10 equivalents, preferably 1 to 3 equivalents, relative to 1 equivalent of the compound of formula (II), and an excess amount may be used if no problem occurs in the reaction.
When N,N-dimethylformamide is used in reaction 1-4, the amount of N,N-dimethylformamide used is a catalytic amount, for example, 0.01 to 0.3 equivalents per equivalent of the compound of formula (II).

 反応1-4は、式(II-a)の化合物のLがアルコキシ又はアリールオキシである場合、通常、溶媒及び脱水縮合剤の存在下で、必要に応じて塩基を加えて、式(II)の化合物とアルコール類又はアリールヒドロキシ類を反応させエステル化を行うことができる。
 反応1-4におけるアルコール類としては、例えばメタノール、エタノールなどが挙げられる。反応1-4におけるアリールヒドロキシ類としては、フェノールなどが挙げられる。前記アルコール類又は前記アリールヒドロキシ類は、式(II)の化合物1当量に対して0.5~5当量、望ましくは0.8~1.5当量使用でき、反応に問題がなければ過剰量を使用してもよい。
 反応1-4における脱水縮合剤としては、上記反応Bに挙げたものが使用できる。反応1-4において前記脱水縮合剤を使用する場合は、必要に応じて脱水縮合剤と一緒に使用される一般的な添加剤(例えば、1-ヒドロキシベンゾトリアゾール(HOBt)など)を添加してもよい。前記脱水縮合剤は、式(II)の化合物1当量に対して、0.5~5当量、望ましくは1~2当量使用でき、前記添加剤は式(II)の化合物1当量に対して、0.2~5当量、望ましくは1~2当量使用できる。反応1-4において前記脱水縮合剤と一緒に塩基を使用する場合は、前記塩基は上記反応Bに挙げたものが使用できる。前記塩基は、式(II)の化合物1当量に対して、0.5~10当量、望ましくは1~5当量使用できる。
In the reaction 1-4, when L of the compound of formula (II-a) is alkoxy or aryloxy, the compound of formula (II) can be reacted with an alcohol or an arylhydroxyl group usually in the presence of a solvent and a dehydration condensing agent, with the addition of a base as necessary, to carry out esterification.
Examples of the alcohols in reaction 1-4 include methanol, ethanol, etc. Examples of the aryl hydroxyl compounds in reaction 1-4 include phenol, etc. The alcohols or aryl hydroxyl compounds can be used in an amount of 0.5 to 5 equivalents, preferably 0.8 to 1.5 equivalents, per equivalent of the compound of formula (II), and an excess amount may be used if no problem occurs in the reaction.
As the dehydration condensation agent in reaction 1-4, those listed in reaction B above can be used. When the dehydration condensation agent is used in reaction 1-4, a general additive (e.g., 1-hydroxybenzotriazole (HOBt) or the like) used together with the dehydration condensation agent may be added as necessary. The dehydration condensation agent can be used in an amount of 0.5 to 5 equivalents, preferably 1 to 2 equivalents, relative to 1 equivalent of the compound of formula (II), and the additive can be used in an amount of 0.2 to 5 equivalents, preferably 1 to 2 equivalents, relative to 1 equivalent of the compound of formula (II). When a base is used together with the dehydration condensation agent in reaction 1-4, those listed in reaction B above can be used. The base can be used in an amount of 0.5 to 10 equivalents, preferably 1 to 5 equivalents, relative to 1 equivalent of the compound of formula (II).

 また、反応1-4において、式(II-a)の化合物のLがアルコキシである場合、通常、溶媒及び塩基を加えて、式(II)の化合物とアルキルハライド類と反応させ、エステル化を行うことができる。
 反応1-4におけるアルキルハライド類としては、例えばヨウ化メチル、ヨウ化エチルなどが挙げられる。前記アルキルハライドは、式(II)の化合物1当量に対して0.5~5当量、望ましくは0.8~1.5当量使用できる。
 反応1-4のアルキルハライド類と反応で使用できる塩基としては、上記反応Dに挙げたものが使用できる。前記塩基は、式(II)の化合物1当量に対して、0.5~10当量、望ましくは1~5当量使用できる。
In addition, in the reaction 1-4, when L in the compound of formula (II-a) is alkoxy, the compound of formula (II) can be reacted with an alkyl halide in the presence of a solvent and a base to carry out esterification.
Examples of the alkyl halide in the reaction 1-4 include methyl iodide, ethyl iodide, etc. The alkyl halide can be used in an amount of 0.5 to 5 equivalents, preferably 0.8 to 1.5 equivalents, per equivalent of the compound of the formula (II).
The base that can be used in the reaction with the alkyl halide in Reaction 1-4 is the same as that mentioned in Reaction D. The base can be used in an amount of 0.5 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (II).

 反応1-4において、式(II-a)の化合物のLがアルキルカルボニルオキシ又はアリールカルボニルオキシである場合、通常、溶媒及び塩基の存在下で、式(II)の化合物とカルボニル化剤と反応させ、カルボニル化を行うことができる。
 反応1-4におけるカルボニル化剤としては、例えばアセチルクロリド、ピバロイルクロリド、ベンゾイルクロリド、無水酢酸、無水安息香酸などが挙げられる。前記カルボニル化剤は、式(II)の化合物1当量に対して0.5~10当量、望ましくは1~5当量使用でき、反応に問題がなければ過剰量を使用してもよい。反応1-4がカルボニル化の場合に使用する塩基としては、上記反応Bに挙げたものが使用できる。前記塩基は、式(II)の化合物1当量に対して、0.5~10当量、望ましくは1~5当量使用できる。
In reaction 1-4, when L of the compound of formula (II-a) is alkylcarbonyloxy or arylcarbonyloxy, the compound of formula (II) can be reacted with a carbonylating agent usually in the presence of a solvent and a base to carry out carbonylation.
Examples of the carbonylating agent in reaction 1-4 include acetyl chloride, pivaloyl chloride, benzoyl chloride, acetic anhydride, and benzoic anhydride. The carbonylating agent can be used in an amount of 0.5 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (II), and an excess amount may be used if no problem occurs in the reaction. When reaction 1-4 is carbonylation, the bases listed in reaction B above can be used. The base can be used in an amount of 0.5 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (II).

 反応1-4における溶媒は、反応に不活性な溶媒であればいずれのものでもよく、例えば、ベンゼン、トルエン、キシレン、クロロベンゼンのような芳香族炭化水素類;四塩化炭素、塩化メチル、クロロホルム、ジクロロメタン、ジクロロエタン、トリクロロエタン、ヘキサン、シクロヘキサンのような脂肪族炭化水素類;ジオキサン、テトラヒドロフラン、ジエチルエーテル、ジメトキシエタンのようなエーテル類;酢酸メチル、酢酸エチルのようなエステル類;ジメチルスルホキシド、スルホラン、N,N-ジメチルアセトアミド、N,N-ジメチルホルムアミド、N-メチルピロリドン、ピリジン、アセトニトリル、プロピオニトリルのような非プロトン性極性溶媒;アセトン、メチルエチルケトンのようなケトン類;メタノール、エタノールのようなプロトン性極性溶媒;水;などから1種又は2種以上を適宜選択できる。 The solvent in reaction 1-4 may be any solvent inert to the reaction, and may be one or more of the following: aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; aliphatic hydrocarbons such as carbon tetrachloride, methyl chloride, chloroform, dichloromethane, dichloroethane, trichloroethane, hexane, and cyclohexane; ethers such as dioxane, tetrahydrofuran, diethyl ether, and dimethoxyethane; esters such as methyl acetate and ethyl acetate; aprotic polar solvents such as dimethyl sulfoxide, sulfolane, N,N-dimethylacetamide, N,N-dimethylformamide, N-methylpyrrolidone, pyridine, acetonitrile, and propionitrile; ketones such as acetone and methyl ethyl ketone; protic polar solvents such as methanol and ethanol; and water.

 反応1-4における反応温度は、通常-50℃~200℃程度、望ましくは-20℃~100℃程度であり、反応時間は、通常0.1~12時間程度である。 The reaction temperature in Reaction 1-4 is usually about -50°C to 200°C, preferably about -20°C to 100°C, and the reaction time is usually about 0.1 to 12 hours.

 反応1-3及び反応1-4で使用される式(II)の化合物は、反応1-1、反応1-2、又は公知の方法に準じて製造することができ、又は市販品を使用しても良い。 The compound of formula (II) used in reactions 1-3 and 1-4 can be produced in accordance with reactions 1-1 and 1-2, or known methods, or a commercially available product may be used.

 反応1-5は、一般的なアミノ基のBoc基による保護の反応条件、例えば、Greene’s PROTECTIVE GROUPS in ORGANIC SYNTHESIS(John Wikey and Sons、2007年、Peter G. M.Wuts、Theodora W. Greene)に記載の方法に準じて行うことができる。 Reactions 1-5 can be carried out according to typical reaction conditions for protecting an amino group with a Boc group, for example, the method described in Greene's PROTECTIVE GROUPS in ORGANIC SYNTHESIS (John Weekey and Sons, 2007, Peter G. M. Wuts, Theodora W. Greene).

 反応1-5で使用される式(VI)の化合物は、公知の方法、例えば国際公開公報第2018/041563号、米国特許出願公開第2008/312255号に記載の方法に準じて製造することができ、又は市販品を使用しても良い。 The compound of formula (VI) used in reaction 1-5 can be produced in accordance with known methods, such as those described in International Publication No. 2018/041563 and U.S. Patent Application Publication No. 2008/312255, or a commercially available product may be used.

[反応2-1]~[反応2-9]
 反応2-1は式(10)の化合物を式(3-a)の化合物と反応させ式(11)の化合物を得る方法である。反応2-2は式(11)の化合物を還元し、式(III)の化合物を得る方法である。反応2-1と反応2-2は式(11)の化合物を単離することなく、連続して行うこともできる。
 反応2-3は式(11-a)の化合物を式(IV)の化合物と反応させることにより、式(11-b)の化合物を得る方法である。
 反応2-4は式(V)の化合物を式(3-a)の化合物と反応させることにより、式(III)の化合物を得る方法である。
 反応2-5はヒドリド還元試薬を用いて式(12)の化合物から式(10)の化合物を得る方法である。反応2-6は式(10)の化合物を還元し、式(13)化合物を得る方法である。反応2-7は、ハロゲン化試薬又はスルホニル化試薬を用いて式(13)化合物から式(V)の化合物を得る方法である。
 反応2-8は、ハロゲン化試薬を用いて式(V-a)化合物から式(V-b)の化合物を得る方法である。反応2-9はハロゲン化剤を用いて式(14)の化合物から式(V-b)の化合物を得る方法である。
[Reaction 2-1] to [Reaction 2-9]
Reaction 2-1 is a method of reacting a compound of formula (10) with a compound of formula (3-a) to obtain a compound of formula (11). Reaction 2-2 is a method of reducing the compound of formula (11) to obtain a compound of formula (III). Reactions 2-1 and 2-2 can be carried out consecutively without isolating the compound of formula (11).
Reaction 2-3 is a method for obtaining a compound of formula (11-b) by reacting a compound of formula (11-a) with a compound of formula (IV).
Reaction 2-4 is a method for obtaining a compound of formula (III) by reacting a compound of formula (V) with a compound of formula (3-a).
Reaction 2-5 is a method for obtaining a compound of formula (10) from a compound of formula (12) using a hydride reducing agent. Reaction 2-6 is a method for obtaining a compound of formula (13) by reducing a compound of formula (10). Reaction 2-7 is a method for obtaining a compound of formula (V) from a compound of formula (13) using a halogenating agent or a sulfonylating agent.
Reaction 2-8 is a method for obtaining a compound of formula (V-b) from a compound of formula (V-a) using a halogenating agent, and Reaction 2-9 is a method for obtaining a compound of formula (V-b) from a compound of formula (14) using a halogenating agent.

 各反応における、式中Lは脱離基であり、例えば、トリフルオロメタンスルホニルオキシ、メタンスルホニルオキシ、パラトルエンスルホニルオキシなどが挙げられ、Lはハロゲンであり、その他の記号は前述の通りである。 In each reaction, L 2 in the formula is a leaving group such as trifluoromethanesulfonyloxy, methanesulfonyloxy, paratoluenesulfonyloxy, etc., L 3 is a halogen, and the other symbols are as defined above.

 反応2-1は、必要に応じて酸、塩基又は脱水剤を添加して行うことができる。また、溶媒の存在下で反応2-1を行うこともできる。反応2-1における式(3-a)の化合物は、式(10)の化合物1当量に対して、1~5当量使用でき、反応に問題がなければ過剰量を使用してもよい。反応2-1における式(3-a)の化合物は式(3-a)の化合物の塩(例えば、塩酸塩、硫酸塩、又はトリフルオロ酢酸塩)を使用してもよい。 Reaction 2-1 can be carried out by adding an acid, a base or a dehydrating agent as necessary. Reaction 2-1 can also be carried out in the presence of a solvent. The compound of formula (3-a) in reaction 2-1 can be used in an amount of 1 to 5 equivalents per equivalent of the compound of formula (10), and an excess amount can be used if there are no problems with the reaction. The compound of formula (3-a) in reaction 2-1 can be a salt of the compound of formula (3-a) (e.g., hydrochloride, sulfate, or trifluoroacetate).

 反応2-1における酸は、無機酸、有機酸のいずれでもよく、無機酸は塩酸、硫酸など、有機酸は酢酸、メタンスルホン酸、パラトルエンスルホン酸などが挙げられる。前記酸は式(10)の化合物1当量に対して、0.1~10当量使用でき、反応に問題がなければ過剰量を使用してもよい。
 反応2-1における塩基は、例えば、ナトリウムメトキシド、ナトリウムエトキシド、カリウムtert-ブトキシドのようなアルカリ金属アルコキシド;炭酸ナトリウム、炭酸カリウムのような炭酸塩;炭酸水素ナトリウム、炭酸水素カリウムのような炭酸水素塩;水酸化ナトリウム、水酸化カリウムのような金属水酸化物;水素化ナトリウム、水素化カリウムのような金属水素化物;トリエチルアミン、N,N-ジイソプロピルエチルアミンのようなアミン類;ピリジン、4-ジメチルアミノピリジン、2,6-ルチジンのようなピリジン類;酢酸ナトリウム、酢酸カリウムなどのアルカリ金属カルボン酸塩;などが挙げられる。前記塩基は式(3-a)の化合物1当量に対して、0.5~5当量使用できる。
The acid in reaction 2-1 may be either an inorganic acid or an organic acid, and examples of the inorganic acid include hydrochloric acid, sulfuric acid, etc., and examples of the organic acid include acetic acid, methanesulfonic acid, paratoluenesulfonic acid, etc. The acid may be used in an amount of 0.1 to 10 equivalents relative to 1 equivalent of the compound of formula (10), and an excess amount may be used if no problem occurs in the reaction.
Examples of the base in reaction 2-1 include alkali metal alkoxides such as sodium methoxide, sodium ethoxide, and potassium tert-butoxide; carbonates such as sodium carbonate and potassium carbonate; hydrogen carbonates such as sodium hydrogen carbonate and potassium hydrogen carbonate; metal hydroxides such as sodium hydroxide and potassium hydroxide; metal hydrides such as sodium hydride and potassium hydride; amines such as triethylamine and N,N-diisopropylethylamine; pyridines such as pyridine, 4-dimethylaminopyridine, and 2,6-lutidine; alkali metal carboxylates such as sodium acetate and potassium acetate; etc. The base can be used in an amount of 0.5 to 5 equivalents relative to 1 equivalent of the compound of formula (3-a).

 反応2-1における脱水剤は、例えば、無水硫酸マグネシウム、無水硫酸ナトリウム、モレキュラーシーブスなどが挙げられる。
 反応2-1における溶媒は、反応に不活性な溶媒であればいずれのものでもよく、例えば、トルエン、キシレンのような芳香族炭化水素類;四塩化炭素、塩化メチル、クロロホルム、ジクロロメタン、ジクロロエタン、トリクロロエタン、ヘキサン、シクロヘキサンのような脂肪族炭化水素類;ジオキサン、テトラヒドロフラン、ジエチルエーテル、ジメトキシエタンのようなエーテル類;酢酸メチル、酢酸エチルのようなエステル類;アセトニトリルのような非プロトン性極性溶媒;メタノール、エタノールのようなプロトン性極性溶媒;水;などから1種又は2種以上を適宜選択することができる。
The dehydrating agent in reaction 2-1 may, for example, be anhydrous magnesium sulfate, anhydrous sodium sulfate, or molecular sieves.
The solvent in Reaction 2-1 may be any solvent inert to the reaction, and may be appropriately selected from, for example, one or more of aromatic hydrocarbons such as toluene and xylene; aliphatic hydrocarbons such as carbon tetrachloride, methyl chloride, chloroform, dichloromethane, dichloroethane, trichloroethane, hexane and cyclohexane; ethers such as dioxane, tetrahydrofuran, diethyl ether and dimethoxyethane; esters such as methyl acetate and ethyl acetate; aprotic polar solvents such as acetonitrile; protic polar solvents such as methanol and ethanol; and water.

 反応2-1の反応温度は、通常-20℃~200℃程度、望ましくは0℃~150℃程度であり、反応時間は、通常0.5~48時間程度、望ましくは1~24時間程度である。 The reaction temperature for reaction 2-1 is usually about -20°C to 200°C, preferably about 0°C to 150°C, and the reaction time is usually about 0.5 to 48 hours, preferably about 1 to 24 hours.

 反応2-1で使用される式(10)の化合物は、反応2-5又は公知の方法に準じて製造でき、又は市販品を使用しても良い。 The compound of formula (10) used in reaction 2-1 can be produced according to reaction 2-5 or a known method, or a commercially available product may be used.

 反応2-2は、通常、還元剤及び溶媒の存在下で行うことができ、また、必要に応じて酸を添加して行うことができる。 Reaction 2-2 can usually be carried out in the presence of a reducing agent and a solvent, and can also be carried out by adding an acid if necessary.

 反応2-2における還元剤は、例えば、水素化ホウ素ナトリウム、水素化シアノホウ素ナトリウム、水素化トリアセトキシホウ素ナトリウム、2-ピコリン・ボラン錯体などが挙げられる。前記還元剤は式(11)の化合物1当量に対して、0.5~10当量、望ましくは1~5当量使用できる。添加する酸としては、無機酸、有機酸いずれでもよく、無機酸としては塩酸など、有機酸としては酢酸、トリフルオロ酢酸などが挙げられる。前記酸は式(11)の化合物1当量に対して、1~10当量使用できる。 The reducing agent in reaction 2-2 may be, for example, sodium borohydride, sodium cyanoborohydride, sodium triacetoxyborohydride, or 2-picoline borane complex. The reducing agent may be used in an amount of 0.5 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (11). The acid to be added may be either an inorganic acid or an organic acid, and examples of the inorganic acid include hydrochloric acid, and examples of the organic acid include acetic acid and trifluoroacetic acid. The acid may be used in an amount of 1 to 10 equivalents per equivalent of the compound of formula (11).

 反応2-2における溶媒は、反応に不活性な溶媒であればいずれのものでもよく、例えば、ベンゼン、トルエン、キシレン、クロロベンゼンのような芳香族炭化水素類;四塩化炭素、塩化メチル、クロロホルム、ジクロロメタン、ジクロロエタン、トリクロロエタン、ヘキサン、シクロヘキサンのような脂肪族炭化水素類;ジオキサン、テトラヒドロフラン、ジエチルエーテル、ジメトキシエタンのようなエーテル類;酢酸メチル、酢酸エチルのようなエステル類;メタノール、エタノールのようなプロトン性極性溶媒;水;などから1種又は2種以上を適宜選択できる。 The solvent in reaction 2-2 may be any solvent that is inert to the reaction, and may be one or more of the following: aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; aliphatic hydrocarbons such as carbon tetrachloride, methyl chloride, chloroform, dichloromethane, dichloroethane, trichloroethane, hexane, and cyclohexane; ethers such as dioxane, tetrahydrofuran, diethyl ether, and dimethoxyethane; esters such as methyl acetate and ethyl acetate; protic polar solvents such as methanol and ethanol; and water.

 反応2-2の反応温度は、通常-20℃~150℃程度、望ましくは0℃~100℃程度であり、反応時間は、通常0.5~48時間程度、望ましくは1~24時間程度である。 The reaction temperature for reaction 2-2 is usually about -20°C to 150°C, preferably about 0°C to 100°C, and the reaction time is usually about 0.5 to 48 hours, preferably about 1 to 24 hours.

 反応2-3は、反応Dに準じて行うことができる。式(IV)の化合物は、式(11-a)の化合物1当量に対して、1~5当量、望ましくは1~2当量使用できる。反応2-3における塩基は、式(11-a)の化合物1当量に対して1~10当量、望ましくは1~5当量使用できる。反応2-3における相間移動触媒は、式(11-a)の化合物1当量に対して、0.1~3当量使用できる。 Reaction 2-3 can be carried out in accordance with reaction D. The compound of formula (IV) can be used in an amount of 1 to 5 equivalents, preferably 1 to 2 equivalents, per equivalent of the compound of formula (11-a). The base in reaction 2-3 can be used in an amount of 1 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (11-a). The phase transfer catalyst in reaction 2-3 can be used in an amount of 0.1 to 3 equivalents per equivalent of the compound of formula (11-a).

 反応2-3の反応温度は、通常-20℃~150℃程度、望ましくは0℃~100℃程度であり、反応時間は、通常10分~48時間程度、望ましくは1~24時間程度である。 The reaction temperature for reaction 2-3 is usually about -20°C to 150°C, preferably about 0°C to 100°C, and the reaction time is usually about 10 minutes to 48 hours, preferably about 1 to 24 hours.

 反応2-4は、反応Eに準じて行うことができる。反応2-4における式(3-a)の化合物は、式(V)の化合物1当量に対して、1~5当量、望ましくは1~3当量使用できる。反応2-4における式(3-a)の化合物は式(3-a)の化合物の塩(例えば、塩酸塩、硫酸塩、又はトリフルオロ酢酸塩)を使用してもよい。反応2-4における塩基は、式(V)の化合物1当量に対して1~10当量、望ましくは1~5当量使用できる。反応2-4における相間移動触媒は、式(V)の化合物1当量に対して、0.1~3当量使用できる。 Reaction 2-4 can be carried out in accordance with reaction E. The compound of formula (3-a) in reaction 2-4 can be used in an amount of 1 to 5 equivalents, preferably 1 to 3 equivalents, per equivalent of the compound of formula (V). The compound of formula (3-a) in reaction 2-4 can be used in the form of a salt of the compound of formula (3-a) (e.g., hydrochloride, sulfate, or trifluoroacetate). The base in reaction 2-4 can be used in an amount of 1 to 10 equivalents, preferably 1 to 5 equivalents, per equivalent of the compound of formula (V). The phase transfer catalyst in reaction 2-4 can be used in an amount of 0.1 to 3 equivalents per equivalent of the compound of formula (V).

 反応2-4の反応温度は、通常-20℃~150℃程度、望ましくは0℃~100℃程度であり、反応時間は、通常10分~48時間程度、望ましくは1~24時間程度である。 The reaction temperature for reaction 2-4 is usually about -20°C to 150°C, preferably about 0°C to 100°C, and the reaction time is usually about 10 minutes to 48 hours, preferably about 1 to 24 hours.

 反応2-4で使用される式(V)の化合物は、公知の方法、反応2-7、反応2-8、又は反応2-9に記載の方法に準じて製造することができ、又は市販品を使用しても良い。 The compound of formula (V) used in reaction 2-4 can be produced in accordance with a known method, the method described in reaction 2-7, reaction 2-8, or reaction 2-9, or a commercially available product can be used.

 反応2-5は、一般的なシアノ基をホルミル基に変換する条件、例えば、Journal of Medicinal Chemistry、2008、51、4021-4029に記載の方法に準じて行うことができる。 Reaction 2-5 can be carried out under general conditions for converting a cyano group to a formyl group, for example, according to the method described in Journal of Medicinal Chemistry, 2008, 51, 4021-4029.

 反応2-5で使用される式(12)の化合物は、公知の方法に準じて製造でき、又は市販品を使用しても良い。 The compound of formula (12) used in reaction 2-5 can be produced according to known methods, or a commercially available product can be used.

 反応2-6は、一般的なホルミル基を還元する条件、例えば、Bioorganic & Medicinal Chemistry Letters、2012、22、901-906に記載の方法に準じて行うことができる。 Reaction 2-6 can be carried out under general conditions for reducing formyl groups, for example, according to the method described in Bioorganic & Medicinal Chemistry Letters, 2012, 22, 901-906.

 反応2-7は、例えば、一般的な水酸基をハロゲン化する条件や一般的な水酸基をスルホニル化する条件で行うことができる。反応2-7の各条件として、Journal of Medicinal Chemistry、2003、46、453-456、国際公開公報第2020/106307号に記載の方法が挙げられる。 Reaction 2-7 can be carried out, for example, under conditions for halogenating a general hydroxyl group or conditions for sulfonylating a general hydroxyl group. Examples of conditions for reaction 2-7 include the methods described in Journal of Medicinal Chemistry, 2003, 46, 453-456 and WO 2020/106307.

 反応2-8は、一般的なメシル基などの脱離基をハロゲン化する条件、例えば、Journal of Medicinal Chemistry、2010、53、8421-8439に記載の方法に準じて行うことができる。 Reaction 2-8 can be carried out under conditions for halogenating a leaving group such as a general mesyl group, for example, according to the method described in Journal of Medicinal Chemistry, 2010, 53, 8421-8439.

 反応2-8で使用される式(V-a)の化合物は、反応2-7又は公知の方法に準じて製造でき、又は市販品を使用しても良い。 The compound of formula (V-a) used in reaction 2-8 can be produced in accordance with reaction 2-7 or a known method, or a commercially available product may be used.

 反応2-9は、一般的なピリジルメチルをハロゲン化する条件、例えば、Journal of Medicinal Chemistry、2011、54、6106-6116に記載の方法に準じて行うことができる。 Reaction 2-9 can be carried out under general conditions for halogenating pyridylmethyl, for example, according to the method described in Journal of Medicinal Chemistry, 2011, 54, 6106-6116.

 反応2-9で使用される式(14)の化合物は、公知の方法に準じて製造でき、又は市販品を使用しても良い。 The compound of formula (14) used in reaction 2-9 can be produced according to known methods, or a commercially available product can be used.

 上記各反応において、反応終了後に、通常の後処理(溶媒の留去、中和、蒸留、洗浄、抽出、ろ過、乾燥等)を行うことで目的の化合物を得ることができる。また、これらの常法による後処理を1種または2種以上を適宜選択し、目的の化合物を単離することができる。また、その後、必要により、カラムクロマトグラフィー、及び再結晶などの常法により目的の化合物を精製してもよい。上記反応によって製造された各々の中間体は、単離又は精製することなく、夫々粗生成物のまま次の工程の反応に用いることもできる。 In each of the above reactions, the target compound can be obtained by carrying out normal post-treatments (solvent removal, neutralization, distillation, washing, extraction, filtration, drying, etc.) after the reaction is completed. The target compound can be isolated by appropriately selecting one or more of these normal post-treatments. If necessary, the target compound can then be purified by normal methods such as column chromatography and recrystallization. Each intermediate produced by the above reactions can also be used as a crude product in the next reaction step without isolation or purification.

 化合物(I)は、有害な植物病害を低薬量で防除できる農園芸用殺菌剤の有効成分として有用である。
 化合物(I)は、例えば卵菌門(Oomycota)、エンドミクサ門(Endomyxa)、フクロカビ門(Olpidiomycota)、子嚢菌門(Ascomycota)、担子菌門(Basidiomycota)、及びコウマクノウキン門(Blastocladiomycota)などに属する植物病原菌に由来する植物病害を防除できる。その中で、卵菌門(Oomycota)、エンドミクサ門(Endomyxa)、及びフクロカビ門(Olpidiomycota)に属する植物病原菌に由来する植物病害の防除に特に有効である。
Compound (I) is useful as an active ingredient of agricultural and horticultural fungicides capable of controlling harmful plant diseases at low doses.
Compound (I) can control plant diseases caused by plant pathogens belonging to, for example, Oomycota, Endomyxa, Olpidiomycota, Ascomycota, Basidiomycota, and Blastocladiomycota. Among them, compound (I) is particularly effective in controlling plant diseases caused by plant pathogens belonging to Oomycota, Endomyxa, and Olpidiomycota.

 上記に属する植物病原菌としては、以下のものが挙げられる。
卵菌門(Oomycota):Albuginales、Anisolpidiales、Lagenidiales、Leptomitales、Myzocytiopsidales、Olpidiopsidales、Peronosporales、Pythiales、Rhipidiales、Saprolegniales、及びSclerosporales等の各分類に属する植物病原菌。
エンドミクサ門(Endomyxa):Haplosporida、Paradiniida、Paramyxida、Gromiida、Phagomyxida、Plasmodiophorida、及びVampyrellida等の各分類に属する植物病原菌。
フクロカビ門(Olpidiomycota):Olpidiales等の分類に属する植物病原菌。
子嚢菌門(Ascomycota):Cladosporiales、Diaporthales、Erysiphales、Glomerellales、Helotiales、Hypocreales、Magnaporthales、Mycosphaerellales、Myriangiales、Pleosporales、及びVenturiales等の各分類に属する植物病原菌。
担子菌門(Basidiomycota):Agaricales、Cantharellales、Pucciniales、及びUstilaginales等の各分類に属する植物病原菌。
コウマクノウキン門(Blastocladiomycota):Physodermatales等の分類に属するものなどが挙げられる。
Examples of plant pathogens that belong to the above-mentioned category include the following.
Oomycota: Plant pathogenic fungi belonging to various classifications such as Albuginales, Anisolopidiales, Lagenidiales, Leptomitales, Myzocytiopsidales, Olpidiopsidales, Peronosporales, Pythiales, Rhipidiales, Saprolegniales, and Sclerosporales.
Endomyxa: Plant pathogenic fungi belonging to the classifications Haplosporida, Paradiniida, Paramyxida, Gromiida, Phagomyxida, Plasmodiophorida, and Vampyrellida.
Olpidiomycota: Plant pathogens belonging to classifications such as Olpidiales.
Ascomycota: Plant pathogenic fungi belonging to various classifications such as Cladosporiales, Diaporthales, Erysiphales, Glomerellales, Helotiales, Hypocreales, Magnaporthales, Mycosphaerellales, Myriangiales, Pleosporales, and Venturiales.
Basidiomycota: Plant pathogenic fungi belonging to various classes such as Agaricales, Cantharellales, Pucciniales, and Ustilaginales.
Blastocladiomycota: Examples include those belonging to the classification Physodermatales, etc.

 前記植物病原菌類の具体例としては、例えば以下のものが挙げられる。
 バレイショ又はトマト疫病菌(Phytophthora infestans)、イチジク疫病菌(Phytophthora palmivora)、ナシ又はイチゴ疫病菌(Phytophthora cactorum)、トウガン、カボチャ、ピーマン又はトウガラシ疫病菌(Phytophthora capsici)、トマト灰色疫病菌(Phytophthora capsici)、ナス又はスイカ褐色腐敗病菌(Phytophthora capsici)、カンキツ褐色腐敗病菌(Phytophthora citricola)、アズキ茎疫病菌(Phytophthora vignae f. sp. adzukicola)、エダマメ茎疫病菌(Phytophthora megasperma var. sojae)、タマネギ又はラッキョウ白色疫病(Phytophthora porri)のようなフィトフトラ(Phytophthora)属菌;キュウリ、カボチャ、メロン、ズッキーニべと病菌(Pseudoperonospora cubensis)、ホップべと病菌(Pseudoperonospora humuli)のようなシュードペロノスポラ(Pseudoperonospora)属菌;ブドウべと病菌(Plasmopara viticola)、ミツバべと病菌(Plasmopara nivea)のようなプラズモパラ(Plasmopara)属菌;キャベツ又はハクサイべと病菌(Hyaloperonospora brassicae)のようなヒアロペロノスポラ(Hyaloperonospora)属菌;レタスべと病菌(Bremia lactucae)のようなブレミア(Bremia)属菌;イネ苗立枯病菌(Pythium graminicola)、コムギ褐色雪腐病菌(Pythium iwayamai)、ハクサイピシウム腐敗病菌(Pythium aphanidermatum)、ミョウガ根茎腐敗病菌(Pythium zingiberis)、ショウガ根茎腐敗病菌(Pythium ultimum var. ultimum)のようなピシウム(Pythium)属菌;ダイコン根くびれ病菌Aphanomyces raphani)、ホウレンソウ根腐病菌(Aphanomyces cochlioides)のようなアファノミセス(Aphanomyces)属菌;ホウレンソウ、カブ、ダイコン又はナバナ白さび病菌(Albugo macrospora)、ワサビ白さび病菌(Albugo wasabiae)、エンサイ白さび病菌(Albugo ipomoeae-aquaticae)のようなアルブゴ(Albugo)属菌;ダイズ又はエダマメべと病菌(Peronospora manshurica)、ブロッコリー又はカブべと病菌(Peronospora parasitica)、ネギ、ワケギ又はタマネギべと病菌(Peronospora destructor)、ホウレンソウべと病菌(Peronospora farinosa f. sp. Spinaciae)、バジルべと病菌(Peronospora belbahrii)のようなペロノスポラ(Peronospora)属菌。
Specific examples of the plant pathogenic fungi include the following.
Potato or tomato phytophthora blight (Phytophthora infestans), fig phytophthora (Phytophthora palmivora), pear or strawberry phytophthora blight (Phytophthora cactorum), wax gourd, pumpkin, bell pepper or chili pepper phytophthora (Phytophthora capsici), tomato gray rot (Phytophthora capsici), eggplant or watermelon brown rot (Phytophthora capsici), citrus brown rot (Phytophthora citricola), adzuki bean stem rot (Phytophthora vignae f. sp. adzukicola), edamame stem rot (Phytophthora megasperma var. sojae), onion or scallion white rot (Phytophthora Phytophthora spp. such as Pseudoperonospora cubensis (cucumber, pumpkin, melon, zucchini downy mildew), Pseudoperonospora humuli (hop downy mildew), Plasmopara spp. such as Plasmopara viticola (grape downy mildew), Plasmopara nivea (honeybee downy mildew), Hyaloperonospora spp. such as Hyaloperonospora brassicae (cabbage or Chinese cabbage downy mildew), Bremia spp. such as Bremia lactucae (lettuce downy mildew), Pythium graminicola (rice seedling blight), Pythium snow rot (wheat snow rot) Pythium genus fungi such as Pythium aphanidermatum, Pythium zingiberis, and Pythium ultimum var. ultimum; Aphanomyces genus fungi such as Aphanomyces raphani and Aphanomyces cochlioides; Albugo genus fungi such as Albugo macrospora, Albugo wasabiae, and Albugo ipomoeae-aquaticae; Peronospora japonica and Peronospora japonica; Peronospora genus fungi such as Peronospora manshurica, Peronospora parasitica, Peronospora destructor, Peronospora farinosa f. sp. Spinaciae, and Peronospora belbahrii.

 ハクサイ、キャベツ、カリフラワー、ナバナ、ブロッコリー又はカブ根こぶ病菌(Plasmodiophora brassicae)のようなネコブカビ(Plasmodiophora)属菌;テンサイそう根病ウイルス(Beet necrotic yellow vein virus)を媒介するポリミキサ ベタエ(Polymyxa betae)のようなポリミキサ(Polymyxa)属菌;バレイショ粉状そうか病菌(Spongospora subterranea)のようなスポンゴスポラ(Spongospora)属菌;レタスビッグベイン病ウイルス(Mirafiori lettuce bigvein virus)を媒介するOlpidium virulentusのようなオルピディウム(Olpidium)属菌。 Plasmodiophora species such as Plasmodiophora brassicae, which causes clubroot disease of Chinese cabbage, cabbage, cauliflower, turnip, broccoli or turnip; Polymyxa species such as Polymyxa betae, which transmits Beet necrotic yellow vein virus; Spongospora species such as Spongospora subterranea, which causes potato powdery scab; Olpidium species such as Olpidium virulentus, which transmits Mirafiori lettuce bigvein virus.

 コムギうどんこ病菌(Erysiphe graminis)のようなエリシフェ(Erysiphe)属菌;トウモロコシすす紋病菌(Setosphaeria turcica)のようなセトスフェリア(Setosphaeria)属菌;キュウリうどんこ病菌(Sphaerotheca fuliginea)、イチゴうどんこ病菌(Sphaerotheca humuli)のようなスファエロテカ(Sphaerotheca)属菌;ブドウうどんこ病菌(Uncinula necator)のようなウンシニュラ(Uncinula)属菌;リンゴうどんこ病菌(Podosphaera leucotricha)のようなポドスファエラ(Podosphaera)属菌;エンドウ褐紋病菌(Mycosphaerella pinodes)、リンゴ黒点病菌(Mycosphaerella pomi)、バナナブラックシガトカ病菌(Mycosphaerella musicola)、カキ円星落葉病菌(Mycosphaerella nawae)、イチゴ蛇の目病菌(Mycosphaerella fragariae)のようなミコスファエレラ(Mycosphaerella)属菌;リンゴ黒星病菌(Venturia inaequalis)、ナシ黒星病菌(Venturia nashicola)のようなヴェンチュリア(Venturia)属菌;オオムギ網斑病菌(Pyrenophora teres)、オオムギ斑葉病菌(Pyrenophora graminea)のようなピレノホラ(Pyrenophora)属菌;インゲン、キュウリ、キャベツ、ハクサイ、トウガラシ、ピーマン又はタマネギ菌核病菌(Sclerotinia sclerotiorum)、コムギ雪腐大粒菌核病菌(Sclerotinia borealis)、トマト小粒菌核病菌(Sclerotinia minor)、アルファルファ菌核病菌(Sclerotinia trifoliorum)のようなスクレロティニア(Sclerotinia)属菌。  Erysiphe species such as wheat powdery mildew (Erysiphe graminis); Setosphaeria species such as corn leaf spot (Setosphaeria turcica); Sphaerotheca species such as cucumber powdery mildew (Sphaerotheca fuliginea) and strawberry powdery mildew (Sphaerotheca humuli); grape powdery mildew (Un Uncinula species such as Podosphaera leucotricha; Mycosphaerella pinodes, Mycosphaerella pomi, Mycosphaerella musicola, Mycosphaerella necator, Mycosphaerella pinodes, Mycosphaerella pomi, Mycosphaerella musicola, Mycosphaerella pinodes ... erella nawae) and Mycosphaerella fragariae; Venturia species such as Venturia inaequalis (apple spot) and Venturia nashicola (pear spot); Pyrenophora teres (barley net blotch) and Pyrenophora graminea (barley leaf spot); Pyrenophora fungi such as Sclerotinia sclerotiorum, which causes sclerotinia rot of beans, cucumbers, cabbage, Chinese cabbage, chili peppers, bell peppers and onions; Sclerotinia borealis, which causes snow mould of wheat, Sclerotinia minor, which causes sclerotinia rot of tomato and Sclerotinia trifoliorum, which causes sclerotinia rot of alfalfa.

 ラッカセイ小菌核病菌(Botryotinia arachidis)のようなボトリオチニア(Botryotinia)属菌;イネごま葉枯病菌(Cochliobolus miyabeanus)のようなコクリオボラス(Cochliobolus)属菌;キュウリつる枯病菌(Didymella bryoniae)のようなディディメラ(Didymella)属菌;イネ馬鹿苗病菌(Gibberella fujikuroi)のようなジベレラ(Gibberella)属菌;ブドウ黒痘病菌(Elsinoe ampelina)、カンキツそうか病菌(Elsinoe fawcettii)のようなエルシノエ(Elsinoe)属菌;カンキツ黒点病菌(Diaporthe citri)、ブドウ枝膨病菌(Diaporthe sp.)のようなディアポルテ(Diaporthe)属菌;リンゴモニリア病菌(Monilinia mali)、モモ灰星病菌(Monilinia fructicola)のようなモニリニア(Monilinia)属菌;ブドウ晩腐病菌(Glomerella cingulata)のようなグロメレラ(Glomerella)属菌。
 イネ紋枯病菌(Rhizoctonia solani)のようなリゾクトニア(Rhizoctonia)属菌;コムギ裸黒穂病菌(Ustilago nuda)のようなウスチラゴ(Ustilago)属菌;エンバク冠さび病菌(Puccinia coronata)、コムギ赤さび病菌(Puccinia recondita)、コムギ黄さび病菌(Puccinia striiformis)のようなプクシニア(Puccinia)属菌;ダイズさび病菌(Phakopsora pachyrhizi)のようなファコプソラ(Phakopsora)属菌;コムギ又はオオムギ雪腐小粒菌核病菌(Typhula incarnata又はTyphula ishikariensis)のようなティフラ(Typhula)属菌。
Botryotinia spp., such as Botryotinia arachidis; Cochliobolus spp., such as Cochliobolus miyabeanus; Didymella spp., such as Didymella bryoniae; Gibberella spp., such as Gibberella fujikuroi; Elsinoe spp., such as Elsinoe ampelina and Elsinoe fawcettii; Diaporthe spp., such as Diaporthe citri and Diaporthe sp.; Monilinia mali and Monilinia fructicola; Glomerella such as Glomerella cingulata.
Rhizoctonia fungi such as Rhizoctonia solani; Ustilago fungi such as Ustilago nuda; Puccinia fungi such as Puccinia coronata, Puccinia recondita, and Puccinia striiformis; Phakopsora fungi such as Phakopsora pachyrhizi; Typhula fungi such as Typhula incarnata or Typhula ishikariensis.

 コムギふ枯病菌(Septoria nodorum)、コムギ葉枯病菌(Septoria tritici)のようなセプトリア(Septoria)属菌;ブドウ、カンキツ、キュウリ、トマト、イチゴ、ナス、インゲン、アズキ、エンドウ、ラッカセイ、トウガラシ、ピーマン、レタス、タマネギ、スターチス、カーネーション、バラ、パンジー又はヒマワリ灰色かび病菌(Botrytis cinerea)、タマネギ灰色腐敗病菌(Botrytis allii)、タマネギのボトリティス属菌による葉枯れ症を引き起こす病原菌(Botrytis squamosa、Botrytis byssoidea又はBotrytis tulipae)のようなボトリティス(Botrytis)属菌;コムギ赤かび病菌(Fusarium graminearum)、キュウリつる割病菌(Fusarium oxysporum)のようなフザリウム(Fusarium)属菌;イネいもち病菌(Pyricularia oryzae)のようなピリキュラリア(Pyricularia)属菌;テンサイ褐斑病菌(Cercospora beticola)、カキ角斑病菌(Cercospora kakivora)のようなサーコスポラ(Cercospora)属菌;キュウリ炭そ病菌(Colletotrichum orbiculare)、コーヒーノキ(Colletotrichum coffeanum)のようなコレトトリカム(Colletotrichum)属菌;リンゴ斑点落葉病菌(Alternaria alternata apple pathotype)、ナシ黒斑病菌(Alternaria alternata Japanese pear pathotype)、バレイショ夏疫またはトマト輪紋病菌(Alternaria solani)、キャベツ又はハクサイ黒斑病菌(Alternaria brassicae)、キャベツ黒すす病菌(Alternaria brassicicola)、タマネギ又はネギ黒斑病菌(Alternaria porri)のようなアルタナリア(Alternaria)属菌;キャベツ根朽病菌(Phoma lingam)のようなフォーマ(Phoma)属菌;コムギ眼紋病菌(Pseudocercosporella herpotrichoides)のようなシュードサーコスポレラ(Pseudocercosporella)属菌;ブドウ褐斑病菌(Pseudocercospora vitis)のようなシュードサーコスポラ(Pseudocercospora)属菌;オオムギ雲形病菌(Rhynchosporium secalis)のようなリンコスポリウム(Rhynchosporium)属菌;モモ黒星病菌(Cladosporium carpophilum)のようなクラドスポリウム(Cladosporium)属菌;モモホモプシス腐敗病菌(Phomopsis sp.)のようなホモプシス(Phomopsis)属菌。カキ炭そ病菌(Gloeosporium kaki)のようなグロエオスポリウム(Gloeosporium)属菌;トマト葉かび病菌(Fulvia fulva)のようなフルビア(Fulvia)属菌;キュウリ褐斑病菌(Corynespora cassiicola)のようなコリネスポラ(Corynespora)属菌;ウモロコシ斑点病菌(Physoderma maydis)のようなPhysoderma属菌類。 Septoria fungi such as Septoria nodorum, Septoria tritici; Botrytis cinerea, Botrytis allii, Botrytis squamosa, Botrytis byssoidea, Botrytis tulipae, Botrytis squam ... rytis fungi; Fusarium fungi such as Fusarium graminearum and Fusarium oxysporum; Pyricularia fungi such as Pyricularia oryzae; Cercospora fungi such as Cercospora beticola and Cercospora kakivora; Colletotrichum fungi such as Colletotrichum orbiculare and Colletotrichum coffeeum; fungi of the genus Alternaria, such as Alternaria alternata apple pathotype, Alternaria alternata Japanese pear pathotype, Alternaria solani, Alternaria brassicae, Alternaria brassicicola, Alternaria porri; fungi of the genus Phoma, such as Phoma lingam; fungi of the genus Wheat eye Pseudocercosporella species, such as Pseudocercosporella herpotrichoides; Pseudocercospora species, such as Pseudocercospora vitis; Rhynchosporium species, such as Rhynchosporium secalis; Cladosporium species, such as Cladosporium carpophilum; and Phomopsis species, such as Phomopsis sp., which causes peach spot rot. Gloeosporium species such as Gloeosporium kaki, which causes anthracnose; Fulvia species such as Fulvia fulva, which causes tomato leaf mold; Corynespora species such as Corynespora cassiicola, which causes brown spot of cucumber; and Physoderma species such as Physoderma maydis, which causes brown spot of corn.

 化合物(I)は前述した各種の植物病原菌類を防除できることから、各種病害を予防的又は治療的に防除することができる。特に化合物(I)は、農園芸分野で問題となる各種病害、例えば、ピシウム菌による苗立枯病、ピリキュラリア菌によるいもち病、フザリウム菌による馬鹿苗病、コクリオボラス菌によるごま葉枯病、リゾクトニア菌による紋枯病等のイネの病害;エリシフェ菌によるうどんこ病、フザリウム菌による赤かび病又はクラウンロット病、プクシニア菌によるさび病、ピシウム菌による褐色雪腐病、ウスチラゴ菌による裸黒穂病、シュードサーコスポラ菌による眼紋病、セプトリア菌による葉枯病又はふ枯病等のムギ類の病害;フザリウム菌による赤かび病、フィソデルマ菌による斑点病、プクシニア菌によるさび病、セトスフェリア菌によるすす紋病、コクリオボラス菌によるごま葉枯病、ピシウム菌による根腐病、ウスチラゴ菌による黒穂病等のトウモロコシの病害;ウスチラゴ菌による黒穂病、スタゴノスポラ菌による葉焼病、プクシニア菌によるさび病、ジベレラ菌による梢頭腐敗病、カルダリオミセス菌によるすす病、シュードサーコスポラ菌による葉枯病等のサトウキビの病害等のイネ科作物の病害;オイディウム菌によるうどんこ病、ファコプソラ菌によるさび病、ペロノスポラ菌によるべと病、フィトフトラ菌による疫病又は茎疫病、コレトトリカム菌による炭そ病、スクレロティニア菌による菌核病、ボトリティス菌による灰色かび病、フザリウム菌による根腐病又は立枯病等のマメ科作物の病害;フザリウム菌による萎黄病、ペロノスポラ菌又はヒアロペロノスポラ菌によるべと病、アルタナリア菌による黒斑病、フォーマ菌による根朽病、プラスモディオフォラ菌による根こぶ病、アファノミセス菌による根くびれ病、ピシウム菌によるピシウム腐敗病等のアブラナ科作物の病害;ブレミア菌によるべと病、フィトフトラ菌による疫病、ボトリティス菌による灰色かび病、スクレロティニア菌による菌核病、アエシジウム菌によるさび病等のキク科作物の病害;アルタナリア菌による輪紋病、フルビア菌による葉かび病、フィトフトラ菌による疫病又は灰色疫病、ボトリティス菌による灰色かび病、オイディウム菌によるうどんこ病、フザリウム菌による萎凋病、シュードサーコスポラ菌によるすすかび病等のトマトの病害;アルタナリア菌による夏疫病、フィトフトラ菌による疫病又は褐色腐敗病、スクレロティニア菌による菌核病、フザリウム菌による乾腐病等のバレイショの病害等のナス科作物の病害;コレトトリカム菌による炭そ病、スファエロテカ菌によるうどんこ病、ディディメラ菌によるつる枯病、シュードペロノスポラ菌によるべと病、フィトフトラ菌による疫病又は褐色腐敗病、コリネスポラ菌による褐斑病、フザリウム菌によるつる割病等のウリ科作物の病害;ペロノスポラ菌によるべと病、フィトフトラ菌による疫病、ボトリティス菌による灰色かび病、スクレロティニア菌による菌核病、プクシニア菌によるさび病等のヒガンバナ科ネギ属作物の病害;プラズモパラ菌によるべと病、アルタナリア菌による黒葉枯病又は黒斑病、ボトリティス菌による灰色かび病、スクレロティニア菌による菌核病、エリシフェ菌によるうどんこ病、サーコスポラ菌による斑点病等のセリ科作物の病害;ボトリティス菌による葉枯病、フィトフトラ菌による疫病、ホモプシス菌による茎枯病等のユリ科作物の病害;ペロノスポラ菌によるべと病、エリシフェ菌によるうどんこ病、リゾクトニア菌による立枯病等のタデ科作物の病害;アルブゴ菌による白さび病、フザリウム菌によるつる割病、セラトシスティス菌による黒斑病、ストレプトマイセス菌による立枯病等のヒルガオ科作物の病害;アファノミセス菌による根腐病、アルブゴ菌による白さび病、ペロノスポラ菌によるべと病、フィトフトラ菌による疫病、ボトリティス菌による灰色かび病、スクレロティニア菌による菌核病、オイディウム菌によるうどんこ病、サーコスポラ菌による褐斑病等のアカザ科作物の病害;エルシノエ菌による黒とう病、コレトトリカム菌による晩腐病、エリシフェ菌によるうどんこ病、プラズモパラ菌によるべと病、ボトリティス菌による灰色かび病、シュードサーコスポラ菌による褐斑病、ディアポルテ菌による枝膨病等のブドウ科作物の病害;スファエロテカ菌によるうどんこ病、ボトリティス菌による灰色かび病、グロメレラ菌による炭そ病、フザリウム菌による乾腐病等のイチゴの病害;モニリニア菌によるモニリア病、ポドスファエラ菌によるうどんこ病、アルタナリア菌による斑点落葉病、ヴェンチュリア菌による黒星病、グロメレラ菌による炭そ病、ディプロカーポン菌による褐斑病、ボトリオスファエリア菌による輪紋病、ジゴフィアラ菌によるすす点病、グロエオデス菌によるすす斑病、ミコスファエレラ菌による黒点病等のリンゴの病害;ヴェンチュリア菌による黒星病、アルタナリア菌による黒斑病、フィラクティニア菌によるうどんこ病、フィトフトラ菌による疫病、フザリウム菌による果実腐敗病等のナシ類の病害;モニリニア菌による灰星病、クラドスポリウム菌による黒星病、ホモプシス菌によるホモプシス腐敗病等のモモの病害等のバラ科作物の病害;ディアポルテ菌による黒点病、エルシノエ菌によるそうか病、フザリウム菌によるフザリウム立枯病等のカンキツの病害等のミカン科作物の病害;グロエオスポリウム菌による炭そ病、サーコスポラ菌による落葉病、フィラクティニア菌によるうどんこ病、ジゴフィアラ菌によるすす点病等のカキノキ科作物の病害;コレトトリカム菌による炭そ病、ペスタロオチオプシス菌による輪斑病、シュードモナス菌による赤焼病、エクソバシディウム菌によるもち病等のツバキ科作物の病害;ピシウム菌による根茎腐敗病等のショウガ科作物の病害;シュードペロノスポラ菌によるべと病等のアサ科作物の病害;ペロノスポラ菌によるべと病等シソ科作物の病害などの植物病害の防除に有効である。 Since compound (I) can control the various plant pathogenic fungi mentioned above, it can preventively or therapeutically control various diseases. In particular, compound (I) is effective against various diseases that are problematic in the agricultural and horticultural fields, for example, rice diseases such as seedling damping-off caused by Pythium, rice blast caused by Pyricularia, bakanae disease caused by Fusarium, whole leaf blight caused by Cochliobolus, and sheath blight caused by Rhizoctonia; wheat diseases such as powdery mildew caused by Erysiphe, red mold disease or crown rot caused by Fusarium, rust caused by Puccinia, brown snow mold caused by Pythium, bare smut caused by Ustilago, eyespot disease caused by Pseudocircospora, leaf blight or streaking blight caused by Septoria; and wheat diseases such as red mold disease caused by Fusarium, spot disease caused by Physoderma, rust caused by Puccinia, sooty leaf blight caused by Cetosphaeria, and sheath blight caused by Cochliobolus. Corn diseases such as southern leaf blight, root rot caused by Pythium, and smut caused by Ustilago; sugarcane diseases such as smut caused by Ustilago, leaf burn caused by Stagonospora, rust caused by Puccinia, top rot caused by Gibberella, sooty mildew caused by Caldariomyces, and leaf blight caused by Pseudocircospora; legume diseases such as powdery mildew caused by Oidium, rust caused by Phakopsora, downy mildew caused by Peronospora, late blight or stem blight caused by Phytophthora, anthracnose caused by Colletotrichum, sclerotinia rot caused by Sclerotinia, gray mold caused by Botrytis, root rot or damping off caused by Fusarium; Diseases of Brassicaceae crops such as downy mildew caused by Spora or Hyaloperonospora, black spot caused by Alternaria, root rot caused by Phoma, clubroot disease caused by Plasmodiophora, root constriction caused by Aphanomyces, and Pythium rot caused by Pythium; diseases of Asteraceae crops such as downy mildew caused by Bremia, late blight caused by Phytophthora, gray mold caused by Botrytis, sclerotinia rot caused by Sclerotinia, and rust caused by Aescidium; ring spot caused by Alternaria, leaf mold caused by Fluvia, late blight or gray mold caused by Phytophthora, gray mold caused by Botrytis, powdery mildew caused by Oidium, wilt caused by Fusarium, and sooty mold caused by Pseudocircospora tomato diseases such as blight; solanaceae crop diseases such as potato diseases such as summer blight caused by Alternaria fungus, late blight or brown rot caused by Phytophthora fungus, sclerotinia sclerotinia, and dry rot caused by Fusarium fungus; cucurbitaceae crop diseases such as anthracnose caused by Colletotrichum fungus, powdery mildew caused by Sphaerotheca fungus, vine blight caused by Didymella fungus, downy mildew caused by Pseudoperonospora fungus, late blight or brown rot caused by Phytophthora fungus, brown spot disease caused by Corynespora fungus, and vine split disease caused by Fusarium fungus; amaryllis and Allium crop diseases such as downy mildew caused by Peronospora fungus, late blight caused by Phytophthora fungus, gray mold caused by Botrytis fungus, sclerotinia sclerotinia, and rust caused by Puccinia fungus; Diseases of Umbelliferae crops such as downy mildew caused by Plasmopara, black leaf blight or black spot caused by Alternaria, gray mold caused by Botrytis, sclerotinia rot caused by Sclerotinia, powdery mildew caused by Erysiphe, and spot disease caused by Circospora; diseases of Liliaceae crops such as leaf blight caused by Botrytis, late blight caused by Phytophthora, and stem blight caused by Phomopsis; diseases of Polygonaceae crops such as downy mildew caused by Peronospora, powdery mildew caused by Erysiphe, and damping-off caused by Rhizoctonia; diseases of Convolvulaceae crops such as white rust caused by Albugo, vine splitting caused by Fusarium, black spot caused by Ceratocystis, and damping-off caused by Streptomyces; root rot caused by Aphanomyces, and stem rot caused by Albugo Diseases of Chenopodiaceae crops such as white rust, downy mildew caused by Peronospora, late blight caused by Phytophthora, gray mold caused by Botrytis, sclerotinia rot caused by Sclerotinia, powdery mildew caused by Oidium, and brown spot caused by Circospora; diseases of Vitaceae crops such as black rot caused by Elsinoe, late rot caused by Colletotrichum, powdery mildew caused by Erysiphe, downy mildew caused by Plasmopara, gray mold caused by Botrytis, brown spot caused by Pseudocircospora, and branch swelling caused by Diaporthe; diseases of strawberry such as powdery mildew caused by Sphaerotheca, gray mold caused by Botrytis, anthracnose caused by Glomerella, and dry rot caused by Fusarium; Monilia disease caused by Monilia, Diseases of apples such as powdery mildew caused by Podosphaera, leaf spot caused by Alternaria, black spot caused by Venturia, anthracnose caused by Glomerella, brown spot caused by Diplocarpon, ring spot caused by Botryosphaeria, sooty spot caused by Zygophiala, sooty spot caused by Gloeodes, and black spot caused by Mycosphaerella; diseases of pears such as black spot caused by Venturia, black spot caused by Alternaria, powdery mildew caused by Phyllactinia, late blight caused by Phytophthora, and fruit rot caused by Fusarium; diseases of Rosaceae crops such as brown spot caused by Monilinia, black spot caused by Cladosporium, and homopsis rot caused by homopsis; diseases of peach such as Diaporte fungus It is effective for controlling plant diseases such as citrus diseases such as black spot disease caused by Elsinoe fungus, common scab caused by Fusarium fungus, and Fusarium wilt disease caused by Fusarium fungus; diseases of Ebenaceae crops such as anthracnose caused by Gloeosporium fungus, leaf spot disease caused by Circospora fungus, powdery mildew caused by Phyllactinia fungus, and sooty spot disease caused by Zygophiala fungus; diseases of Theaceae crops such as anthracnose caused by Colletotrichum fungus, ring spot disease caused by Pestaloothiopsis fungus, red burn caused by Pseudomonas fungus, and blast disease caused by Exobasidium fungus; diseases of Zingiberaceae crops such as rhizome rot caused by Pythium fungus; diseases of Cannabaceae crops such as downy mildew caused by Pseudoperonospora fungus; and diseases of Lamiaceae crops such as downy mildew caused by Peronospora fungus.

 また、フザリウム菌による赤かび病又はクラウンロット病、コレトトリカム菌による炭そ病、チレチア菌によるなまぐさ黒穂病、ウスチラゴ菌による裸黒穂病、セファロスポリウム菌による条斑病、セプトリア菌によるふ枯病等のムギ類の病害;ビポラリス菌によるごま葉枯病、コレトトリカム菌による炭そ病、フザリウム菌による苗立枯病等のトウモロコシの病害;グロメレラ菌による赤腐病、セラトシスティス菌による黒腐病、スクレロスポラ菌によるべと病等のサトウキビの病害等のイネ科作物の病害;サーコスポラ菌による紫斑病、ペロノスポラ菌によるべと病、フザリウム菌による立枯病、セプトリア菌による褐紋病、ディアポルテ菌による黒点病、コレトトリカム菌による炭そ病、セプトグロエウム菌によるねむり病等のダイズの病害等のマメ科作物の病害;アルタナリア菌による黒斑病または黒すす病、ペロノスポラ菌によるべと病、シュードモナス菌による黒斑細菌病、ザントモナス菌による黒腐病、フォーマ菌による根朽病等のキャベツの病害;アルタナリア菌による黒斑病、フザリウム菌による萎黄病、ザントモナス菌による黒腐病等のダイコンの病害;アルタナリア菌による黒斑病、ザントモナス菌による黒腐病、バーティシリウム菌による黄化病等のハクサイの病害等のアブラナ科作物の病害;アルタナリア菌による輪紋病、クラビバクター菌によるかいよう病、ザントモナス菌による斑点細菌病等のトマトの病害;アルタナリア菌による褐斑病、ホモプシス菌による褐紋病等のナスの病害;ストレプトマイセス菌によるそうか病、ヘルミントスポリウム菌による銀か病、スポンゴスポラ菌による粉状そうか病等のバレイショの病害等ナス科作物の病害;アルタナリア菌による黒斑病、シュードモナス菌による斑点細菌病、ザントモナス菌による褐斑細菌病等のキュウリの病害等のウリ科作物の病害;アルタナリア菌による黒斑病、ボトリティス菌による灰色腐敗病又は菌糸性腐敗病、フザリウム菌による乾腐病、ペロノスポラ菌によるべと病、フィトフトラ菌による白色疫病又は茎疫病等のヒガンバナ科ネギ属作物の病害;アルタナリア菌による黒葉枯病又は黒斑病、ザントモナス菌による斑点細菌病等のニンジンの病害;セプトリア菌による葉枯病、スクレロティニア菌による菌核病、シュードモナス菌による葉枯細菌病等のセルリーの病害等のセリ科作物の病害;ペロノスポラ菌によるべと病、フザリウム菌による萎凋病、コレトトリカム菌による炭そ病等のホウレンソウの病害等のアカザ科作物の病害;などの種子伝染性病害にも有効である。  Also, diseases of wheat such as red mold or crown rot caused by Fusarium, anthracnose caused by Colletotrichum, cattail smut caused by Tillettsia, bare smut caused by Ustilago, stripe disease caused by Cephalosporium, and spot blight caused by Septoria; diseases of corn such as southern leaf spot caused by Bipolaris, anthracnose caused by Colletotrichum, and damping-off caused by Fusarium; diseases of rice crops such as red rot caused by Glomerella, black rot caused by Ceratocystis, and downy mildew caused by Sclerospora; purple spot caused by Circospora, downy mildew caused by Peronospora, and downy mildew caused by Fusarium. Diseases of legume crops such as soybean diseases such as damping-off, ascochyta caused by Septoria fungus, black spot caused by Diaporthe fungus, anthracnose caused by Colletotrichum fungus, and sleeping disease caused by Septogloeum fungus; cabbage diseases such as black spot or black sooty mold caused by Alternaria fungus, downy mildew caused by Peronospora fungus, black spot bacterial disease caused by Pseudomonas fungus, black rot caused by Xanthomonas fungus, and root rot caused by Phoma fungus; radish diseases such as black spot caused by Alternaria fungus, yellows caused by Fusarium fungus, and black rot caused by Xanthomonas fungus; Chinese cabbage diseases such as black spot caused by Alternaria fungus, black rot caused by Xanthomonas fungus, and yellowing disease caused by Verticillium fungus. Brassicaceae crop diseases such as blight; tomato diseases such as ring spot caused by Alternaria, canker caused by Clavibacter, and bacterial spot caused by Xanthomonas; eggplant diseases such as brown spot caused by Alternaria and brown spot caused by Phomopsis; potato diseases such as scab caused by Streptomyces, silver scab caused by Helminthosporium, and powdery scab caused by Spongospora; cucurbit diseases such as black spot caused by Alternaria, bacterial spot caused by Pseudomonas, and bacterial brown spot caused by Xanthomonas; cucurbit diseases such as black spot caused by Alternaria and ash spot caused by Botrytis. It is also effective against seed-borne diseases such as color rot or mycelial rot, dry rot caused by Fusarium, downy mildew caused by Peronospora, white blight or stem blight caused by Phytophthora, carrot diseases such as black leaf blight or black spot caused by Alternaria, and bacterial spot disease caused by Xanthomonas, diseases of Umbelliferae crops such as celery diseases such as leaf blight caused by Septoria, sclerotinia rot caused by Sclerotinia, and bacterial leaf blight caused by Pseudomonas, and diseases of Chenopodiaceae crops such as downy mildew caused by Peronospora, wilt caused by Fusarium, and anthracnose caused by Colletotrichum, among others.

 さらに、フザリウム菌、ピシウム菌、リゾクトニア菌、バーティシリウム菌、プラズモディオホーラ菌、チエラビオプシス菌などの植物病原菌によって引き起こされる土壌病害の防除にも有効である。 Furthermore, it is also effective in controlling soil diseases caused by plant pathogens such as Fusarium, Pythium, Rhizoctonia, Verticillium, Plasmodiophora, and Thielaviopsis.

 化合物(I)は、上述の各種病害を予防的又は治療的に防除することができる。下記の実施例に記載された試験方法を用いて、一定の本発明化合物(I)は、低濃度(例えば、100ppm、25ppm、12.5ppm、6.3ppm、3.1ppm、1.6ppm、0.8ppm、0.4ppm、0.2ppm又は0.1ppm)で、優れた予防的又は治療的な防除効果を発揮することができる。 Compound (I) can preventively or therapeutically control the various diseases mentioned above. Using the test method described in the Examples below, certain compounds (I) of the present invention can exert excellent preventive or therapeutic control effects at low concentrations (e.g., 100 ppm, 25 ppm, 12.5 ppm, 6.3 ppm, 3.1 ppm, 1.6 ppm, 0.8 ppm, 0.4 ppm, 0.2 ppm, or 0.1 ppm).

 また、化合物(I)は、優れた耐雨性、残効性、浸達性を有していることから、化合物(I)を植物体に施用することによって植物の地上部の有害菌類を一定の期間防除することができる。 In addition, compound (I) has excellent rain resistance, residual activity, and penetrability, so that applying compound (I) to a plant body can control harmful fungi on the above-ground parts of the plant for a certain period of time.

 種々の有害な植物病害を防除するために、有効量の化合物(I)を植物体、植物病原菌又は土壌に施用することができる。
 前記有効量とは、化合物(I)が種々の有害な植物病害に対して防除効果を発揮する、化合物(I)の施用量を意味する。
 前記植物体とは、樹幹、茎、葉、花、穂、果実のような植物の地上部、塊茎、根茎、根のような植物の地下部、並びに植物の種子、実生、及び移植苗等を意味する。
 前記土壌とは、畑、水田、果樹園等の農耕地、及び芝生、森林等の非農耕地などの植物の栽培地を意味する。
In order to control various harmful plant diseases, an effective amount of compound (I) can be applied to plants, plant pathogens or soil.
The above-mentioned effective amount means the application amount of compound (I) at which compound (I) exerts a control effect against various harmful plant diseases.
The plant body means above-ground parts of a plant such as trunks, stems, leaves, flowers, spikes, and fruits, underground parts of a plant such as tubers, rhizomes, and roots, as well as seeds, seedlings, and transplants of a plant.
The soil means agricultural land such as fields, paddy fields, orchards, and non-agricultural land such as lawns and forests where plants are cultivated.

 化合物(I)が施用される植物は農園芸上有用なものであれば特に制限は無いが、例えば、イネ科作物(イネ、コムギ、オオムギ、エンバク、ライムギ、トウモロコシ、サトウキビ等)、マメ科作物(ダイズ、インゲンマメ、アズキ、エンドウ、ラッカセイ、エダマメ、アルファルファ等)、アブラナ科作物(キャベツ、ハクサイ、ダイコン、カブ、ブロッコリー、カリフラワー、ナバナ、セイヨウアブラナ、ワサビ等)、キク科作物(レタス、ゴボウ、シュンギク、ヒマワリ等)、ナス科作物(バレイショ、ナス、トマト、ピーマン、タバコ、トウガラシ等)、ウリ科作物(キュウリ、カボチャ、メロン、スイカ、トウガン、ズッキーニ等)、ヒガンバナ科ネギ属作物(ネギ、ニラ、ラッキョウ、ニンニク、タマネギ、ワケギ等)、セリ科作物(セルリー、ニンジン、パセリ、ミツバ等)、ユリ科作物(ユリ、チューリップ、アスパラガス等)、タデ科作物(ソバ等)、ヒルガオ科作物(サツマイモ、エンサイ等)、アカザ科作物(ホウレンソウ、テンサイ等)、ブドウ科作物(ブドウ等)、バラ科作物(バラ、イチゴ、リンゴ、ナシ、モモ、ビワ、アーモンド等)、ミカン科作物(ミカン、レモン、オレンジ、カンキツ等)、カキノキ科作物(カキ等)、クワ科作物(イチジク等)、ツバキ科作物(チャ等)、モクセイ科作物(オリーブ、ジャスミン等)、アオイ科作物(ワタ、カカオ、オクラ等)、バショウ科作物(バナナ等)、ショウガ科作物(ショウガ、ミョウガ等)、アサ科作物(ホップ等)、シソ科作物(バジル等)、アカネ科作物(コーヒーノキ等)、パイナップル科作物(パイナップル、アナナス等)、イソマツ科作物(スターチス等)、ナデシコ科作物(カーネーション等)、スミレ科作物(パンジー等)が挙げられる。 The plants to which compound (I) is applied are not particularly limited as long as they are agriculturally and horticulturally useful, and examples thereof include Gramineae crops (rice, wheat, barley, oats, rye, corn, sugarcane, etc.), Leguminous crops (soybean, kidney bean, adzuki bean, pea, peanut, edamame, alfalfa, etc.), Brassicaceae crops (cabbage, Chinese cabbage, radish, turnip, broccoli, cauliflower, rapeseed, rapeseed, etc.), and the like. Wasabi, etc.), Asteraceae crops (lettuce, burdock, chrysanthemum, sunflower, etc.), Solanaceae crops (potato, eggplant, tomato, bell pepper, tobacco, chili pepper, etc.), Cucurbitaceae crops (cucumber, pumpkin, melon, watermelon, wax gourd, zucchini, etc.), Amaryllidaceae Allium crops (green onion, Chinese chive, shallot, garlic, onion, scallion, etc.), Umbelliferae crops (celery, carrot, parsley, mitsuba, etc.), Liliaceae crops (lily, tulip, etc.), crops of the Polygonaceae family (buckwheat, etc.), crops of the Convolvulaceae family (sweet potato, water beet, etc.), crops of the Chenopodiaceae family (spinach, sugar beet, etc.), crops of the Vitaceae family (grapes, etc.), crops of the Rosaceae family (roses, strawberries, apples, pears, peaches, loquats, almonds, etc.), crops of the Rutaceae family (tangerines, lemons, oranges, citrus fruits, etc.), crops of the Ebenaceae family (persimmons, etc.), crops of the Mulberry family (figs, etc.), crops of the Theaceae family (tea, etc.), crops of the Oleaceae family ( These include: Malvaceae crops (cotton, cacao, okra, etc.), Musaceae crops (bananas, etc.), Zingiberaceae crops (ginger, ginger, etc.), Cannabaceae crops (hops, etc.), Lamiaceae crops (basil, etc.), Rubiaceae crops (coffee trees, etc.), Bromeliaceae crops (pineapple, bromeliad, etc.), Plumeriaceae crops (static, etc.), Caryophyllaceae crops (carnation, etc.), and Violaceae crops (pansies, etc.).

 前記植物には、遺伝子組み換え技術や遺伝子編集技術を用いて育成された植物、例えば、環境ストレス耐性、除草剤耐性、害虫耐性、病害耐性などを付与された植物、又は、成長、稔性形質、生産物の品質や収量などを改変された植物を含む。 These plants include plants that have been developed using genetic engineering or gene editing techniques, such as plants that have been endowed with environmental stress resistance, herbicide resistance, pest resistance, or disease resistance, or plants that have been modified in terms of growth, fertility, product quality, yield, etc.

 化合物(I)は、通常、化合物(I)と補助剤とを混合して粉剤、粒剤、顆粒水和剤、水和剤、水性懸濁剤、油性懸濁剤、水溶剤、乳剤、液剤、ペースト剤、エアゾール剤、微量散布剤、マイクロカプセル剤などの種々の形態に製剤し使用されるが、本発明の目的に適合するかぎり、通常の当該分野に用いられているあらゆる製剤形態にすることができる。製剤に使用する前記補助剤としては、固体担体、液体担体が挙げられるが、必要に応じて、界面活性剤、その他の製剤用補助剤を添加することもできる。 Compound (I) is usually formulated and used in various forms, such as dusts, granules, granular water-dispersible agents, wettable powders, aqueous suspensions, oily suspensions, water-soluble agents, emulsions, liquids, pastes, aerosols, micro-dispersible agents, and microcapsules, by mixing compound (I) with an auxiliary agent. However, as long as the object of the present invention is met, any formulation form normally used in the relevant field can be used. Examples of the auxiliary agents used in the formulation include solid carriers and liquid carriers, and surfactants and other formulation auxiliary agents can also be added as necessary.

 前記固体担体の具体例としては、珪藻土、消石灰、炭酸カルシウム、タルク、ホワイトカーボン、カオリン、ベントナイト、カオリナイト、セリサイト、クレー、炭酸ナトリウム、重曹、芒硝、ゼオライト、澱粉、微粉シリカが挙げられる。 Specific examples of the solid carrier include diatomaceous earth, slaked lime, calcium carbonate, talc, white carbon, kaolin, bentonite, kaolinite, sericite, clay, sodium carbonate, baking soda, mirabilite, zeolite, starch, and finely powdered silica.

 前記液体担体の具体例としては、水、トルエン、キシレン、ソルベントナフサ、ジオキサン、アセトン、イソホロン、メチルイソブチルケトン、クロロベンゼン、シクロヘキサン、ジメチルスルホキシド、N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、N-メチル-2-ピロリドン、アルコールが挙げられる。 Specific examples of the liquid carrier include water, toluene, xylene, solvent naphtha, dioxane, acetone, isophorone, methyl isobutyl ketone, chlorobenzene, cyclohexane, dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, and alcohol.

 前記界面活性剤の具体例としては、脂肪酸塩、安息香酸塩、アルキルスルホコハク酸塩、ジアルキルスルホコハク酸塩、ポリカルボン酸塩、アルキル硫酸エステル塩、アルキル硫酸塩、アルキルアリール硫酸塩、アルキルジグリコールエーテル硫酸塩、アルコール硫酸エステル塩、アルキルスルホン酸塩、アルキルアリールスルホン酸塩、アリールスルホン酸塩、リグニンスルホン酸塩、アルキルジフェニルエーテルジスルホン酸塩、ポリスチレンスルホン酸塩、アルキルリン酸エステル塩、アルキルアリールリン酸塩、スチリルアリールリン酸塩、ポリオキシエチレンアルキルエーテル硫酸エステル塩、ポリオキシエチレンアルキルアリールエーテルリン酸塩、ポリオキシエチレンアルキルアリールエーテル硫酸塩、ポリオキシエチレンアルキルアリールエーテル硫酸エステル塩、ポリオキシエチレンアルキルエーテルリン酸塩、ポリオキシエチレンアルキルアリールリン酸エステル塩、ナフタレンスルホン酸ホルマリン縮合物の塩のような陰イオン系の界面活性剤や展着剤;ソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、脂肪酸ポリグリセライド、脂肪酸アルコールポリグリコールエーテル、アセチレングリコール、アセチレンアルコール、オキシアルキレンブロックポリマー、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルアリールエーテル、ポリオキシエチレンスチリルアリールエーテル、ポリオキシエチレングリコールアルキルエーテル、ポリエチレングリコール、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシプロピレン脂肪酸エステルのような非イオン系の界面活性剤や展着剤が挙げられる。 Specific examples of the surfactant include fatty acid salts, benzoates, alkyl sulfosuccinates, dialkyl sulfosuccinates, polycarboxylates, alkyl sulfates, alkyl sulfates, alkylaryl sulfates, alkyl diglycol ether sulfates, alcohol sulfates, alkyl sulfonates, alkylaryl sulfonates, aryl sulfonates, lignin sulfonates, alkyl diphenyl ether disulfonates, polystyrene sulfonates, alkyl phosphates, alkylaryl phosphates, styrylaryl phosphates, polyoxyethylene alkyl ether sulfates, polyoxyethylene alkylaryl ether phosphates, polyoxyethylene alkylaryl ether sulfate ... Examples of such surfactants and spreaders include anionic surfactants and spreaders such as oxyethylene alkylaryl phosphate ester salts and salts of naphthalenesulfonic acid formalin condensates; and nonionic surfactants and spreaders such as sorbitan fatty acid esters, glycerin fatty acid esters, fatty acid polyglycerides, fatty acid alcohol polyglycol ethers, acetylene glycol, acetylene alcohol, oxyalkylene block polymers, polyoxyethylene alkyl ethers, polyoxyethylene alkylaryl ethers, polyoxyethylene styrylaryl ethers, polyoxyethylene glycol alkyl ethers, polyethylene glycol, polyoxyethylene fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene glycerin fatty acid esters, polyoxyethylene hydrogenated castor oil, and polyoxypropylene fatty acid esters.

 その他の製剤用補助剤の具体例としては、オリーブ油、カポック油、ひまし油、シュロ油、椿油、ヤシ油、ごま油、トウモロコシ油、米ぬか油、落花生油、綿実油、大豆油、菜種油、亜麻仁油、きり油、液状パラフィンなどの植物油や鉱物油;シリコーン;ザンサンガムなどが挙げられる。 Specific examples of other formulation adjuvants include vegetable oils and mineral oils such as olive oil, kapok oil, castor oil, palm oil, camellia oil, coconut oil, sesame oil, corn oil, rice bran oil, peanut oil, cottonseed oil, soybean oil, rapeseed oil, linseed oil, tung oil, and liquid paraffin; silicones; and xanthan gum.

 これら補助剤の各成分は、本発明の目的から逸脱しないかぎり、1種又は2種以上を適宜選択して使用することができる。また、前記した補助剤以外にも当該分野で知られたものの中から適宜選んで使用することもでき、例えば、増量剤、増粘剤、沈降防止剤、凍結防止剤、分散安定剤、薬害軽減剤、防黴剤など通常使用される各種補助剤も使用することができる。化合物(I)と各種補助剤との配合割合は、重量比で、一般に0.001:99.999~95:5、望ましくは0.005:99.995~90:10である。これら製剤の実際の使用に際しては、そのまま使用するか、または水等の希釈剤を用いて所定濃度に希釈し、必要に応じて各種展着剤(界面活性剤、植物油、鉱物油など)を添加して使用することができる。 Each component of these auxiliary agents may be appropriately selected and used, either alone or in combination, as long as it does not deviate from the object of the present invention. In addition to the above-mentioned auxiliary agents, those known in the art may also be appropriately selected and used, for example, various commonly used auxiliary agents such as bulking agents, thickening agents, antisettling agents, antifreezing agents, dispersion stabilizers, phytotoxicity reducing agents, and antifungal agents. The mixing ratio of compound (I) to various auxiliary agents is generally 0.001:99.999 to 95:5, preferably 0.005:99.995 to 90:10, by weight. When these preparations are actually used, they may be used as is, or diluted to a predetermined concentration with a diluent such as water, and various spreading agents (surfactants, vegetable oils, mineral oils, etc.) may be added as necessary.

 化合物(I)の施用は、気象条件、製剤形態、対象作物、施用時期、施用場所、有害な植物病害の種類や発生状況などの相違により一概に規定できないが、通常、一般に行なわれている施用方法、すなわち、散布処理、土壌処理、種子処理等により、有効量の化合物(I)を施用することができる。一般に行われている施用方法で有効量の化合物(I)を施用する場合、0.1~10,000ppm、好ましくは1~2,000ppm、より好ましくは1~1,000ppmの有効成分濃度で化合物(I)を施用することができる。
 一般に行われている施用方法において、有効成分として化合物(I)を含む組成物(以下、本組成物ともいう)又はその希釈物の施用を行うことができる。一般に散布処理の場合、その施用適量としては、1ヘクタールあたり本組成物が、10~100,000g程度とすることができる。土壌処理の場合、その施用適量としては、1ヘクタールあたり本組成物が0.01~1,000g程度とすることができる。種子処理の場合、その施用適量としては、種子1kgあたり本組成物が0.001~100g、望ましくは0.01~1g程度とすることができる。
Although the application of compound (I) cannot be generally specified due to differences in weather conditions, formulation form, target crop, application time, application site, type and occurrence of harmful plant diseases, etc., an effective amount of compound (I) can be applied by a commonly used application method, i.e., spray treatment, soil treatment, seed treatment, etc. When an effective amount of compound (I) is applied by a commonly used application method, compound (I) can be applied at an active ingredient concentration of 0.1 to 10,000 ppm, preferably 1 to 2,000 ppm, more preferably 1 to 1,000 ppm.
In a commonly used application method, a composition containing compound (I) as an active ingredient (hereinafter also referred to as the present composition) or a diluted version thereof can be applied. In general, in the case of spray treatment, the appropriate application amount can be about 10 to 100,000 g of the present composition per hectare. In the case of soil treatment, the appropriate application amount can be about 0.01 to 1,000 g of the present composition per hectare. In the case of seed treatment, the appropriate application amount can be about 0.001 to 100 g, preferably about 0.01 to 1 g, of the present composition per kg of seeds.

 前記散布処理とは、植物の樹幹、芽、茎葉、花、穂、果実の表面或いは植物病原菌に、本組成物の有効量を散布することにより、植物病原菌を防除する処理方法である。例えば、茎葉散布、樹幹散布等が挙げられる。
 前記土壌処理とは、植物病原菌による被害から作物を保護するため、化合物(I)の有効量を植物の根部等から植物の内部に浸透移行させるために、土壌に本組成物を処理する方法である。例えば、潅注処理(本組成物を植物の栽培土壌に潅注する)、土壌混和処理(植物の栽培土壌と本組成物を混和する)、植穴処理、株元又は株間への処理(散布又は灌注)、培土、育苗箱、育苗トレイ、ペーパーポット又は苗床等に使用する土壌への混和処理等が挙げられる。
 前記種子処理とは、植物病原菌による被害から作物を保護するため、作物の種子、球根等に直接或いは近傍に本組成物を処理することにより、植物病原菌を防除する処理方法である。例えば、塗布処理、粉衣処理、浸漬処理等が挙げられる。
 その他、苗処理(灌注又は浸漬)、球根、塊茎、鱗茎、根等への浸漬処理、さらに、水耕栽培養液に混合するような水耕処理が挙げられる。処理は植物の全体であっても一部分(茎葉、芽、花、穂、果実、樹幹、種子、球根、塊茎、鱗茎、根等)であっても良い。
The spray treatment is a treatment method for controlling plant pathogens by spraying an effective amount of the composition onto the surface of the trunk, buds, stems, leaves, flowers, spikes, or fruits of a plant, or onto plant pathogens. Examples of the spray treatment include spraying onto stems and leaves, and spraying onto tree trunks.
The soil treatment is a method of treating soil with the present composition in order to transfer an effective amount of compound (I) from the roots of a plant to the inside of the plant in order to protect crops from damage caused by plant pathogens. Examples of the treatment include irrigation treatment (irrigating the present composition into the soil for plant cultivation), soil incorporation treatment (mixing the present composition with the soil for plant cultivation), planting hole treatment, treatment at the base of a plant or between plants (spraying or irrigation), and incorporation treatment into soil used for culture soil, seedling boxes, seedling trays, paper pots, seedling beds, etc.
The seed treatment is a treatment method for controlling plant pathogens by treating the seeds, bulbs, etc. of crops with the present composition directly or in the vicinity thereof in order to protect crops from damage caused by plant pathogens. Examples of the treatment include coating treatment, dressing treatment, and immersion treatment.
Other examples include seedling treatment (irrigation or immersion), immersion treatment of bulbs, tubers, bulbs, roots, etc., and hydroponic treatment such as mixing with a hydroponic nutrient solution. Treatment may be performed on the whole plant or a part of it (stems, leaves, buds, flowers, ears, fruits, trunks, seeds, bulbs, tubers, bulbs, roots, etc.).

 本組成物は、他の農園芸用薬剤、肥料、薬害軽減剤などから選ばれる他の成分と混用又は併用することができ、この場合に一層優れた効果、作用性を示すことがある。
 前記混用又は併用とは、本組成物と他の成分とを、同時に、別々に又は時間間隔をおいて使用することを意味する。
 他の農園芸用薬剤は、除草剤、殺虫剤、殺ダニ剤、殺線虫剤、殺土壌害虫剤、殺菌剤、抗ウイルス剤、誘引剤、抗生物質、植物ホルモン、植物成長調整剤などが挙げられる。特に、本組成物、並びに他の殺菌剤の有効成分化合物の1種又は2種以上と混用或いは併用した混合殺菌組成物は、適用範囲、薬剤処理の時期、防除活性等を好ましい方向へ改良することがある。尚、本組成物、並びに他の殺菌剤の有効成分化合物は、各々別々に製剤したものを散布時に混合して使用しても、両者を一緒に製剤して使用してもよい。本発明には、このような混合殺菌剤も含まれる。
The present composition can be mixed or used in combination with other ingredients selected from other agricultural and horticultural chemicals, fertilizers, safeners, etc., and in this case, even more excellent effects and activity may be exhibited.
The above-mentioned mixture or combination use means that the present composition and other components are used simultaneously, separately or with an interval of time.
Other agricultural and horticultural drugs include herbicides, insecticides, acaricides, nematicides, soil pesticides, fungicides, antiviral agents, attractants, antibiotics, plant hormones, plant growth regulators, etc. In particular, the mixed fungicide composition in which the present composition and one or more active ingredient compounds of other fungicides are mixed or used in combination may improve the scope of application, timing of drug treatment, control activity, etc. in a favorable direction. The present composition and the active ingredient compounds of other fungicides may be formulated separately and mixed at the time of spraying, or both may be formulated together and used. Such mixed fungicides are also included in the present invention.

 化合物(I)、並びに他の殺菌剤の有効成分化合物との混合比は、気象条件、製剤形態、対象作物、施用時期、施用場所、有害な植物病害の種類や発生状況、などの相違により一概に規定できないが、重量比で、一般に1:300~300:1、望ましくは1:100~100:1とすることができる。また、施用適量としては、1ヘクタール当りの総有効成分化合物量は0.1~70,000g、望ましくは1~30,000gとすることができる。本発明には、このような混合殺菌組成物の施用による有害な植物病害の防除方法も含まれる。 The mixing ratio of compound (I) and the active ingredient compounds of other fungicides cannot be specified in general due to differences in weather conditions, formulation form, target crop, application time, application location, type and occurrence of harmful plant diseases, etc., but can generally be 1:300 to 300:1, preferably 1:100 to 100:1, by weight. The appropriate application amount is 0.1 to 70,000 g, preferably 1 to 30,000 g, of the total active ingredient compounds per hectare. The present invention also includes a method for controlling harmful plant diseases by applying such a mixed fungicidal composition.

 本組成物の施用にあたっては、他の農園芸用薬剤、例えば殺菌剤、殺虫剤、殺ダニ剤、殺線虫剤、殺土壌害虫剤、抗ウイルス剤、誘引剤、除草剤、植物成長調整剤等をさらに併せて処理することもできる。 When applying this composition, other agricultural and horticultural chemicals, such as fungicides, insecticides, acaricides, nematicides, soil pesticides, antiviral agents, attractants, herbicides, plant growth regulators, etc., can also be used in combination.

 上記他の農園芸用薬剤中の、殺菌剤の有効成分化合物(一般名)とは、例えば、下記の化合物群から適宜選択することができる。特に記載がない場合であっても、これら化合物に、塩、アルキルエステル、光学異性体のような各種構造異性体などが存在する場合は、当然それらも含まれる。 The active ingredient compounds (common names) of the fungicides in the above other agricultural and horticultural agents can be appropriately selected, for example, from the following compound groups. Even if not specifically stated, if these compounds have various structural isomers such as salts, alkyl esters, and optical isomers, these are of course included.

 メパニピリム(mepanipyrim)、ピリメタニル(pyrimethanil)、シプロジニル(cyprodinil)のようなアニリノピリミジン系化合物;
 アメトクトラジン(ametoctradin)のようなトリアゾロピリミジン系化合物;
 トリシクラゾール(tricyclazole)のようなトリアゾロベンゾチアゾール系化合物;
 フルアジナム(fluazinam)のようなピリジナミン系化合物;
 トリアジメホン(triadimefon)、ビテルタノール(bitertanol)、トリフルミゾール(triflumizole)、エタコナゾール(etaconazole)、プロピコナゾール(propiconazole)、ペンコナゾール(penconazole)、フルシラゾール(flusilazole)、ミクロブタニル(myclobutanil)、シプロコナゾール(cyproconazole)、テブコナゾール(tebuconazole)、ヘキサコナゾール(hexaconazole)、フルコナゾール・シス(furconazole-cis)、プロクロラズ(prochloraz)、メトコナゾール(metconazole)、エポキシコナゾール(epoxiconazole)、テトラコナゾール(tetraconazole)、オキスポコナゾールフマル酸塩(oxpoconazole fumarate)、プロチオコナゾール(prothioconazole)、トリアジメノール(triadimenol)、フルトリアホール(flutriafol)、ジフェノコナゾール(difenoconazole)、フルキンコナゾール(fluquinconazole)、フェンブコナゾール(fenbuconazole)、ブロムコナゾール(bromuconazole)、ジニコナゾール(diniconazole)、シメコナゾール(simeconazole)、ペフラゾエート(pefurazoate)、イプコナゾール(ipconazole)、イミベンコナゾール(imibenconazole)、アザコナゾール(azaconazole)、トリチコナゾール(triticonazole)、イマザリル(imazalil)、イプフェントリフルコナゾール(ipfentrifluconazole)、メフェントリフルコナゾール(mefentrifluconazole)のようなアゾール系化合物;
Anilinopyrimidine compounds such as mepanipyrim, pyrimethanil, and cyprodinil;
Triazolopyrimidine compounds such as ametoctradin;
Triazolobenzothiazole compounds such as tricyclazole;
Pyridinamine compounds such as fluazinam;
Triadimefon, bitertanol, triflumizole, etaconazole, propiconazole, penconazole, flusilazole, myclobutanil, cyproconazole, tebuconazole, hexaconazole, fluconazole-cis, prochloraz, metconazole, epoxiconazole, tetraconazole, oxpoconazole fumarate azole compounds such as fumarate, prothioconazole, triadimenol, flutriafol, difenoconazole, fluquinconazole, fenbuconazole, bromuconazole, diniconazole, simeconazole, pefurazoate, ipconazole, imibenconazole, azaconazole, triticonazole, imazalil, ipfentrifluconazole, and mefentrifluconazole;

 キノメチオナート(chinomethionat)のようなキノキサリン系化合物;
 マンネブ(maneb)、ジネブ(zineb)、マンゼブ(mancozeb)、ポリカーバメート(polycarbamate)、メチラム(metiram)、プロピネブ(propineb)、チラム(thiram)のようなジチオカーバメート系化合物;
 フサライド(phthalide)、クロロタロニル(chlorothalonil)、キントゼン(quintozene)のような有機塩素系化合物;
 ベノミル(benomyl)、チオファネートメチル(thiophanate-methyl)、カルベンダジム(carbendazim)、チアベンダゾール(thiabendazole)、フベリアゾール(fuberiazole)のようなイミダゾール系化合物;
 シモキサニル(cymoxanil)のようなシアノアセトアミド系化合物;
 メタラキシル(metalaxyl)、メタラキシル-M(metalaxyl-M;別名メフェノキサム(mefenoxam))、オキサジキシル(oxadixyl)、オフレース(ofurace)、ベナラキシル(benalaxyl)、ベナラキシル-M(benalaxyl-M、別名キララキシル(kiralaxyl、chiralaxyl))、フララキシル(furalaxyl)、バリフェナレート(valifenalate)のようなアシルアミノ酸系化合物;
 シプロフラム(cyprofuram)、カルボキシン(carboxin)、オキシカルボキシン(oxycarboxin)、チフルザミド(thifluzamide)、ボスカリド(boscalid)、フェンヘキサミド(fenhexamid)、イソチアニル(isotianil)、チアジニル(tiadinil)、ピラジフルミド(pyraziflumid)のようなアニリド系化合物;
Quinoxaline compounds such as chinomethionat;
Dithiocarbamate compounds such as maneb, zineb, mancozeb, polycarbamate, metiram, propineb, thiram;
Organochlorine compounds such as phthalide, chlorothalonil, and quintozene;
Imidazole compounds such as benomyl, thiophanate-methyl, carbendazim, thiabendazole, and fuberiazole;
Cyanoacetamide compounds such as cymoxanil;
acylamino acid compounds such as metalaxyl, metalaxyl-M (also known as mefenoxam), oxadixyl, ofurace, benalaxyl, benalaxyl-M (also known as chiralaxyl or chiralaxyl), furalaxyl, and valifenalate;
Anilides such as cyprofuram, carboxin, oxycarboxin, thifluzamide, boscalid, fenhexamid, isotianil, tiadinil, and pyraziflumid;

 ジクロフルアニド(dichlofluanid)のようなスルファミド系化合物;
 水酸化第二銅(cupric hydroxide)、有機銅(oxine copper)、無水硫酸銅、ノニルフェノールスルホン酸銅、8-ヒドロキシキノリン銅、ドデシルベンゼンスルホン酸ビスエチレンジアミン銅錯塩(II)(別名DBEDC)のような銅系化合物;
 ホセチルアルミニウム(fosetyl-Al)、トルクロホスメチル(tolclofos-Methyl)、エジフェンホス(edifenphos)、イプロベンホス(iprobenfos)のような有機リン系化合物;
 キャプタン(captan)、カプタホール(captafol)、フォルペット(folpet)のようなフタルイミド系化合物;
 プロシミドン(procymidone)、イプロジオン(iprodione)、ビンクロゾリン(vinclozolin)のようなジカルボキシイミド系化合物;
 フルトラニル(flutolanil)、メプロニル(mepronil)、ベノダニル(benodanil)、フルフェノキサジアザム(flufenoxadiazam)のようなベンズアニリド系化合物;
 カルプロパミド(carpropamid)、ジクロシメット(diclocymet)、シルチオファム(silthiofam)、フェノキサニル(fenoxanil)のようなアミド系化合物;
 ベンゾビンジフルピル(benzovindiflupyr)、ビキサフェン(bixafen)、フルーインダピル(fluindapyr)、フルキサピロキサド(fluxapyroxad)、フラメトピル(furametpyr)、イソピラザム(isopyrazam)、ペンフルフェン(penflufen)、ペンチオピラド(penthiopyrad)、ピジフルメトフェン(pydiflumetofen)、セダキサン(sedaxane)、イソフルーシプラム(isoflucypram)、インピルフルキサム(inpyrfluxam)、ピラプロポイン(pyrapropoyne)、フェノピラミド(fenopyramid)のようなピラゾールカルボキサミド系化合物;
Sulfamide compounds such as dichlofluanid;
Copper compounds such as cupric hydroxide, oxine copper, anhydrous copper sulfate, copper nonylphenolsulfonate, copper 8-hydroxyquinoline, and copper dodecylbenzenesulfonate bis(ethylenediamine)copper(II) complex (also known as DBEDC);
Organophosphates such as fosetyl-Al, tolclofos-Methyl, edifenphos, iprobenfos;
Phthalimide compounds such as captan, captafol, and folpet;
Dicarboximide compounds such as procymidone, iprodione, and vinclozolin;
Benzanilide compounds such as flutolanil, mepronil, benodanil, and flufenoxadiazam;
Amide compounds such as carpropamid, diclocymet, silthiofam, and fenoxanil;
pyrazolecarboxamide compounds such as benzovindiflupyr, bixafen, fluindapyr, fluxapyroxad, furametpyr, isopyrazam, penflufen, penthiopyrad, pydiflumetofen, sedaxane, isoflucipram, inpyrfluxam, pyrapropoyne, fenopyramid;

 フルオピコリド(fluopicolide)、フルオピラム(fluopyram)、ゾキサミド(zoxamide)、フルーオピモミド(fluopimomide)のようなベンズアミド系化合物;
 フェンフラム(fenfuram)のようなフラニリド系化合物;
 イソフェタミド(isofetamid)のようなチオフェンアミド系化合物;
 トリホリン(triforine)のようなピペラジン系化合物;
 ピリフェノックス(pyrifenox)、ピリソキサゾール(pyrisoxazole)、アミノピリフェン(aminopyrifen)のようなピリジン系化合物;
 フェナリモル(fenarimol)、フェリムゾン(ferimzone)、ヌアリモール(nuarimol)、フルメチルスルホリム(flumetylsulforim)のようなピリミジン系化合物;
 フェンプロピディン(fenpropidin)のようなピペリジン系化合物;
 フェンプロピモルフ(fenpropimorph)、トリデモルフ(tridemorph)のようなモルホリン系化合物;
 水酸化トリフェニルスズ(fentin hydroxide)、酢酸トリフェニルスズ(fentin acetate)のような有機スズ系化合物;
 ペンシキュロン(pencycuron)のような尿素系化合物;
 ジメトモルフ(dimethomorph)、フルモルフ(flumorph)、ピリモルフ(pyrimorph)、イプロバリカルブ(iprovalicarb)、ベンチアバリカルブ-イソプロピル(benthiavalicarb-isopropyl)、マンジプロパミド(mandipropamid)のようなカルボン酸アミド系化合物;
 ジエトフェンカルブ(diethofencarb)のようなフェニルカーバメート系化合物;
 フルジオキソニル(fludioxonil)、フェンピクロニル(fenpiclonil)のようなシアノピロール系化合物;
benzamide compounds such as fluopicolide, fluopyram, zoxamide, and fluopimomide;
Furanilide compounds such as fenfuram;
Thiophene amide compounds such as isofetamide;
Piperazine compounds such as triforine;
Pyridine compounds such as pyrifenox, pyrisoxazole, and aminopyrifen;
Pyrimidine compounds such as fenarimol, ferimzone, nuarimol, and flumetylsulforim;
Piperidine compounds such as fenpropidin;
Morpholine compounds such as fenpropimorph and tridemorph;
Organotin compounds such as fentin hydroxide and fentin acetate;
Urea compounds such as pencycuron;
Carboxylic acid amide compounds such as dimethomorph, flumorph, pyrimorph, iprovalicarb, benthiavalicarb-isopropyl, and mandipropamid;
Phenylcarbamate compounds such as diethofencarb;
cyanopyrrole compounds such as fludioxonil and fenpiclonil;

 アゾキシストロビン(azoxystrobin)、クレソキシムメチル(kresoxim-methyl)、メトミノストロビン(metominostrobin)、トリフロキシストロビン(trifloxystrobin)、ピコキシストロビン(picoxystrobin)、オリザストロビン(oryzastrobin)、ジモキシストロビン(dimoxystrobin)、ピラクロストロビン(pyraclostrobin)、フルオキサストロビン(fluoxastrobin)、ピラオキシストロビン(Pyraoxystrobin)、ピラメトストロビン(Pyrametostrobin)、クモキシストロビン(coumoxystrobin)、エノキサストロビン(enoxastrobin)、フェナミンストロビン(fenaminstrobin)、フルフェノキシストロビン(flufenoxystrobin)、トリクロピリカルブ(triclopyricarb)、マンデストロビン(mandestrobin)のようなストロビルリン系化合物;
 ファモキサドン(famoxadone)、オキサチアピプロリン(oxathiapiprolin)のようなオキサゾール系化合物;
 エタボキサム(ethaboxam)のようなチアゾールカルボキサミド系化合物;
 フェンアミドン(フェナミドン、fenamidone)のようなイミダゾリノン系化合物;
 フルスルファミド(flusulfamide)のようなベンゼンスルホンアミド系化合物;
 シフルフェナミド(cyflufenamid)のようなオキシムエーテル系化合物;
 ジチアノン(dithianon)のようなアントラキノン系化合物;
 メプチルジノカップ(meptyldinocap)のようなクロトン酸系化合物;
 バリダマイシン(validamycin)、カスガマイシン(kasugamycin)、ストレプトマイシン(streptomycin)、ポリオキシン(polyoxins)のような抗生物質;
strobilurin compounds such as azoxystrobin, kresoxim-methyl, metominostrobin, trifloxystrobin, picoxystrobin, oryzastrobin, dimoxystrobin, pyraclostrobin, fluoxastrobin, pyraoxystrobin, pyrametostrobin, coumoxystrobin, enoxastrobin, phenaminestrobin, flufenoxystrobin, triclopyricarb, and mandestrobin;
Oxazole compounds such as famoxadone and oxathiapiprolin;
Thiazolecarboxamide compounds such as ethaboxam;
Imidazolinone compounds such as fenamidone;
benzenesulfonamide compounds such as flusulfamide;
Oxime ether compounds such as cyflufenamid;
Anthraquinone compounds such as dithianon;
Crotonic acid compounds such as meptyldinocap;
Antibiotics such as validamycin, kasugamycin, streptomycin, polyoxins;

 イミノクタジン(iminoctadine)、ドジン(dodine)、グアザチン(guazatine)のようなグアニジン系化合物;
 ブチルアミン(butylamine)、セボクチラミン(seboctylamine)のような脂肪族窒素系化合物;
 テブフロキン(tebufloquin)、キノキシフェン(quinoxyfen)、キノフメリン(quinofumelin)、イプフルフェノキン(ipflufenoquin)、フェネプタミドキン(feneptamidoquin)のようなキノリン系化合物;
 フルチアニル(flutianil)のようなチアゾリジン系化合物;
 プロパモカルブ塩酸塩(propamocarb hydrochloride)、ピリベンカルブ(pyribencarb)、トルプロカルブ(tolprocarb)のようなカーバメート系化合物;
 ピカルブトラゾクス(picarbutrazox)、メチルテトラプロール(metyltetraprole)のようなテトラゾール系化合物;
 アミスルブロム(amisulbrom)、シアゾファミド(cyazofamid)のようなスルホンアミド系化合物;
 メトラフェノン(metrafenone)、ピリオフェノン(pyriofenone)のようなアリルフェニルケトン系化合物;
 プロベナゾール(probenazole)、ジクロベンチアゾクス(dichlobentiazox)のようなベンゾチアゾール系化合物;
 フェンピラザミン(fenpyrazamine)のようなフェニルピラゾール系化合物;
 イソプロチオラン(isoprothiolane)のようなジチオラン系化合物;
 フェンピコキサミド(fenpicoxamid)、フロリルピコキサミド(florylpicoxamid)のようなピコリンアミド系化合物;
Guanidine compounds such as iminoctadine, dodine, and guazatine;
Aliphatic nitrogen-based compounds such as butylamine and seboctylamine;
Quinoline compounds such as tebufloquin, quinoxyfen, quinofumelin, ipflufenoquin, and feneptamidoquin;
Thiazolidine compounds such as flutianil;
Carbamate compounds such as propamocarb hydrochloride, pyribencarb, and tolprocarb;
Tetrazole compounds such as picarbutrazox and metyltetraprole;
Sulfonamide compounds such as amisulbrom and cyazofamid;
Allyl phenyl ketone compounds such as metrafenone and pyriophenone;
Benzothiazole compounds such as probenazole and dichlobentiazox;
Phenylpyrazole compounds such as fenpyrazamine;
Dithiolane compounds such as isoprothiolane;
Picolinamide compounds such as fenpicoxamid and florylpicoxamid;

 硫黄(Sulfur)、石灰硫黄剤のような硫黄系化合物;
 その他の化合物として、ピロキロン(pyroquilon)、ジクロメジン(diclomezine)、クロルピクリン(chloropicrin)、ダゾメット(dazomet)、メタムナトリウム塩(metam-sodium)、プロキナジド(proquinazid)、スピロキサミン(spiroxamine)、ジピメチトロン(dipymetitrone)など;
 Bacillus amyloliqefaciens strain QST713、Bacillus amyloliqefaciens strain FZB24、Bacillus amyloliqefaciens strain MBI600、Bacillus amyloliqefaciens strain D747、Pseudomonas fluorescens、Bacillus subtilis、Trichoderma atroviride SKT-1のような微生物殺菌剤;及び
 ティーツリー油(Tea tree oil)のような植物抽出物。
Sulfur, sulfur-based compounds such as lime sulfur;
Other compounds include pyroquilon, diclomezine, chloropicrin, dazomet, metam-sodium, proquinazid, spiroxamine, dipymetitrone, etc.;
Microbial germicides such as Bacillus amyloliqefaciens strain QST713, Bacillus amyloliqefaciens strain FZB24, Bacillus amyloliqefaciens strain MBI600, Bacillus amyloliqefaciens strain D747, Pseudomonas fluorescens, Bacillus subtilis, Trichoderma atroviride SKT-1; and plant extracts such as tea tree oil.

 上記他の農園芸用薬剤中の、殺虫剤、殺線虫剤、殺ダニ剤、又は殺土壌害虫剤の有効成分化合物(一般名)とは、例えば、下記の化合物群から適宜選択することができる。特に記載がない場合であっても、これら化合物に、塩、アルキルエステル、光学異性体のような各種構造異性体などが存在する場合は、当然それらも含まれる。 The active ingredient compounds (common names) of the insecticides, nematicides, acaricides, or soil pesticides among the other agricultural and horticultural agents mentioned above can be appropriately selected, for example, from the following compound groups. Even if not specifically stated, if these compounds have various structural isomers such as salts, alkyl esters, and optical isomers, these are of course included.

 プロフェノホス(profenofos)、ジクロルボス(dichlorvos)、フェナミホス(fenamiphos)、フェニトロチオン(fenitrothion)、EPN((RS)-(O-ethyl O-4-nitrophenyl phenylphosphonothioate))、ダイアジノン(diazinon)、クロルピリホス(chlorpyrifos)、クロルピリホスメチル(chlorpyrifos-methyl)、アセフェート(acephate)、プロチオホス(prothiofos)、ホスチアゼート(fosthiazate)、カズサホス(cadusafos)、ジスルホトン(disulfoton)、イソキサチオン(isoxathion)、イソフェンホス(isofenphos)、エチオン(ethion)、エトリムホス(etrimfos)、キナルホス(quinalphos)、ジメチルビンホス(dimethylvinphos)、ジメトエート(dimethoate)、スルプロホス(sulprofos)、チオメトン(thiometon)、バミドチオン(vamidothion)、ピラクロホス(pyraclofos)、ピリダフェンチオン(pyridaphenthion)、ピリミホスメチル(pirimiphos-methyl)、プロパホス(propaphos)、ホサロン(phosalone)、ホルモチオン(formothion)、マラチオン(malathion)、テトラクロルビンホス(tetrachlorvinphos)、クロルフェンビンホス(chlorfenvinphos)、シアノホス(cyanophos)、トリクロルホン(trichlorfon)、メチダチオン(methidathion)、フェントエート(phenthoate)、オキシデプロホス(oxydeprofos、別名ESP)、アジンホスメチル(azinphos-methyl)、フェンチオン(fenthion)、ヘプテノホス(heptenophos)、パラチオン(parathion)、ホスホカルブ(phosphocarb)、デメトン-S-メチル(demeton-S-methyl)、モノクロトホス(monocrotophos)、メタミドホス(methamidophos)、イミシアホス(imicyafos)、パラチオン-メチル(parathion-methyl)、テルブホス(terbufos)、ホスファミドン(phosphamidon)、ホスメット(phosmet)、ホレート(phorate)のような有機リン酸エステル系化合物; Profenofos, dichlorvos, fenamiphos, fenitrothion, EPN ((RS)-(O-ethyl O-4-nitrophenyl phenylphosphonothioate)), diazinon, chlorpyrifos, chlorpyrifos-methyl, acephate, prothiofos, fosthiazate, cadusafos adusafos, disulfoton, isoxathion, isofenphos, ethion, etrimfos, quinalphos, dimethylvinphos, dimethoate, sulprofos, thiometon, vamidothion, pyraclofos, pyridaphenthion, pirimiphos-methyl iphos-methyl), propaphos, phosalone, formothion, malathion, tetrachlorvinphos, chlorfenvinphos, cyanophos, trichlorfon, methidathion, phenthoate, oxydeprofos (also known as ESP), azinphos-methyl, phen Organophosphate compounds such as fenthion, heptenophos, parathion, phosphocarb, demeton-S-methyl, monocrotophos, methamidophos, imicyafos, parathion-methyl, terbufos, phosphamidon, phosmet, and phorate;

 カルバリル(carbaryl)、プロポキスル(propoxur)、アルジカルブ(aldicarb)、カルボフラン(carbofuran)、チオジカルブ(thiodicarb)、メソミル(methomyl)、オキサミル(oxamyl)、エチオフェンカルブ(ethiofencarb)、ピリミカルブ(pirimicarb)、フェノブカルブ(fenobucarb)、カルボスルファン(carbosulfan)、ベンフラカルブ(benfuracarb)、ベンダイオカルブ(bendiocarb)、フラチオカルブ(furathiocarb)、イソプロカルブ(isoprocarb)、メトルカルブ(metolcarb)、キシリルカルブ(xylylcarb)、XMC(3,5-xylyl methylcarbamate)、フェノチオカルブ(fenothiocarb)のようなカーバメート系化合物;
 カルタップ(cartap)、チオシクラム(thiocyclam)、シュウ酸水素チオシクラム(thiocyclam oxalate)、チオシクラム塩酸塩(thiocyclam hydrochloride)、ベンスルタップ(bensultap)、チオスルタップ(thiosultap)、モノスルタップ(monosultap;別名チオスルタップモノナトリウム(thiosultap-monosodium)、ビスルタップ(bisultap;別名チオスルタップジナトリウム(thiosultap-disodium)、ポリチアラン(polythialan)のようなネライストキシン誘導体;
 ジコホル(dicofol)、テトラジホン(tetradifon)、エンドスルファン(endosulfan)、ジエノクロル(dienochlor)、ディルドリン(dieldrin)、メトキシクロル(methoxychlor)のような有機塩素系化合物;
 酸化フェンブタスズ(fenbutatin oxide)、シヘキサチン(cyhexatin)のような有機金属系化合物;
Carbamate compounds such as carbaryl, propoxur, aldicarb, carbofuran, thiodicarb, methomyl, oxamyl, ethiofencarb, pirimicarb, fenobucarb, carbosulfan, benfuracarb, bendiocarb, furathiocarb, isoprocarb, metolcarb, xylylcarb, XMC (3,5-xylyl methylcarbamate), and fenothiocarb;
Nereistoxin derivatives such as cartap, thiocyclam, thiocyclam oxalate, thiocyclam hydrochloride, bensultap, thiosultap, monosultap (also known as thiosultap-monosodium), bisultap (also known as thiosultap-disodium), and polythialan;
Organochlorines such as dicofol, tetradifon, endosulfan, dienochlor, dieldrin, and methoxychlor;
Organometallic compounds such as fenbutatin oxide and cyhexatin;

 フェンバレレート(fenvalerate)、ペルメトリン(permethrin)、シペルメトリン(cypermethrin)、アルファ-シペルメトリン(alpha-cypermethrin)、ゼータ-シペルメトリン(zeta-cypermethrin)、シータ-シペルメトリン(theta-cypermethrin)、ベータ-シペルメトリン(beta-cypermethrin)、デルタメトリン(deltamethrin)、シハロトリン(cyhalothrin)、ガンマ-シハロトリン(gamma-cyhalothrin)、ラムダ-シハロトリン(lambda-cyhalothrin)、テフルトリン(tefluthrin)、カッパ-テフルトリン(kappa-tefluthrin)、エトフェンプロックス(ethofenprox)、フルフェンプロックス(flufenprox)、シフルトリン(cyfluthrin)、ベータ-シフルトリン(beta-cyfluthrin)、フェンプロパトリン(fenpropathrin)、フルシトリネート(flucythrinate)、フルバリネート(fluvalinate)、シクロプロトリン(cycloprothrin)、ピレスリン(pyrethrins)、エスフェンバレレート(esfenvalerate)、テトラメスリン(tetramethrin)、レスメスリン(resmethrin)、プロトリフェンブト(protrifenbute)、ビフェントリン(bifenthrin)、カッパ-ビフェントリン(kappa-bifenthrin)、アクリナトリン(acrinathrin)、アレスリン(allethrin)、タウ-フルバリネート(tau-fluvalinate)、トラロメトリン(tralomethrin)、プロフルトリン(profluthrin)、メトフルトリン(metofluthrin)、イプシロンメトフルトリン(epsilon-metofluthrin)、ヘプタフルトリン(heptafluthrin)、フェノトリン(phenothrin)、フルメトリン(flumethrin)、モムフルオロトリン(momfluorothrin)、イプシロンモムフルオロトリン(epsilon-momfluorothrin)、シラフルオフェン(silafluofen)、クロロプラレトリン(chloroprallethrin)のようなピレスロイド系化合物; Fenvalerate, permethrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, theta-cypermethrin, beta-cypermethrin, deltamethrin, cyhalothrin, gamma-cyhalothrin , lambda-cyhalothrin, tefluthrin, kappa-tefluthrin, etofenprox, flufenprox, cyfluthrin, beta-cyfluthrin, fenpropathrin, flucythrinate, fluvalinate, cycloprotrin hrin), pyrethrins, esfenvalerate, tetramethrin, resmethrin, protrifenbute, bifenthrin, kappa-bifenthrin, acrinathrin, allethrin, tau-fluvalinate, tralomethrin, profluthrin, pyrethroids such as profluthrin, metofluthrin, epsilon-metofluthrin, heptafluthrin, phenothrin, flumethrin, momfluorothrin, epsilon-momfluorothrin, silafluofen, and chloroprallethrin;

 ジフルベンズロン(diflubenzuron)、クロルフルアズロン(chlorfluazuron)、テフルベンズロン(teflubenzuron)、フルフェノクスロン(flufenoxuron)、ルフェヌロン(lufenuron)、ノバルロン(novaluron)、トリフルムロン(triflumuron)、ヘキサフルムロン(hexaflumuron)、ビストリフルロン(bistrifluron)、ノビフルムロン(noviflumuron)、フルアズロン(fluazuron)、フルフェノクスロン(flufenoxuron)のようなベンゾイルウレア系化合物;
 メトプレン(methoprene)、ピリプロキシフェン(pyriproxyfen)、フェノキシカルブ(fenoxycarb)、ジオフェノラン(diofenolan)のような幼若ホルモン様化合物;
 ピリダベン(pyridaben)のようなピリダジノン系化合物;
 フェンピロキシメート(fenpyroximate)、フィプロニル(fipronil)、エチピロール(ethiprole)、アセトプロール(acetoprole)、ピラフルプロール(pyrafluprole)、ピリプロール(pyriprole)、シエノピラフェン(cyenopyrafen)、フルフィプロール(flufiprole)のようなピラゾール系化合物;
 ピフルブミド(pyflubumide)、テブフェンピラド(tebufenpyrad)、トルフェンピラド(tolfenpyrad)、ジンプロピリダズ(dimpropyridaz)のようなピラゾールカルボキサミド系化合物;
 クロラントラニリプロール(chlorantraniliprole)、シアントラニリプロール(cyantraniliprole)、シクラニリプロール(cyclaniliprole)、テトラニリプロール(tetraniliprole)、チクロピラゾフロル(tyclopyrazoflor)、フルクロルジニリプロール(fluchlordiniliprole)、チオラントラニリプロール(tiorantraniliprole)のようなピリジルピラゾール系化合物;
Benzoyl urea compounds such as diflubenzuron, chlorfluazuron, teflubenzuron, flufenoxuron, lufenuron, novaluron, triflumuron, hexaflumuron, bistrifluron, noviflumuron, fluazuron, and flufenoxuron;
Juvenile hormone-like compounds such as methoprene, pyriproxyfen, fenoxycarb, diofenolan;
Pyridazinone compounds such as pyridaben;
Pyrazole compounds such as fenpyroximate, fipronil, ethiprole, acetoprole, pyrafluprole, pyriprole, cyenopyrafen, and flufiprole;
Pyrazolecarboxamide compounds such as pyflubumide, tebufenpyrad, tolfenpyrad, dimpropyridaz;
Pyridylpyrazole compounds such as chlorantraniliprole, cyantraniliprole, cyclaniliprole, tetraniliprole, tyclopyrazoflor, fluchlordiniliprole, and thiorantraniliprole;

 イミダクロプリド(imidacloprid)、ニテンピラム(nitenpyram)、アセタミプリド(acetamiprid)、チアクロプリド(thiacloprid)、チアメトキサム(thiamethoxam)、クロチアニジン(clothianidin)、ニジノテフラン(nidinotefuran)、ジノテフラン(dinotefuran)、ニチアジン(nithiazine)のようなネオニコチノイド系化合物;
 テブフェノジド(tebufenozide)、メトキシフェノジド(methoxyfenozide)、クロマフェノジド(chromafenozide)、ハロフェノジド(halofenozide)のようなヒドラジン系化合物;
 ピリダリル(pyridalyl)、フロニカミド(flonicamid)、フルメト二カム(flumetnicam)のようなピリジン系化合物;
 スピロジクロフェン(spirodiclofen)、スピロメシフェン(spiromesifen)、スピロブジフェン(spirobudifen)のようなテトロン酸系化合物;
 スピロテトラマト(spirotetramat)、スピロピジオン(spiropidion)のようなテトラミン酸系化合物;
 フルアクリピリム(fluacrypyrim)、ビフェメトストロビン(bifemetstrobin)、ピリミノストロビン(pyriminostrobin)、フルピロキシストロビン(flupyroxystrobin)のようなストロビルリン系化合物;
 フルフェネリム(flufenerim)、ピリミジフェン(pyrimidifen)のようなピリミジナミン系化合物;
 マラチオン(malathion)のような有機硫黄化合物;
 シロマジン(cyromazine)のようなトリアジン系化合物;
 ヒドラメチルノン(hydramethylnon)のようなヒドラゾン系化合物;
 フルベンジアミド(flubendiamide)、ブロフラニリド(broflanilide)、シハロジアミド(cyhalodiamide)、ピオキサニリプロール(pioxaniliprole)、ピペルフラニリド(piperflanilide)のようなジアミド系化合物;
Neonicotinoid compounds such as imidacloprid, nitenpyram, acetamiprid, thiacloprid, thiamethoxam, clothianidin, nidinotefuran, dinotefuran, and nithiazine;
Hydrazine compounds such as tebufenozide, methoxyfenozide, chromafenozide, and halofenozide;
Pyridine compounds such as pyridalyl, flonicamid, and flumetnicam;
Tetronic acid compounds such as spirodiclofen, spiromesifen, and spirobudifen;
Tetramic acid compounds such as spirotetramat and spiropidione;
Strobilurin compounds such as fluacrypyrim, bifemetstrobin, pyriminostrobin, and flupyroxystrobin;
Pyrimidinamine compounds such as flufenerim and pyrimidifen;
Organosulfur compounds such as malathion;
Triazine compounds such as cyromazine;
Hydrazone compounds such as hydramethylnon;
Diamide compounds such as flubendiamide, broflanilide, cyhalodiamide, pioxaniliprole, and piperflanilide;

 ジアフェンチウロン(diafenthiuron)、クロロメチウロン(chloromethiuron)のようなチオウレア系化合物;
 アミトラズ(amitraz)、クロルジメホルム(chlordimeform)、クロロメブホルム(chloromebuform)のようなホルムアミジン系化合物;
 ピメトロジン(pymetrozine)、ピリフルキナゾン(pyrifluquinazone)のようなピリジンアゾメチン系化合物;
 アフォキソラネル(afoxolaner)、フルララネル(fluralaner)、フルキサメタミド(fluxametamide)、サロラネル(sarolaner)、イソフルアラナム(isoflualanam)のようなイソキサゾリン系化合物;
 また、その他の化合物として、ブプロフェジン(buprofezin)、ヘキシチアゾクス(hexythiazox)、トリアザメート(triazamate)、クロルフェナピル(chlorfenapyr)、インドキサカルブ(indoxacarb)、アセキノシル(acequinocyl)、エトキサゾール(etoxazole)、1,3-ジクロロプロペン(1,3-dichloropropene)、ベンクロチアズ(benclothiaz)、ビフェナゼート(bifenazate)、プロパルギット(propargite)、クロフェンテジン(clofentezine)、メタフルミゾン(metaflumizone)、シフルメトフェン(cyflumetofen)、フェナザキン(fenazaquin)、アミドフルメト(amidoflumet)、スルフルラミド(sulfluramid)、ヒドラメチルノン(hydramethylnon)、メタアルデヒド(metaldehyde)、スルホキサフロル(sulfoxaflor)、フルエンスルホン(fluensulfone)、ベルブチン(verbutin)、ジクロロメゾチアズ(dicloromezotiaz)、トリフルメゾピリム(triflumezopyrim)、フルヘキサホン(fluhexafon)、チオキサザフェン(tioxazafen)、アフィドピロペン(afidopyropen)、フロメトキン(flometoquin)、フルピラジフロン(flupyradifurone)、フルアザインドリジン(fluazaindolizine)、アシノナピル(acynonapyr)、ベンツピリモキサン(benzpyrimoxan)、フルーピリミン(flupyrimin)、オキサゾスルフィル(oxazosulfyl)、スルフィフルミン(sulfiflumin)、ビスルフルフェン(bisulflufen)、サイベンゾキサスルフィル(cybenzoxasulfyl)、ガルキン(galquin)、チアピラクロール(tiapyrachlor)、ベンチオフルミン(bentioflumin)のような化合物など。
Thiourea compounds such as diafenthiuron and chloromethiuron;
Formamidine compounds such as amitraz, chlordimeform, and chloromebuform;
Pyridine azomethine compounds such as pymetrozine and pyrifluquinazone;
Isoxazolines such as afoxolaner, fluralaner, fluxametamide, sarolaner, and isoflualanam;
Other compounds include buprofezin, hexythiazox, triazamate, chlorfenapyr, indoxacarb, acequinocyl, etoxazole, 1,3-dichloropropene, benclothiaz, bifenazate, propargite, clofentezine, metaflumizone, cyflumetofen, fenazaquin, amidoflumet, sulfluramid, hydramethylnon, metaldehyde, sulfoxaflor, and fluence. Compounds such as fluensulfone, verbin, dichloromezotiaz, triflumezopyrim, fluhexafon, tioxazafen, afidopyropen, flometoquin, flupyradifurone, fluazaindolizine, acinonapyr, benzpyrimoxan, flupyrimin, oxazosulfyl, sulfiflumin, bisulflufen, cybenzoxasulfyl, galquin, tiapyrachlor, bentiofluorin, and the like.

 また、本組成物は下記化合物と組み合わせて施用してもよい。
 Bacillus thuringiensis aizawai、Bacillus thuringiensis kurstaki、Bacillus thuringiensis israelensis、Bacillus thuringiensis japonensis、Bacillus thuringiensis tenebrionis等のBacillus thuringiensisが生成する結晶タンパク毒素、昆虫病原ウイルス剤、昆虫病原糸状菌剤、線虫病原糸状菌剤などのような微生物農薬;
 アバメクチン(abamectin)、エマメクチン安息香酸塩(emamectin benzoate)、イベルメクチン(ivermectin)、ミルベメクチン(milbemectin)、ミルベマイシンオキシム(milbemycin oxime)、レピメクチン(lepimectin)、スピノサド(spinosad)、スピネトラム(spinetoram)のような抗生物質及び半合成抗生物質;
 アザディラクチン(azadirachtin)、ロテノン(rotenone)、リアノジン(ryanodine)のような天然物;
 ディート(deet)のような忌避剤;
 パラフィン油、鉱物油(mineral oil)のような物理的防除剤;
 レドプロナ(ledprona)、ヴァデスカナ(vadescana)のようなRNAi農薬。
The present composition may also be applied in combination with the following compounds:
Microbial pesticides such as crystal protein toxins produced by Bacillus thuringiensis, such as Bacillus thuringiensis aizawai, Bacillus thuringiensis kurstaki, Bacillus thuringiensis israelensis, Bacillus thuringiensis japonensis, and Bacillus thuringiensis tenebrionis, insect pathogenic virus agents, insect pathogenic fungal agents, and nematode pathogenic fungal agents;
Antibiotics and semi-synthetic antibiotics such as abamectin, emamectin benzoate, ivermectin, milbemectin, milbemycin oxime, lepimectin, spinosad, spinetoram;
Natural products such as azadirachtin, rotenone, and ryanodine;
repellents such as deet;
Physical control agents such as paraffin oil, mineral oil;
RNAi pesticides such as ledprona and vadescana.

 本発明の望ましい態様は以下の通りである。但し、本発明はこれらに限定されるものではない。
〔1〕式(I)で表されるN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔2〕Rが、少なくとも1個のTで置換されていてもよい(C-C)アルキル、(C-C)アルキニル、又は(C-C)アルケニルである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔3〕Rが、少なくとも1個のTで置換されていてもよい(C-C)アルキル又は(C-C)アルキニルである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔4〕Rが、(C-C)アルキル、(C-C)アルキニル、又は(C-C)アルケニルである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔5〕Rが、(C-C)アルキル又は(C-C)アルキニルである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔6〕Rが、(C-C)アルキル又は(C-C)アルキニルである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔7〕Rが、メチル、エチル、プロパルギル、シアノメチル、メトキシカルボニルメチル、又はアリルである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔8〕Rが、メチル、エチル、プロパルギル、又はアリルである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔9〕Rが、メチル、エチル、又はプロパルギルである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔10〕Rが、メチル又はプロパルギルである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔11〕Rが、メチル又はエチルである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔12〕Rが、メチルである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔13〕Rが、エチルである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔14〕Rが、プロパルギルである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
Preferred embodiments of the present invention are as follows, but the present invention is not limited to these.
[1] An N-substituted oxy-2-aminothiazolecarboxamide compound represented by formula (I) or a salt thereof:
[2] The N-substituted oxy-2- aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkynyl, or (C 2 -C 6 ) alkenyl optionally substituted with at least one T 1.
[3] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is (C 1 -C 6 ) alkyl or (C 2 -C 6 ) alkynyl optionally substituted with at least one T 1.
[4] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkynyl, or (C 2 -C 6 ) alkenyl.
[5] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is (C 1 -C 6 ) alkyl or (C 2 -C 6 ) alkynyl.
[6] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is (C 1 -C 3 ) alkyl or (C 2 -C 3 ) alkynyl.
[7] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is methyl, ethyl, propargyl, cyanomethyl, methoxycarbonylmethyl, or allyl.
[8] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is methyl, ethyl, propargyl, or allyl.
[9] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is methyl, ethyl, or propargyl.
[10] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is methyl or propargyl.
[11] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is methyl or ethyl.
[12] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is methyl.
[13] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is ethyl.
[14] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is propargyl.

〔15〕Yが、ハロゲン、(C-C)アルキル、(C-C)アルケニル、(C-C)ハロアルキル、シアノ、又はニトロである、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔16〕Yが、ハロゲン、(C-C)アルキル、(C-C)アルケニル、(C-C)ハロアルキル、シアノ、又はニトロである、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔17〕Yが、フッ素原子、塩素原子、水素原子、メチル、トリフルオロメチル、ビニル、シアノ、又はニトロである、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
[15] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is halogen, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 1 -C 6 ) haloalkyl, cyano, or nitro.
[16] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is halogen, (C 1 -C 3 ) alkyl, (C 2 -C 3 ) alkenyl, (C 1 -C 3 ) haloalkyl, cyano, or nitro.
[17] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is a fluorine atom, a chlorine atom, a hydrogen atom, methyl, trifluoromethyl, vinyl, cyano, or nitro.

〔18〕Y及びYが、同時に水素原子になることはない、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔19〕Y及びYが、それぞれ独立に、ハロゲン、(C-C)アルキル、又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔20〕Y及びYが、それぞれ独立に、ハロゲン、(C-C)アルキル、又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔21〕Y及びYが、 それぞれ独立に、フッ素原子、塩素原子、メチル、又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔22〕Yが、ハロゲン又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔23〕Yが、塩素原子又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
[18] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 and Y 4 are not simultaneously a hydrogen atom.
[19] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 2 and Y 3 are each independently a halogen, a (C 1 -C 6 ) alkyl, or a hydrogen atom.
[20] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 2 and Y 3 are each independently a halogen, a (C 1 -C 3 ) alkyl, or a hydrogen atom.
[21] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y2 and Y3 are each independently a fluorine atom, a chlorine atom, a methyl atom, or a hydrogen atom.
[22] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 4 is a halogen or a hydrogen atom.
[23] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 4 is a chlorine atom or a hydrogen atom.

〔24〕Y、Y、Y及びYが、それぞれ独立に、ハロゲン、水素原子、(C-C)アルキル、(C-C)アルケニル、(C-C)ハロアルキル、シアノ、又はニトロである、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔25〕Y、Y、Y及びYが、それぞれ独立に、ハロゲン、水素原子、(C-C)アルキル、(C-C)ハロアルキル、又はニトロである、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔26〕Y、Y、Y及びYが、それぞれ独立に、ハロゲン、水素原子、(C-C)アルキル、(C-C)ハロアルキル、又はニトロである、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔27〕Y、Y、Y及びYが、それぞれ独立に、ハロゲン、水素原子、メチル、トリフルオロメチル、ビニル、シアノ、又はニトロである、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔28〕Y、Y、Y及びYが、それぞれ独立に、フッ素原子、塩素原子、水素原子、メチル、トリフルオロメチル、ビニル、シアノ、又はニトロである、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
[24] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [ 1 ] to [14] above, wherein Y 1 , Y 2 , Y 3 and Y 4 are each independently halogen, a hydrogen atom, a (C 1 -C 3 ) alkyl, a (C 2 -C 3 ) alkenyl, a (C 1 -C 3 ) haloalkyl, cyano, or nitro.
[25] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [ 1 ] to [14] above, wherein Y 1 , Y 2 , Y 3 and Y 4 are each independently halogen, a hydrogen atom, a (C 1 -C 6 ) alkyl, a (C 1 -C 6 ) haloalkyl, or nitro.
[26] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [ 1 ] to [14] above, wherein Y 1 , Y 2 , Y 3 and Y 4 are each independently halogen, a hydrogen atom, a (C 1 -C 3 ) alkyl, a (C 1 -C 3 ) haloalkyl, or nitro.
[27] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 , Y 2 , Y 3 and Y 4 are each independently halogen, a hydrogen atom, methyl, trifluoromethyl, vinyl, cyano or nitro.
[28] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 , Y 2 , Y 3 and Y 4 are each independently a fluorine atom, a chlorine atom, a hydrogen atom, methyl, trifluoromethyl, vinyl, cyano, or nitro.

〔29〕Y及びYが、それぞれ独立に、水素原子、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、(C-C)アルケニル、シアノ、又はニトロであり、但し、Y及びYが同時に水素原子になることはなく、Y及びYが、それぞれ独立に、ハロゲン、(C-C)アルキル、又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔30〕Y及びYが、それぞれ独立に、ハロゲン、水素原子、(C-C)アルキル、(C-C)ハロアルキル、シアノ又はニトロであり、但し、Y及びYが同時に水素原子になることはなく、Y及びYが、それぞれ独立に、ハロゲン又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔31〕Y及びYが、それぞれ独立に、水素原子、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、(C-C)アルケニル、シアノ、又はニトロであり、但し、Y及びYが同時に水素原子になることはなく、Y及びYが、それぞれ独立に、フッ素原子、塩素原子、メチル、又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔32〕Y及びYが、それぞれ独立に、水素原子、フッ素原子、塩素原子、メチル、ビニル、トリフルオロメチル、シアノ又はニトロであり、但し、Y及びYが同時に水素原子になることはなく、Y及びYが、それぞれ独立に、フッ素原子、塩素原子、又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
[29] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [ 14 ] above, wherein Y 1 and Y 4 are each independently a hydrogen atom, halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 2 -C 6 ) alkenyl, cyano, or nitro, with the proviso that Y 1 and Y 4 are not both hydrogen atoms, and Y 2 and Y 3 are each independently a halogen, (C 1 -C 6 ) alkyl, or a hydrogen atom.
[30] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [ 1 ] to [ 14 ] above, wherein Y1 and Y4 are each independently a halogen atom, a hydrogen atom, a (C1-C6) alkyl, a ( C1 - C6 ) haloalkyl, a cyano or a nitro, provided that Y1 and Y4 are not both hydrogen atoms, and Y2 and Y3 are each independently a halogen atom or a hydrogen atom.
[31] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1 ] to [ 14 ] above, wherein Y 1 and Y 4 are each independently a hydrogen atom, a halogen, a (C 1 -C 3 ) alkyl, a (C 1 -C 3 ) haloalkyl, a (C 2 -C 3 ) alkenyl, a cyano, or a nitro, provided that Y 1 and Y 4 are not both hydrogen atoms, and Y 2 and Y 3 are each independently a fluorine atom, a chlorine atom, a methyl, or a hydrogen atom.
[32] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [ 1 ] to [ 14] above, wherein Y1 and Y4 are each independently a hydrogen atom, a fluorine atom, a chlorine atom, methyl, vinyl, trifluoromethyl, cyano, or nitro, provided that Y1 and Y4 are not both hydrogen atoms, and Y2 and Y3 are each independently a fluorine atom, a chlorine atom, or a hydrogen atom.

〔33〕Yが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、(C-C)アルケニル、シアノ、又はニトロであり、Y、Y及びYが、それぞれ独立に、ハロゲン、(C-C)アルキル、又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔34〕Yが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、(C-C)アルケニル、シアノ、又はニトロであり、Y、Y及びYが、それぞれ独立に、ハロゲン、(C-C)アルキル、又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔35〕Yが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又はニトロであり、Y、Y及びYが、それぞれ独立に、ハロゲン又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔36〕Yが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又はニトロであり、Y、Y及びYが、それぞれ独立に、ハロゲン又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔37〕Yが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又はニトロであり、Y、Y及びYが、それぞれ独立に、フッ素原子、塩素原子、又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔38〕Yが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又はニトロであり、Y、Y及びYが、それぞれ独立に、フッ素原子、塩素原子、又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔39〕Yが、フッ素原子、塩素原子、メチル、トリフルオロメチル、シアノ又はニトロであり、Y、Y及びYが、それぞれ独立に、フッ素原子、塩素原子、又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔40〕Yが、フッ素原子、塩素原子、メチル、トリフルオロメチル、シアノ、又はニトロであり、Y、Y及びYが、それぞれ独立に、フッ素原子、塩素原子、又は水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
[33] The N-substituted oxy- 2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 2 -C 6 ) alkenyl, cyano, or nitro, and Y 2 , Y 3 , and Y 4 are each independently halogen , (C 1 -C 6 ) alkyl, or a hydrogen atom.
[34] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 4 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 2 -C 6 ) alkenyl, cyano, or nitro, and Y 1 , Y 2, and Y 3 are each independently halogen, (C 1 -C 6 ) alkyl, or a hydrogen atom.
[35] The N-substituted oxy- 2 -aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, or nitro, and Y 2 , Y 3 , and Y 4 are each independently halogen or a hydrogen atom.
[36] The N-substituted oxy- 2 -aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 4 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, or nitro, and Y 1 , Y 2 , and Y 3 are each independently halogen or a hydrogen atom.
[37] The N-substituted oxy -2 -aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is halogen, (C 1 -C 3 ) alkyl, (C 1 -C 3 ) haloalkyl, or nitro, and Y 2 , Y 3 , and Y 4 are each independently a fluorine atom, a chlorine atom, or a hydrogen atom.
[38] The N-substituted oxy -2 -aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 4 is halogen, (C 1 -C 3 ) alkyl, (C 1 -C 3 ) haloalkyl, or nitro, and Y 1 , Y 2 , and Y 3 are each independently a fluorine atom, a chlorine atom, or a hydrogen atom.
[39] The N-substituted oxy -2- aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is a fluorine atom, a chlorine atom, methyl, trifluoromethyl, cyano or nitro, and Y 2 , Y 3 and Y 4 are each independently a fluorine atom, a chlorine atom or a hydrogen atom.
[40] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [ 1 ] to [14] above, wherein Y 4 is a fluorine atom, a chlorine atom, methyl, trifluoromethyl, cyano, or nitro, and Y 1 , Y 2 , and Y 3 are each independently a fluorine atom, a chlorine atom, or a hydrogen atom.

〔41〕Yが、フッ素原子、塩素原子、メチル、トリフルオロメチル、又はニトロであり、Y及びYが、それぞれ独立に、フッ素原子又は水素原子であり、Yが水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔42〕Yが、フッ素原子、塩素原子、又はメチルであり、Y及びYが、それぞれ独立に、フッ素原子又は水素原子であり、Yが水素原子である、前記〔1〕~前記14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔43〕Yが、フッ素原子、塩素原子、又はトリフルオロメチルであり、Y及びYが、それぞれ独立に、フッ素原子又は水素原子であり、Yが水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔44〕Yが、フッ素原子、塩素原子、又はニトロであり、Y及びYが、それぞれ独立に、フッ素原子又は水素原子であり、Yが水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔45〕Yが、フッ素原子、塩素原子、又はシアノであり、Y及びYが、それぞれ独立に、フッ素原子又は水素原子であり、Yが水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔46〕Yが、フッ素原子又は塩素原子であり、Y及びYが、それぞれ独立に、フッ素原子又は水素原子であり、Yが水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
[41] The N-substituted oxy -2 -aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is a fluorine atom, a chlorine atom, methyl, trifluoromethyl, or nitro, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom, and Y 4 is a hydrogen atom.
[42] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is a fluorine atom, a chlorine atom, or methyl, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom, and Y 4 is a hydrogen atom.
[43] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is a fluorine atom, a chlorine atom, or trifluoromethyl, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom, and Y 4 is a hydrogen atom.
[44] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [ 1 ] to [14] above, wherein Y 1 is a fluorine atom, a chlorine atom, or a nitro, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom, and Y 4 is a hydrogen atom.
[45] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is a fluorine atom, a chlorine atom, or a cyano, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom, and Y 4 is a hydrogen atom.
[46] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is a fluorine atom or a chlorine atom, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom, and Y 4 is a hydrogen atom.

〔47〕Yが、メチルであり、Y及びYが、それぞれ独立に、フッ素原子又は水素原子であり、Yが水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔48〕Yが、トリフルオロメチルであり、Y及びYが、それぞれ独立に、フッ素原子又は水素原子であり、Yが水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔49〕Yが、ニトロであり、Y及びYが、それぞれ独立に、フッ素原子又は水素原子であり、Yが水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔50〕Yが、シアノであり、Y及びYが、それぞれ独立に、フッ素原子又は水素原子であり、Yが水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔51〕Yが、フッ素原子又は塩素原子であり、Y及びYが、それぞれ独立に、フッ素原子又は水素原子であり、Yが水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔52〕Yが、塩素原子であり、Y及びYが、それぞれ独立に、フッ素原子又は水素原子であり、Yが水素原子である、前記〔1〕~前記〔14〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
[47] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is methyl, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom, and Y 4 is a hydrogen atom.
[48] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is trifluoromethyl, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom, and Y 4 is a hydrogen atom.
[49] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is nitro, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom, and Y 4 is a hydrogen atom.
[50] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 1 is cyano, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom, and Y 4 is a hydrogen atom.
[51] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 4 is a fluorine atom or a chlorine atom, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom , and Y 1 is a hydrogen atom.
[52] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [14] above, wherein Y 4 is a chlorine atom, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom, and Y 1 is a hydrogen atom.

〔53〕Xが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、シアノ、又は水素原子である、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔54〕Xが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又は水素原子である、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔55〕Xが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又は水素原子である、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔56〕Xが、ハロゲンである、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔57〕Xが、(C-C)アルキルである、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔58〕Xが、(C-C)ハロアルキルである、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
[53] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is halogen, (C 1 -C 3 ) alkyl, (C 1 -C 3 ) haloalkyl, cyano, or a hydrogen atom.
[54] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, or a hydrogen atom.
[55] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is halogen, (C 1 -C 3 ) alkyl, (C 1 -C 3 ) haloalkyl, or a hydrogen atom.
[56] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is a halogen.
[57] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is (C 1 -C 3 ) alkyl.
[58] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is (C 1 -C 3 ) haloalkyl.

〔59〕Xが、フッ素原子、塩素原子、メチル、ジフルオロメチル、トリフルオロメチル、シアノ、又は水素原子である、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔60〕Xが、フッ素原子、塩素原子、ジフルオロメチル、トリフルオロメチル、又は水素原子である、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔61〕Xが、フッ素原子、塩素原子、メチル、又は水素原子である、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔62〕Xが、フッ素原子、塩素原子、又はメチルである、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔63〕Xが、フッ素原子又は塩素原子である、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔64〕Xが、ジフルオロメチル又はトリフルオロメチルである、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔65〕Xが、フッ素原子である、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔66〕Xが、塩素原子である、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔67〕Xが、メチルである、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔68〕Xが、水素原子である、前記〔1〕~前記〔52〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
[59] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is a fluorine atom, a chlorine atom, methyl, difluoromethyl, trifluoromethyl, cyano, or a hydrogen atom.
[60] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is a fluorine atom, a chlorine atom, difluoromethyl, trifluoromethyl, or a hydrogen atom.
[61] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is a fluorine atom, a chlorine atom, a methyl, or a hydrogen atom.
[62] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is a fluorine atom, a chlorine atom, or methyl.
[63] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is a fluorine atom or a chlorine atom.
[64] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is difluoromethyl or trifluoromethyl.
[65] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is a fluorine atom.
[66] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is a chlorine atom.
[67] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is methyl.
[68] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [1] to [52] above, wherein X 1 is a hydrogen atom.

〔69〕Rが、(C-C)鎖式炭化水素であり、Xが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又は水素原子であり、Y、Y、Y及びYが、それぞれ独立に、ハロゲン、水素原子、(C-C)アルキル、(C-C)ハロアルキル、又はニトロである、前記〔1〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔70〕Rが、(C-C)アルキル又は(C-C)アルキニルである、前記〔69〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔71〕Rが、(C-C)アルキル又は(C-C)アルキニルである、前記〔69〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔72〕Rが、メチル又はプロパルギルである、前記〔69〕に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔73〕Yが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又はニトロであり、Y、Y及びYが、それぞれ独立に、ハロゲン又は水素原子である、前記〔69〕~前記〔72〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔74〕Yが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又はニトロであり、Y、Y及びYが、それぞれ独立に、フッ素原子、塩素原子、又は水素原子である、前記〔69〕~前記〔72〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔75〕Yが、フッ素原子、塩素原子、メチル、トリフルオロメチル、又はニトロであり、Y及びYが、それぞれ独立に、フッ素原子又は水素原子であり、Yが水素原子である、前記〔69〕~前記〔72〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔76〕Xが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又は水素原子である、前記〔69〕~前記〔75〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔77〕Xが、フッ素原子、塩素原子、ジフルオロメチル、トリフルオロメチル、又は水素原子である、前記〔69〕~前記〔75〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
〔78〕前記〔1〕~前記〔77〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩を有効成分として含有する農園芸用殺菌剤。
〔79〕前記〔1〕~前記〔77〕のいずれか一つに記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩の有効量を、植物体、植物病原菌又は土壌に施用する、植物病害を防除する方法。
[69] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to the above [1], wherein R 1 is a (C 1 -C 6 ) chain hydrocarbon, X 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, or a hydrogen atom, and Y 1 , Y 2 , Y 3 , and Y 4 are each independently halogen, hydrogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, or nitro.
[70] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to [69] above, wherein R 1 is (C 1 -C 6 ) alkyl or (C 2 -C 6 ) alkynyl.
[71] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to [69] above, wherein R 1 is (C 1 -C 3 ) alkyl or (C 2 -C 3 ) alkynyl.
[72] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to [69] above, wherein R 1 is methyl or propargyl.
[73] The N-substituted oxy -2 -aminothiazolecarboxamide compound or a salt thereof according to any one of [69] to [72] above, wherein Y 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, or nitro, and Y 2 , Y 3 , and Y 4 are each independently halogen or a hydrogen atom.
[74] The N-substituted oxy -2 -aminothiazolecarboxamide compound or a salt thereof according to any one of [69] to [72] above, wherein Y 1 is halogen, (C 1 -C 3 ) alkyl, (C 1 -C 3 ) haloalkyl, or nitro, and Y 2 , Y 3 , and Y 4 are each independently a fluorine atom, a chlorine atom, or a hydrogen atom.
[75] The N-substituted oxy -2 -aminothiazolecarboxamide compound or a salt thereof according to any one of [69] to [72] above, wherein Y 1 is a fluorine atom, a chlorine atom, methyl, trifluoromethyl, or nitro, Y 2 and Y 3 are each independently a fluorine atom or a hydrogen atom, and Y 4 is a hydrogen atom.
[76] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [69] to [75] above, wherein X 1 is halogen, (C 1 -C 3 ) alkyl, (C 1 -C 3 ) haloalkyl, or a hydrogen atom.
[77] The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of [69] to [75] above, wherein X 1 is a fluorine atom, a chlorine atom, difluoromethyl, trifluoromethyl, or a hydrogen atom.
[78] An agricultural and horticultural fungicide comprising the N-substituted oxy-2-aminothiazolecarboxamide compound or its salt according to any one of [1] to [77] above as an active ingredient.
[79] A method for controlling plant diseases, comprising applying an effective amount of the N-substituted oxy-2-aminothiazolecarboxamide compound or its salt according to any one of [1] to [77] to a plant body, a plant pathogen, or soil.

 次に本発明の実施例を記載するが、本発明はこれらに限定されるものではない。本発明化合物の物性値である融点は、融点測定装置(Buchi社製 型番M-565)で測定した。H-NMRスペクトルデータは、測定溶媒中で、FT-NMR装置(JEOL社製 製品名JNM- ECX(500MHz)又はBruker社製 製品名AVANCE III HD(300MHz))にて測定した(H-核磁気共鳴分光法)。なお、測定溶媒は内部標準としてテトラメチルシラン(TMS)を含む場合もある。
 また、本明細書において、室温は10~30℃程度を意味する。
Examples of the present invention are described below, but the present invention is not limited thereto. The melting point, which is a physical property value of the compound of the present invention, was measured using a melting point measuring device (Buchi, model number M-565). 1 H-NMR spectrum data was measured in a measurement solvent using an FT-NMR device (JEOL, product name JNM-ECX (500 MHz) or Bruker, product name AVANCE III HD (300 MHz)) ( 1 H-nuclear magnetic resonance spectroscopy). The measurement solvent may contain tetramethylsilane (TMS) as an internal standard.
In this specification, room temperature means a temperature of about 10 to 30°C.

[合成例]
合成例1:2-アミノ-4-クロロ-N-{2-クロロ-5,6-ジフルオロピリジン-3-イル)メチル}-N-メトキシチアゾール-5-カルボキサミド(化合物No.17)の合成
(1)(2-クロロ-5,6-ジフルオロピリジン-3-イル)メタノール:
 国際公開2016/097862の67頁、Example 2、Step 1に記載の2-クロロ-3-シアノ-5,6-ジフルオロピリジン(2.0g)のジクロロメタン(60mL)溶液に窒素雰囲気下、-78℃で水素化ジイソブチルアルミニウムのヘキサン溶液(1.03M、36.9mL)を滴下し、得られた混合物を同温で1.5時間撹拌した。メタノール(1.8mL)及び10%塩酸水溶液(18mL)を順次加え、同温で30分間撹拌したのち、室温下で10分間撹拌した。有機層を分離し、水層を飽和炭酸水素ナトリウム水溶液にて中和し、セライトを用いてろ過した。ろ液を酢酸エチルを用いて抽出した。抽出により得られた有機層を飽和酒石酸カリウムナトリウム水溶液、水、飽和食塩水で順次洗浄し、無水硫酸ナトリウムで乾燥、ろ過した後、減圧下濃縮し、油状の2-クロロ-5,6-ジフルオロニコチンアルデヒドの粗生成物(2.03g)を得た。
 前記粗生成物(2.03g)をメタノール(100mL)に溶解させ、得られた溶液に0℃で水素化ホウ素ナトリウム(0.52g)を加え、得られた混合物を室温下で一晩撹拌し反応溶液を得た。前記反応溶液に塩酸水溶液を加えてクエンチした。クエンチした反応溶液を飽和炭酸水素ナトリウム水溶液で中和した。メタノールを留去し、得られた残渣に酢酸エチルを加えた。有機層を分取し、水層を酢酸エチルを用いて抽出した。抽出により得られた有機層を水及び飽和食塩水で順次洗浄し、無水硫酸ナトリウムで乾燥、ろ過した後、減圧下濃縮した。得られた残渣をカラムクロマトグラフィー(溶離液:酢酸エチル/ヘプタン)で精製して、油状の(2-クロロ-5,6-ジフルオロピリジン-3-イル)メタノール(1.49g)を得た。このもののH-NMRスペクトラムデータは以下の通りである。
1H NMR (CDCl3/300MHz):δ(ppm)= 7.85 (t, 1H), 4.76 (d, 2H), 2.07 (t, 1H).
(2)N-[(2-クロロ-5,6-ジフルオロピリジン-3-イル)メチル]-O-メチルヒドロキシルアミン:
(i)(2-クロロ-5,6-ジフルオロピリジン-3-イル)メタノール(294mg)及びトリエチルアミン(0.46mL)をテトラヒドロフラン(15mL)に混合した。得られた混合物へ塩化メタンスルホニル(0.14mL)を0℃で加え、室温にて4.5時間撹拌し反応溶液を得た。前記反応溶液に飽和炭酸水素ナトリウム水溶液を加えてクエンチした。クエンチした反応溶液に酢酸エチルを加え、水層を酢酸エチルを用いて抽出した。抽出により得られた有機層を水及び飽和食塩水で順次洗浄し、無水硫酸ナトリウムで乾燥、ろ過した後、減圧下濃縮し、油状の(2-クロロ-5,6-ジフルオロピリジン-3-イル)メチル メタンスルホネート(409mg)の粗生成物を得た。
(ii)上記(2)(i)で得た粗生成物(409mg)をアセトン(15mL)に溶解させ、得られた溶液に臭化リチウム(207mg)を室温下で加え、加熱還流下で2.5時間撹拌した。室温に放冷後、反応溶液に水を加えてクエンチした。クエンチした反応溶液に酢酸エチルを加え、水層を酢酸エチルを用いて抽出した。抽出により得られた有機層を水及び飽和食塩水で順次洗浄し、無水硫酸ナトリウムで乾燥、ろ過した後、減圧下濃縮し、油状の3-(ブロモメチル)-2-クロロ-5,6-ジフルオロピリジン(233mg)を粗生成物として得た。
(iii)上記(2)(ii)で得た粗生成物(233mg)、ジイソプロピルエチルアミン(0.5mL)、及びN,N-ジメチルホルムアミド(5mL)を混合し混合物を得た。得られた混合物にO-メチルヒドロキシルアミン塩酸塩(96.31mg)を室温下で加え、50℃で7.5時間撹拌し反応溶液を得た。得られた反応溶液を室温に放冷後、前記反応溶液に水を加えてクエンチした。クエンチした反応溶液に酢酸エチル及びヘプタンを順次加え、水層を酢酸エチル-ヘプタンの混合溶媒を用いて抽出した。抽出により得られた有機層を水及び飽和食塩水で順次洗浄し、無水硫酸ナトリウムで乾燥、ろ過した後、減圧下濃縮した。得られた残渣をカラムクロマトグラフィー(溶離液:酢酸エチル/ヘプタン)で精製して、油状のN-[(2-クロロ-5,6-ジフルオロピリジン-3-イル)メチル]-O-メチルヒドロキシルアミン(102mg)を得た。このもののH-NMRスペクトラムデータは以下の通りである。
1H NMR (CDCl3/300MHz):δ(ppm)= 7.76 (t, 1H), 5.89 (brs, 1H), 4.11 (d, 2H), 3.53 (s, 3H).
[Synthesis Example]
Synthesis Example 1: Synthesis of 2-amino-4-chloro-N-{2-chloro-5,6-difluoropyridin-3-yl)methyl}-N-methoxythiazole-5-carboxamide (Compound No. 17) (1) (2-chloro-5,6-difluoropyridin-3-yl)methanol:
A hexane solution (1.03 M, 36.9 mL) of diisobutylaluminum hydride was dropped at −78° C. under a nitrogen atmosphere to a dichloromethane (60 mL) solution of 2-chloro-3-cyano-5,6-difluoropyridine (2.0 g) described in WO 2016/097862, page 67, Example 2, Step 1, and the resulting mixture was stirred at the same temperature for 1.5 hours. Methanol (1.8 mL) and a 10% aqueous hydrochloric acid solution (18 mL) were added successively, and the mixture was stirred at the same temperature for 30 minutes, and then stirred at room temperature for 10 minutes. The organic layer was separated, and the aqueous layer was neutralized with a saturated aqueous sodium bicarbonate solution and filtered using Celite. The filtrate was extracted with ethyl acetate. The organic layer obtained by extraction was washed successively with a saturated aqueous solution of potassium sodium tartrate, water, and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure to obtain an oily crude product of 2-chloro-5,6-difluoronicotinaldehyde (2.03 g).
The crude product (2.03 g) was dissolved in methanol (100 mL), and sodium borohydride (0.52 g) was added to the resulting solution at 0° C., and the resulting mixture was stirred overnight at room temperature to obtain a reaction solution. Aqueous hydrochloric acid was added to the reaction solution to quench it. The quenched reaction solution was neutralized with saturated aqueous sodium bicarbonate solution. Methanol was distilled off, and ethyl acetate was added to the resulting residue. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate. The organic layer obtained by extraction was washed successively with water and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure. The resulting residue was purified by column chromatography (eluent: ethyl acetate/heptane) to obtain oily (2-chloro-5,6-difluoropyridin-3-yl)methanol (1.49 g). The 1 H-NMR spectrum data of this product is as follows.
1 H NMR (CDCl 3 /300MHz): δ(ppm)= 7.85 (t, 1H), 4.76 (d, 2H), 2.07 (t, 1H).
(2) N-[(2-chloro-5,6-difluoropyridin-3-yl)methyl]-O-methylhydroxylamine:
(i) (2-chloro-5,6-difluoropyridin-3-yl)methanol (294 mg) and triethylamine (0.46 mL) were mixed in tetrahydrofuran (15 mL). To the resulting mixture, methanesulfonyl chloride (0.14 mL) was added at 0° C., and the mixture was stirred at room temperature for 4.5 hours to obtain a reaction solution. The reaction solution was quenched by adding a saturated aqueous sodium bicarbonate solution. Ethyl acetate was added to the quenched reaction solution, and the aqueous layer was extracted with ethyl acetate. The organic layer obtained by extraction was washed successively with water and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure to obtain a crude product of (2-chloro-5,6-difluoropyridin-3-yl)methyl methanesulfonate (409 mg) as an oil.
(ii) The crude product (409 mg) obtained in (2)(i) above was dissolved in acetone (15 mL), and lithium bromide (207 mg) was added to the obtained solution at room temperature, followed by stirring under heating and reflux for 2.5 hours. After cooling to room temperature, water was added to the reaction solution to quench the reaction. Ethyl acetate was added to the quenched reaction solution, and the aqueous layer was extracted with ethyl acetate. The organic layer obtained by extraction was washed successively with water and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure to obtain oily 3-(bromomethyl)-2-chloro-5,6-difluoropyridine (233 mg) as a crude product.
(iii) The crude product (233 mg) obtained in (2)(ii) above, diisopropylethylamine (0.5 mL), and N,N-dimethylformamide (5 mL) were mixed to obtain a mixture. O-methylhydroxylamine hydrochloride (96.31 mg) was added to the obtained mixture at room temperature, and the mixture was stirred at 50° C. for 7.5 hours to obtain a reaction solution. The obtained reaction solution was allowed to cool to room temperature, and then water was added to the reaction solution to quench it. Ethyl acetate and heptane were added successively to the quenched reaction solution, and the aqueous layer was extracted with a mixed solvent of ethyl acetate and heptane. The organic layer obtained by extraction was washed successively with water and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure. The obtained residue was purified by column chromatography (eluent: ethyl acetate/heptane) to obtain oily N-[(2-chloro-5,6-difluoropyridin-3-yl)methyl]-O-methylhydroxylamine (102 mg). The 1 H-NMR spectrum data of this product is as follows:
1H NMR (CDCl 3 /300MHz): δ(ppm)= 7.76 (t, 1H), 5.89 (brs, 1H), 4.11 (d, 2H), 3.53 (s, 3H).

(3)2-[(tert-ブトキシカルボニル)アミノ]-4-クロロチアゾール-5-カルボン酸:
 国際公開公報2008/063888号の108頁に記載のExample 27、Step 1に基づき合成したtert-ブチル(4-クロロ-5-ホルミルチアゾール-2-イル)カーバメート(15.86g)及び2-メチル-2-ブテン(32mL)を、テトラヒドロフラン(130mL)及びtert-ブタノール(130mL)の混合溶媒と混合し溶液を得た。得られた溶液にリン酸二水素ナトリウム(14.49g)の水溶液(22mL)を0℃で加え、撹拌し混合物を得た。15分後、前記混合物に亜塩素酸ナトリウム(13.6g、80%)の水溶液(44mL)を加え、室温下で一晩撹拌した。反応溶液に塩酸水溶液を加え酸性に調節し、さらに酢酸エチルを加え抽出した。抽出した有機層を、水及び飽和食塩水で順次洗浄し、無水硫酸ナトリウムで乾燥、ろ過した後、減圧下濃縮した。得られた固体を飽和炭酸水素ナトリウム水溶液に溶解させ、水層を酢酸エチルで洗浄した。酢酸エチルで洗浄した水層に塩酸水溶液を加え酸性に調節した。酸性に調節した水層に酢酸エチルを加え、水層を酢酸エチルで抽出した。抽出により得られた有機層を、水及び飽和食塩水で順次洗浄し、無水硫酸ナトリウムで乾燥、ろ過した後、減圧下濃縮し、固体を得た。得られた固体を50%酢酸エチル/ヘプタン溶液で洗浄し、白色固体の2-[(tert-ブトキシカルボニル)アミノ]-4-クロロチアゾール-5-カルボン酸(15.57g)を得た。このもののH-NMRスペクトラムデータは以下の通りである。
1H NMR (DMSO-d6/300MHz):δ(ppm)= 12.19 (s, 1H), 1.49 (s, 9H).
(3) 2-[(tert-butoxycarbonyl)amino]-4-chlorothiazole-5-carboxylic acid:
Tert-butyl (4-chloro-5-formylthiazol-2-yl) carbamate (15.86 g) synthesized based on Example 27, Step 1 described on page 108 of International Publication WO 2008/063888 and 2-methyl-2-butene (32 mL) were mixed with a mixed solvent of tetrahydrofuran (130 mL) and tert-butanol (130 mL) to obtain a solution. To the obtained solution, an aqueous solution (22 mL) of sodium dihydrogen phosphate (14.49 g) was added at 0° C., and the mixture was stirred to obtain a mixture. After 15 minutes, an aqueous solution (44 mL) of sodium chlorite (13.6 g, 80%) was added to the mixture, and the mixture was stirred overnight at room temperature. An aqueous solution of hydrochloric acid was added to the reaction solution to adjust it to acidic, and ethyl acetate was further added for extraction. The extracted organic layer was washed successively with water and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure. The obtained solid was dissolved in a saturated aqueous solution of sodium hydrogen carbonate, and the aqueous layer was washed with ethyl acetate. Aqueous hydrochloric acid was added to the aqueous layer washed with ethyl acetate to adjust it to acidity. Ethyl acetate was added to the aqueous layer adjusted to acidity, and the aqueous layer was extracted with ethyl acetate. The organic layer obtained by extraction was washed successively with water and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure to obtain a solid. The obtained solid was washed with a 50% ethyl acetate/heptane solution to obtain 2-[(tert-butoxycarbonyl)amino]-4-chlorothiazole-5-carboxylic acid (15.57 g) as a white solid. The 1 H-NMR spectrum data of this product is as follows:
1H NMR (DMSO-d 6 /300MHz): δ(ppm)= 12.19 (s, 1H), 1.49 (s, 9H).

(4)tert-ブチル[4-クロロ-5-[{(2-クロロ-5,6-ジフルオロピリジン-3-イル)メチル}(メトキシ)カルバモイル]チアゾール-2-イル]カーバメート:
 2-[(tert-ブトキシカルボニル)アミノ]-4-クロロチアゾール-5-カルボン酸(146.97mg)のテトラヒドロフラン(5mL)溶液に、氷冷下、塩化オキサリル(0.05mL)、触媒量のN,N-ジメチルホルムアミドを加えて、窒素雰囲気下で撹拌した。15分後室温に昇温し、さらに30分間撹拌した。反応溶液を減圧下濃縮し、2-[(tert-ブトキシカルボニル)アミノ]-4-クロロチアゾール-5-カルボン酸クロリド(以下、酸クロリドともいう)を得た。得られた酸クロリドにテトラヒドロフラン(3mL)を加えて溶解させ、次に、N-[(2-クロロ-5,6-ジフルオロピリジン-3-イル)メチル]-O-メチルヒドロキシルアミン(100mg)のテトラヒドロフラン(2mL)溶液、及びジイソプロピルエチルアミン(0.13mL)を室温下で順次加え、窒素雰囲気下50℃で2.5時間撹拌し反応溶液を得た。得られた反応溶液を室温へ放冷後、飽和炭酸水素ナトリウム水溶液を用いて前記反応溶液をクエンチした。クエンチした反応溶液に酢酸エチルを加え、水層を酢酸エチルを用いて抽出した。抽出により得られた有機層を、水及び飽和食塩水で順次洗浄し、無水硫酸ナトリウムで乾燥、ろ過した後、減圧下濃縮した。得られた残渣をカラムクロマトグラフィー(溶離液:酢酸エチル/ヘプタン)で精製して、非晶質のtert-ブチル[4-クロロ-5-[{(2-クロロ-5,6-ジフルオロピリジン-3-イル)メチル}(メトキシ)カルバモイル]チアゾール-2-イル]カーバメート(189mg)を得た。このもののH-NMRスペクトラムデータは以下の通りである。
1H NMR (DMSO-d6/300MHz):δ(ppm)= 12.13 (brs, 1H), 8.12 (t, 1H), 5.01 (s, 2H), 3.72 (s, 3H), 1.49 (s, 9H).
(4) tert-butyl [4-chloro-5-[{(2-chloro-5,6-difluoropyridin-3-yl)methyl}(methoxy)carbamoyl]thiazol-2-yl]carbamate:
To a solution of 2-[(tert-butoxycarbonyl)amino]-4-chlorothiazole-5-carboxylic acid (146.97 mg) in tetrahydrofuran (5 mL), oxalyl chloride (0.05 mL) and a catalytic amount of N,N-dimethylformamide were added under ice cooling, and the mixture was stirred under a nitrogen atmosphere. After 15 minutes, the temperature was raised to room temperature and the mixture was stirred for an additional 30 minutes. The reaction solution was concentrated under reduced pressure to obtain 2-[(tert-butoxycarbonyl)amino]-4-chlorothiazole-5-carboxylic acid chloride (hereinafter also referred to as acid chloride). Tetrahydrofuran (3 mL) was added to the obtained acid chloride to dissolve it, and then a solution of N-[(2-chloro-5,6-difluoropyridin-3-yl)methyl]-O-methylhydroxylamine (100 mg) in tetrahydrofuran (2 mL) and diisopropylethylamine (0.13 mL) were added successively at room temperature, and the mixture was stirred at 50° C. for 2.5 hours under a nitrogen atmosphere to obtain a reaction solution. The obtained reaction solution was allowed to cool to room temperature, and then the reaction solution was quenched using a saturated aqueous solution of sodium bicarbonate. Ethyl acetate was added to the quenched reaction solution, and the aqueous layer was extracted with ethyl acetate. The organic layer obtained by extraction was washed successively with water and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure. The resulting residue was purified by column chromatography (eluent: ethyl acetate/heptane) to give amorphous tert-butyl [4-chloro-5-[{(2-chloro-5,6-difluoropyridin-3-yl)methyl}(methoxy)carbamoyl]thiazol-2-yl]carbamate (189 mg), the 1 H-NMR spectrum data of which is as follows:
1H NMR (DMSO-d 6 /300MHz): δ(ppm)= 12.13 (brs, 1H), 8.12 (t, 1H), 5.01 (s, 2H), 3.72 (s, 3H), 1.49 (s, 9H).

(5)2-アミノ-4-クロロ-N-{2-クロロ-5,6-ジフルオロピリジン-3-イル)メチル}-N-メトキシチアゾール-5-カルボキサミド(化合物No.17):
 tert-ブチル[4-クロロ-5-[{(2-クロロ-5,6-ジフルオロピリジン-3-イル)メチル}(メトキシ)カルバモイル]チアゾール-2-イル]カーバメート(189mg)のジクロロメタン(3mL)溶液にトリフルオロ酢酸(0.62mL)を加え、40℃で一晩撹拌し反応溶液を得た。得られた反応溶液を室温へ放冷後、反応溶液に飽和炭酸水素ナトリウム水溶液をゆっくり加え、反応溶液を塩基性に調節した。塩基性に調節した反応溶液の水層を酢酸エチルを用いて抽出した。抽出により得られた有機層を、水及び飽和食塩水で順次洗浄し、無水硫酸ナトリウムで乾燥、ろ過した後、減圧下濃縮した。得られた残渣をカラムクロマトグラフィー(溶離液:酢酸エチル/ヘプタン)で精製して、固体の表題の目的化合物(化合物No.17、117mg)を得た。このもののH-NMRスペクトラムデータは以下の通りである。
1H NMR (DMSO-d6/300MHz):δ(ppm)= 8.08-8.02 (m, 3H), 4.94 (s, 2H), 3.69 (s, 3H).
(5) 2-amino-4-chloro-N-{2-chloro-5,6-difluoropyridin-3-yl)methyl}-N-methoxythiazole-5-carboxamide (Compound No. 17):
Trifluoroacetic acid (0.62 mL) was added to a solution of tert-butyl [4-chloro-5-[{(2-chloro-5,6-difluoropyridin-3-yl)methyl}(methoxy)carbamoyl]thiazol-2-yl]carbamate (189 mg) in dichloromethane (3 mL), and the mixture was stirred at 40° C. overnight to obtain a reaction solution. The obtained reaction solution was allowed to cool to room temperature, and then a saturated aqueous solution of sodium bicarbonate was slowly added to the reaction solution to adjust the reaction solution to basicity. The aqueous layer of the reaction solution adjusted to basicity was extracted with ethyl acetate. The organic layer obtained by extraction was washed successively with water and saturated saline, dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure. The obtained residue was purified by column chromatography (eluent: ethyl acetate/heptane) to obtain the title target compound (compound No. 17, 117 mg) as a solid. The 1 H-NMR spectrum data of this product is as follows.
1H NMR (DMSO-d 6 /300MHz): δ(ppm)= 8.08-8.02 (m, 3H), 4.94 (s, 2H), 3.69 (s, 3H).

 次に、化合物(I)の代表例を第1表に具体的に挙げる。これらの化合物は前記製造方法及び前記合成例、並びに本技術分野において公知の方法に基づいて合成することができる。
 第1表中、No.は本発明化合物の化合物No.を示す。第1表中では、Me:メチル基、Et:エチル基、Pr:ノルマルプロピル基、Hex:ノルマルヘキシル基、NO:ニトロ基、-:単結合、=:二重結合、≡:三重結合を表す。
Next, representative examples of compound (I) are specifically listed in Table 1. These compounds can be synthesized based on the above-mentioned production methods and synthesis examples, as well as methods known in the art.
In Table 1, No. indicates the compound number of the compound of the present invention. In Table 1, Me: methyl group, Et: ethyl group, Pr: normal propyl group, Hex: normal hexyl group, NO 2 : nitro group, -: single bond, =: double bond, ≡: triple bond.

 また、化合物(I)の塩である場合は、第1表中の備考欄にその塩の種類を示す。例えば、第1表中の備考欄に、HCl塩と記載した化合物は塩酸塩、TsOH塩と記載した化合物はパラトルエンスルホン酸塩、Na塩と記載した化合物はナトリウム塩である。例えば化合物No.68は化合物No.17の塩酸塩である。化合物No.69は化合物No.17のパラトルエンスルホン酸塩である。化合物No.70は化合物No.17のナトリウム塩である。 In addition, in the case of a salt of compound (I), the type of salt is indicated in the remarks column in Table 1. For example, in the remarks column in Table 1, compounds described as HCl salt are hydrochlorides, compounds described as TsOH salt are paratoluenesulfonates, and compounds described as Na salt are sodium salts. For example, compound No. 68 is the hydrochloride salt of compound No. 17. Compound No. 69 is the paratoluenesulfonate salt of compound No. 17. Compound No. 70 is the sodium salt of compound No. 17.







Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000012



Figure JPOXMLDOC01-appb-T000013
Figure JPOXMLDOC01-appb-T000013


Figure JPOXMLDOC01-appb-T000014
Figure JPOXMLDOC01-appb-T000014


Figure JPOXMLDOC01-appb-T000015
Figure JPOXMLDOC01-appb-T000015


 前記製造方法及び実施例に準じて合成した化合物(I)の物性値を第2表及び第3表に示す。第2表では、化合物(I)の融点を示す。第3表では、化合物(I)の1H-NMRスペクトラムデータ〔1H-核磁気共鳴分光法にて測定;δは化学シフト値(ppm)である〕を示す。なお、第2表及び第3表中のNo.は、第1表と同様の意味を表す。
 第2表中の融点において、*1は、化合物の融点を測定した時に分解した温度を表す。
 第3表中の1H-NMRスペクトラムデータにおいて、sはシングレット(一重線)、brsはブロードしたシングレット、dはダブレット(二重線)、tはトリプレット(三重線)、qはカルテット(四重線)、mはマルチプレット(多重線)である。
The physical properties of compound (I) synthesized according to the above-mentioned production method and examples are shown in Tables 2 and 3. Table 2 shows the melting point of compound (I). Table 3 shows the 1 H-NMR spectrum data of compound (I) [measured by 1 H-nuclear magnetic resonance spectroscopy; δ is the chemical shift value (ppm)]. The numbers in Tables 2 and 3 have the same meanings as in Table 1.
In the melting points in Table 2, *1 indicates the temperature at which the compound decomposed when its melting point was measured.
In the 1 H-NMR spectrum data in Table 3, s is singlet, brs is broadened singlet, d is doublet, t is triplet, q is quartet, and m is multiplet.






 次に、本発明の化合物の有害な植物病害に対して優れた防除効果及び有用性を、具体的な試験例で説明する。また、比較対象として、下記に示した、特許文献1に記載のExample68(以下、比較化合物Aともいう)を用いて、各試験を実施した。

Figure JPOXMLDOC01-appb-C000018
Next, the excellent control effect and usefulness of the compound of the present invention against harmful plant diseases will be described with specific test examples. In addition, each test was carried out using Example 68 (hereinafter also referred to as comparative compound A) described in Patent Document 1 shown below as a comparison subject.
Figure JPOXMLDOC01-appb-C000018

[試験例]
 供試化合物を含む薬液の調製:
 供試化合物とアセトン又はジメチルスルホキシドとを混合し、供試化合物を溶解させた。供試化合物の溶液に水を加えて、有効成分である供試化合物が所定の濃度(400ppm)になるように希釈して薬液を得た。この薬液を、以下の試験例1~試験例3にて利用した。
[Test Example]
Preparation of drug solutions containing test compounds:
The test compound was mixed with acetone or dimethyl sulfoxide to dissolve the test compound. Water was added to the test compound solution to dilute the test compound, which is the active ingredient, to a predetermined concentration (400 ppm) to obtain a drug solution. This drug solution was used in the following Test Examples 1 to 3.

試験例1:トマト疫病(Phytophthora infestans)に対する殺菌効果試験(予防効果試験)
 直径6cmのビニールポットでトマトを栽培し、4.5~5.5葉期に達した時に薬液10mlをスプレーガンにて散布した。薬液が乾燥した後(処理当日)に、トマト疫病菌(Phytophthora infestans)の胞子懸濁液を噴霧接種し、温度20℃、湿度95%以上の接種箱に16時間入れた。その後、20℃の恒温室内に置き、接種3日後に病斑面積率を目視で調査し、下記計算式に従って防除率を算出した。その結果、供試化合物として以下の各本発明化合物を用いた各薬液(有効成分濃度は400ppm)がトマト疫病に対して80%以上の防除率を示した。
[防除率の計算式]
防除率(%)=100-(X/Y)×100
X:供試化合物の病斑面積率(%)、Y:無処理区の病斑面積率(%)
供試化合物:化合物No.1、2、3、7、8、10、11、13、17、19、32、34、41、43、47、51、53、54、55、57、58、61、71、75、84、85、86、87、90、93、94
 一方、比較化合物Aを用いた薬液(有効成分濃度は400ppm)は30%未満の防除率であった。
Test Example 1: Fungicidal effect test against tomato late blight ( Phytophthora infestans ) (preventive effect test)
Tomatoes were grown in vinyl pots with a diameter of 6 cm, and when they reached the 4.5-5.5 leaf stage, 10 ml of the drug solution was sprayed with a spray gun. After the drug solution dried (on the day of treatment), a spore suspension of Phytophthora infestans was sprayed and inoculated, and the plants were placed in an inoculation box at a temperature of 20°C and a humidity of 95% or more for 16 hours. The plants were then placed in a thermostatic chamber at 20°C, and 3 days after inoculation, the lesion area rate was visually examined, and the control rate was calculated according to the following formula. As a result, each drug solution (active ingredient concentration 400 ppm) using the following compounds of the present invention as test compounds showed a control rate of 80% or more against tomato late blight.
[Calculation formula for control rate]
Control rate (%) = 100 - (X/Y) x 100
X: Lesion area rate of test compound (%), Y: Lesion area rate of untreated area (%)
Test compound: Compound No. 1, 2, 3, 7, 8, 10, 11, 13, 17, 19, 32, 34, 41, 43, 47, 51, 53, 54, 55, 57, 58, 61, 71, 75, 84, 85, 86, 87, 90, 93, 94
On the other hand, the control rate of the solution containing the comparative compound A (active ingredient concentration: 400 ppm) was less than 30%.

試験例2:キュウリべと病(Pseudoperonospora cubensis)に対する殺菌効果試験(予防効果試験)
 直径6cmのビニールポットでキュウリを栽培し、1.2~1.5葉期に達した時に薬液10mlをスプレーガンにて散布した。薬液が乾燥した後(処理当日または処理翌日)に、キュウリべと病菌(Pseudoperonospora cubensis)の胞子懸濁液を噴霧接種し、温度20℃、湿度95%以上の接種箱に24時間入れた。その後、20℃の恒温室内に置き、接種7日後に上記試験例1と同じ基準で病斑面積率を調査し、上記試験例1と同じ計算式により防除率を算出した。その結果、供試化合物として以下の各本発明化合物を用いた各薬液(有効成分濃度が400ppm)がキュウリべと病に対して80%以上の防除率を示した。
供試化合物:化合物No.1、7、8、10、11、13、19、34、41、51、53、54、55、57、58、61、75、84、85、86、87、90、93、94
 一方、比較化合物Aを用いた薬液(有効成分濃度は400ppm)は30%未満の防除率であった。
Test Example 2: Fungicidal effect test against cucumber downy mildew ( Pseudoperonospora cubensis ) (preventive effect test)
Cucumbers were grown in vinyl pots with a diameter of 6 cm, and when they reached the 1.2-1.5 leaf stage, 10 ml of the drug solution was sprayed with a spray gun. After the drug solution dried (on the day of treatment or the day after treatment), a spore suspension of cucumber downy mildew ( Pseudoperonospora cubensis ) was sprayed and inoculated, and the plants were placed in an inoculation box at a temperature of 20°C and a humidity of 95% or more for 24 hours. Thereafter, the plants were placed in a thermostatic chamber at 20°C, and 7 days after inoculation, the lesion area rate was investigated using the same criteria as in Test Example 1 above, and the control rate was calculated using the same formula as in Test Example 1 above. As a result, each drug solution (active ingredient concentration 400 ppm) using the following compounds of the present invention as test compounds showed a control rate of 80% or more against cucumber downy mildew.
Test compound: Compound No. 1, 7, 8, 10, 11, 13, 19, 34, 41, 51, 53, 54, 55, 57, 58, 61, 75, 84, 85, 86, 87, 90, 93, 94
On the other hand, the control rate of the solution containing the comparative compound A (active ingredient concentration: 400 ppm) was less than 30%.

試験例3:トマト疫病(Phytophthora infestans)に対する殺菌効果試験(治療効果試験)
 直径6cmのビニールポットでトマトを栽培し、4.5~5.5葉期に達した時にトマト疫病菌(Phytophthora infestans)の胞子懸濁液を噴霧接種し、温度20℃、湿度95%以上の接種箱に4時間入れた。その後、薬液10mlをスプレーガンにて散布し、薬液が乾燥した後(処理当日)に、20℃の恒温室内に置き、接種3日後に上記試験例1と同じ基準で病斑面積率を調査し、上記試験例1と同じ計算式により防除率を算出した。その結果、供試化合物として以下の各本発明化合物を用いた各薬液(有効成分濃度は400ppm)がトマト疫病に対して80%以上の防除率を示した。
供試化合物:化合物No.3、7、8、10、11、13、17、19、32、34、41、51、54、55、57、58、61、84、87
 一方、比較化合物Aを用いた薬液(有効成分濃度は400ppm)は30%未満の防除率であった。
Test Example 3: Fungicidal effect test against tomato late blight ( Phytophthora infestans ) (therapeutic effect test)
Tomatoes were grown in vinyl pots with a diameter of 6 cm, and when they reached the 4.5-5.5 leaf stage, they were inoculated by spraying a spore suspension of Phytophthora infestans , and placed in an inoculation box at a temperature of 20°C and a humidity of 95% or more for 4 hours. Then, 10 ml of the liquid was sprayed with a spray gun, and after the liquid dried (on the day of treatment), the pot was placed in a thermostatic chamber at 20°C. Three days after inoculation, the lesion area rate was investigated using the same criteria as in Test Example 1, and the control rate was calculated using the same formula as in Test Example 1. As a result, each liquid (active ingredient concentration 400 ppm) using the following compounds of the present invention as test compounds showed a control rate of 80% or more against tomato late blight.
Test compound: Compound No. 3, 7, 8, 10, 11, 13, 17, 19, 32, 34, 41, 51, 54, 55, 57, 58, 61, 84, 87
On the other hand, the control rate of the solution containing the comparative compound A (active ingredient concentration: 400 ppm) was less than 30%.

 上記の各試験例より、本発明化合物は有害な植物病害に対して優れた防除効果を発揮することを見出した。したがって、本発明化合物は農園芸用殺菌剤として有用である。 From the above test examples, it was found that the compound of the present invention exhibits excellent control effects against harmful plant diseases. Therefore, the compound of the present invention is useful as an agricultural and horticultural fungicide.

 次に、化合物(I)を含む製剤例を記載するが、配合割合、剤型などは記載例に限定されるものではない。
 製剤例1
(1)化合物(I)                    20重量部
(2)クレー                       72重量部
(3)リグニンスルホン酸ソーダ               8重量部
以上のものを均一に混合して水和剤とする。
 製剤例2
(1)化合物(I)                     5重量部
(2)タルク                       95重量部
以上のものを均一に混合して粉剤とする。
 製剤例3
(1)化合物(I)                    20重量部
(2)N,N-ジメチルアセトアミド            20重量部
(3)ポリオキシエチレンアルキルフェニルエーテル     10重量部
(4)キシレン                      50重量部
以上のものを均一に混合、溶解して乳剤とする。
Next, examples of formulations containing compound (I) will be described, but the blending ratio, dosage form, etc. are not limited to the described examples.
Formulation Example 1
(1) 20 parts by weight of compound (I) (2) 72 parts by weight of clay (3) 8 parts by weight of sodium lignin sulfonate The above ingredients are uniformly mixed to give a wettable powder.
Formulation Example 2
(1) Compound (I) 5 parts by weight (2) Talc 95 parts by weight or more are uniformly mixed to give a dusting agent.
Formulation Example 3
(1) Compound (I) 20 parts by weight (2) N,N-dimethylacetamide 20 parts by weight (3) Polyoxyethylene alkylphenyl ether 10 parts by weight (4) Xylene 50 parts by weight The above ingredients are uniformly mixed and dissolved to prepare an emulsion.

 製剤例4
(1)クレー                       68重量部
(2)リグニンスルホン酸ソーダ               2重量部
(3)ポリオキシエチレンアルキルアリールサルフェート    5重量部
(4)微粉シリカ                     25重量部
以上の各成分の混合物と、化合物(I)とを4:1の重量割合で混合し、水和剤とする。
 製剤例5
(1)化合物(I)                    50重量部
(2)ポリオキシエチレンアルキルフェニルエーテルリン酸トリエタノールアミン塩
                              2重量部
(3)シリコーン                    0.2重量部
(4)水                       47.8重量部
以上のものを均一に混合、粉砕した原液に更に
(5)ポリカルボン酸ナトリウム               5重量部
(6)無水硫酸ナトリウム               42.8重量部
を加え均一に混合、造粒、乾燥して顆粒水和剤とする。
 製剤例6
(1)化合物(I)                     5重量部
(2)ポリオキシエチレンオクチルフェニルエーテル      1重量部
(3)ポリオキシエチレンの燐酸エステル         0.1重量部
(4)粒状炭酸カルシウム               93.9重量部
(1)~(3)を予め均一に混合し、適量のアセトンで希釈した後、(4)に吹付け、アセトンを除去して粒剤とする。
Formulation Example 4
(1) 68 parts by weight of clay (2) 2 parts by weight of sodium lignin sulfonate (3) 5 parts by weight of polyoxyethylene alkylaryl sulfate (4) 25 parts by weight of finely powdered silica A mixture of the above components and compound (I) are mixed in a weight ratio of 4:1 to obtain a wettable powder.
Formulation Example 5
(1) 50 parts by weight of compound (I), (2) 2 parts by weight of polyoxyethylene alkylphenyl ether phosphate triethanolamine salt, (3) 0.2 parts by weight of silicone, and (4) 47.8 parts by weight of water. The above ingredients are uniformly mixed and pulverized to obtain a stock solution to which (5) 5 parts by weight of sodium polycarboxylate and (6) 42.8 parts by weight of anhydrous sodium sulfate are further added, mixed uniformly, granulated, and dried to obtain a water dispersible granule.
Formulation Example 6
(1) 5 parts by weight of compound (I) (2) 1 part by weight of polyoxyethylene octylphenyl ether (3) 0.1 part by weight of polyoxyethylene phosphate (4) 93.9 parts by weight of granular calcium carbonate (1) to (3) are mixed uniformly in advance, diluted with an appropriate amount of acetone, and then sprayed onto (4), and the acetone is removed to obtain a granule.

 製剤例7
(1)化合物(I)                   2.5重量部
(2)N-メチル-2-ピロリドン            2.5重量部
(3)大豆油                     95.0重量部
以上のものを均一に混合、溶解して微量散布剤(ultra low volume formulation)とする。
 製剤例8
(1)化合物(I)                    20重量部
(2)ポリオキシエチレンアルキルフェニルエーテルリン酸トリエタノールアミン塩
                              2重量部
(3)シリコーン                    0.2重量部
(4)ザンサンガム                   0.1重量部
(5)エチレングリコール                  5重量部
(6)水                       72.7重量部
以上のものを均一に混合、粉砕して水性懸濁剤とする。
Formulation Example 7
(1) Compound (I) 2.5 parts by weight (2) N-methyl-2-pyrrolidone 2.5 parts by weight (3) Soybean oil 95.0 parts by weight The above ingredients are uniformly mixed and dissolved to prepare an ultra low volume formulation.
Formulation Example 8
(1) 20 parts by weight of compound (I) (2) 2 parts by weight of polyoxyethylene alkylphenyl ether phosphate triethanolamine salt (3) 0.2 parts by weight of silicone (4) 0.1 parts by weight of xanthan gum (5) 5 parts by weight of ethylene glycol (6) 72.7 parts by weight of water The above ingredients are uniformly mixed and pulverized to obtain an aqueous suspension.

 なお、2023年12月15日に出願された日本特許出願2023-212115号の明細書、特許請求の範囲および要約書の全内容をここに引用し、本発明の明細書の開示として、取り入れるものである。 The entire contents of the specification, claims and abstract of Japanese Patent Application No. 2023-212115, filed on December 15, 2023, are hereby incorporated by reference as the disclosure of the specification of the present invention.

Claims (10)

 式(I):
Figure JPOXMLDOC01-appb-C000001
[式中、Rは、少なくとも1個のTで置換されていてもよい(C-C)鎖式炭化水素であり、
は、シアノ、又は-C(=O)O-Rであり、
は、(C-C)アルキルであり、
は、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、シアノ又は水素原子であり、
、Y、Y及びYは、それぞれ独立に、ハロゲン、水素原子、(C-C)アルキル、(C-C)アルケニル、(C-C)ハロアルキル、シアノ、又はニトロである]で表されるN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
Formula (I):
Figure JPOXMLDOC01-appb-C000001
[In the formula, R 1 is a (C 1 -C 6 ) chain hydrocarbon optionally substituted with at least one T 1 ,
T 1 is cyano or -C(=O)O-R 2 ;
R2 is ( C1 - C3 ) alkyl;
X 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, cyano or a hydrogen atom;
Y 1 , Y 2 , Y 3 and Y 4 each independently represent a halogen atom, a hydrogen atom, a (C 1 -C 6 ) alkyl, a (C 2 -C 6 ) alkenyl, a (C 1 -C 6 ) haloalkyl, cyano, or nitro, or a salt thereof.
 Rが、(C-C)アルキル又は(C-C)アルキニルである、請求項1に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。 2. The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to claim 1, wherein R 1 is (C 1 -C 6 ) alkyl or (C 2 -C 6 ) alkynyl.  Rが、メチル、エチル、又はプロパルギルである、請求項1に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。 The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to claim 1, wherein R 1 is methyl, ethyl, or propargyl.  Y及びYが、それぞれ独立に、ハロゲン、水素原子、(C-C)アルキル、(C-C)ハロアルキル、シアノ又はニトロであり、但し、Y及びYが同時に水素原子になることはなく、
及びYが、それぞれ独立に、ハロゲン又は水素原子である、請求項1から請求項3のいずれか一項に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
Y 1 and Y 4 are each independently halogen, a hydrogen atom, a (C 1 -C 6 ) alkyl, a (C 1 -C 6 ) haloalkyl, cyano, or nitro, provided that Y 1 and Y 4 are not both hydrogen atoms at the same time;
The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of claims 1 to 3, wherein Y2 and Y3 are each independently a halogen or a hydrogen atom.
 Rが、(C-C)鎖式炭化水素であり、
が、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又は水素原子であり、
、Y、Y及びYが、それぞれ独立に、ハロゲン、水素原子、(C-C)アルキル、(C-C)ハロアルキル、又はニトロである、請求項1に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
R 1 is a (C 1 -C 6 ) linear hydrocarbon;
X 1 is halogen, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, or a hydrogen atom;
The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to claim 1, wherein Y 1 , Y 2 , Y 3 and Y 4 are each independently halogen, a hydrogen atom, a (C 1 -C 6 ) alkyl, a (C 1 -C 6 ) haloalkyl, or nitro.
 Rが、(C-C)アルキル又は(C-C)アルキニルである、請求項5に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。 6. The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to claim 5, wherein R 1 is (C 1 -C 6 ) alkyl or (C 2 -C 6 ) alkynyl.  Rが、メチル、又はプロパルギルである、請求項5に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。 The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to claim 5, wherein R 1 is methyl or propargyl.  Yが、ハロゲン、(C-C)アルキル、(C-C)ハロアルキル、又はニトロであり、
、Y及びYが、それぞれ独立に、ハロゲン又は水素原子である、請求項1から請求項3及び請求項5のいずれか一項に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩。
Y 1 is halogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )haloalkyl, or nitro;
The N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of claims 1 to 3 and claim 5, wherein Y 2 , Y 3 and Y 4 each independently represent a halogen or a hydrogen atom.
 請求項1から請求項3及び請求項5から請求項7のいずれか一項に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩を有効成分として含有する農園芸用殺菌剤。 An agricultural and horticultural fungicide containing, as an active ingredient, an N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of claims 1 to 3 and claims 5 to 7.  請求項1から請求項3及び請求項5から請求項7のいずれか一項に記載のN-置換オキシ-2-アミノチアゾールカルボキサミド化合物又はその塩の有効量を、植物体、植物病原菌又は土壌に施用する、有害な植物病害を防除する方法。 A method for controlling harmful plant diseases, comprising applying an effective amount of an N-substituted oxy-2-aminothiazolecarboxamide compound or a salt thereof according to any one of claims 1 to 3 and claims 5 to 7 to a plant body, a plant pathogen, or soil.
PCT/JP2024/041728 2023-12-15 2024-11-26 N-substituted oxy-2-aminothiazolecarboxamide compound or salt thereof and agricultural and horticultural bactericide Pending WO2025126830A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023-212115 2023-12-15
JP2023212115 2023-12-15

Publications (1)

Publication Number Publication Date
WO2025126830A1 true WO2025126830A1 (en) 2025-06-19

Family

ID=96057363

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2024/041728 Pending WO2025126830A1 (en) 2023-12-15 2024-11-26 N-substituted oxy-2-aminothiazolecarboxamide compound or salt thereof and agricultural and horticultural bactericide

Country Status (1)

Country Link
WO (1) WO2025126830A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010504946A (en) * 2006-09-29 2010-02-18 バイエル・クロツプサイエンス・エス・アー Bactericides N-cycloalkyl-carboxamides, thiocarboxamides and N-substituted-carboximidamide derivatives
JP2013541554A (en) * 2010-10-21 2013-11-14 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー N-benzyl heterocyclic carboxamides
JP2020514340A (en) * 2017-03-10 2020-05-21 シンジェンタ パーティシペーションズ アーゲー Microbicide oxadiazole derivative

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010504946A (en) * 2006-09-29 2010-02-18 バイエル・クロツプサイエンス・エス・アー Bactericides N-cycloalkyl-carboxamides, thiocarboxamides and N-substituted-carboximidamide derivatives
JP2013541554A (en) * 2010-10-21 2013-11-14 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー N-benzyl heterocyclic carboxamides
JP2020514340A (en) * 2017-03-10 2020-05-21 シンジェンタ パーティシペーションズ アーゲー Microbicide oxadiazole derivative

Similar Documents

Publication Publication Date Title
CN111094258B (en) Oxadiazole compounds and agricultural and horticultural fungicides
CN105492432A (en) Tetrazolinone compounds and uses thereof
TW201930267A (en) N-methoxyamide compound or salt thereof, and agricultural and horticultural fungicide containing same
WO2019124538A1 (en) N-methoxyamide compound or salt thereof, and agricultural and horticultural fungicide containing same
WO2019031384A1 (en) 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4-(1h,3h)dione compound and agricultural or horticultural bactericide
WO2019065483A1 (en) 1, 3, 5, 6-tetra substituted thieno[2, 3-d]pyrimidine-2, 4(1h, 3h)dione compound and bactericide for agricultural and horticultural use
JP2017197433A (en) Nicotinate compound, agricultural and horticultural bactericide, and method of controlling plant disease
TWI771410B (en) N-(4-pyridyl)nicotinamide compound or salt thereof
WO2013062024A1 (en) Plant disease control agent containing arylamidine derivative or salt thereof
WO2009133923A1 (en) Agricultural/horticultural bactericidal agent comprising 1,2,3-substituted imidazolium salt as active ingredient
JP2017001954A (en) Nitrogen-containing saturated heterocyclic compound
KR101326371B1 (en) Fungicidal composition containing carboxylic acid amide derivative
JP2025068631A (en) Bactericidal composition including thiazole carboxylic acid hydrazide compound
JP2019142776A (en) Pest control agent containing n-(4-pyridyl) benzamide compound or salt thereof as active ingredient
WO2025126830A1 (en) N-substituted oxy-2-aminothiazolecarboxamide compound or salt thereof and agricultural and horticultural bactericide
JP2013018738A (en) Benzoylacrylic acid derivative or salt thereof and agricultural and horticultural bactericide containing those
WO2025057723A1 (en) N–substituted oxyamide compound or salt thereof
TW202540092A (en) N-substituted oxy-2-aminothiazolecarboxamide compound or salt thereof and agricultural and horticultural fungicide
JP2016179944A (en) Difluoromethylene compound
JP2017057151A (en) Amino ethylene compound or salt thereof, microbicide for agricultural and horticultural use comprising the same and method of controlling plant disease by applying the same
JP2023137573A (en) Bactericidal composition including thiazole carboxylic acid hydrazide compound
JP2016056117A (en) Nicotinic acid ester compound, and bactericide for agricultural and horticultural use
WO2020054531A1 (en) Plant disease control agent
JP2016056100A (en) Nicotinic acid ester compound
JP2025101731A (en) Formhydrazone compounds or their salts and agricultural and horticultural nematicides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24903489

Country of ref document: EP

Kind code of ref document: A1